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Abstract 
The mammalian utricle has shown limited capacity for spontaneous regeneration of hair 
cells within a damaged sensory epithelium. In vivo and in vitro exposure of the tissue to 
ototoxic aminoglycosides has been utilised to induce hair cell loss, in order to study 
these regenerative events. The mammalian utricle is believed to regenerate hair cells by 
the direct transdifferentiation of supporting cells without a mitotic event. The cellular 
and molecular mechanisms behind this regenerative capability continue to be the subject 
of inner ear research.   
The integrin family of cell surface receptors are known for their key role in cellular 
adhesion, both to the extracellular matrix and to neighbouring cells. Studies of integrins 
have shown that they are also involved in numerous cellular processes including 
proliferation, differentiation and migration. They are therefore a likely candidate for 
involvement in the cellular events which underlie the regenerative ability demonstrated 
by the mammalian utricle.  
This study has identified a subset of the mammalian integrin subunits as being present 
in the normal adult mouse utricle. The identification of these integrins was achieved by 
both degenerate PCR and qPCR screening of utricular cDNA. Through 
immunohistochemistry, β1 and α6 have been shown to localise at the basement 
membrane of normal utricular tissue. Integrins β3 and β5 appear to be expressed within 
vestibular hair cells. Integrins β1, αV, β5, β3 and α6 are also present within the 
mesenchyme.  
The utricular macula of adult mice was utilised as an in vitro model in order to induce 
hair cell loss by gentamicin treatment and investigate integrin expression in the utricle 
during this process and subsequent regeneration. Relative quantification of qPCR data 
has indicated that a number of integrins including β1, αV and β3 show an increase in 
expression level at 4 days post treatment. Immunohistochemistry shows some changes 
in integrin localisation between 4 and 21 days post-gentamicin.  
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1.1 Integrins 
Integrins are a family of cell-surface glycoproteins which are widely expressed in many 
different cell types. They are heterodimeric proteins, consisting of a non-covalently 
associated alpha subunit and beta subunit. The integrins and their homologs are well 
conserved across a broad range of organisms, both vertebrate and invertebrate; in 
Drosophila, homologs to the vertebrate integrins called position specific antigens exist 
as two ‘alpha’ subunits (PS1 and PS2) and just a single ‘beta’ subunit (PS3) which can 
associate with either of the alphas, resulting in two functional heterodimers 
(Marcantonio et al, 1988). In vertebrate species such as humans and mice, there are 
currently 18 known α subunits and 8 β subunits, however, not every α subunit possesses 
the ability to form a functional association with every β subunit (van der Flier et al, 
2001). At present, 24 different heterodimers are known to exist; some subunits, such as 
integrin αV (Itgav) and integrin β1 (Itgb1) are considered the most ‘prolific’ and are 
able to form numerous heterodimers, whereas most of the other known subunits are 
only present in one or two functional integrin proteins.  
This section of this chapter introduces the integrin family in terms of their structure and 
function. This thesis aims to investigate the presence of integrins in the murine 
vestibular system, a tissue known to be capable of a limited degree of spontaneous 
regeneration in response to damage induced by ototoxic aminoglycosides. The cellular 
mechanisms, signalling pathways and proteins which initiate and regulate this 
regenerative capacity, an ability which is lacking in the mammalian auditory epithelium, 
are the subject of ongoing research. As established from previous studies, the integrin 
family are known to be involved in numerous cellular processes including signalling, 
differentiation and cell adhesion, in addition to having been identified as playing a role 
in tissue repair and regeneration in other organ systems. The work carried out during 
this study is based upon the hypothesis that integrins could be considered, based upon 
this knowledge of their capabilities, as potentially being important molecules in the 
regeneration which occurs in the mouse utricular epithelium.  
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1.1.1 Integrin Structure and Ligand Binding 
Nomenclature 
The integrin family of cell adhesion molecules was so named due to their critical role in 
maintaining the ‘integrity’ of the adhesion  of cells to the extracellular matrix (ECM) 
and the interaction of this ECM with the intracellular cytoskeleton  (Hynes, 2004). 
Although linked by certain conserved DNA sequences in key functional areas, the 
integrins are a diverse protein family; many have previously been known by other 
names as they were first studied and categorised as separate groups of cell surface 
molecules by scientists working independently, before eventually being brought 
together under the integrin family.  
The names, including synonyms and previous names under alternative classification 
systems, of the currently known vertebrate integrin subunits are summarised in table 1-1 
and table 1-2. Many of the integrin subunits have also been named under the ‘cluster of 
differentiation/determinants’ or ‘CD’ classification system.  
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Protein Name Gene Name Synonyms 
 
Integrin α1 ITGA1 VLA1, CD49a 
   
Integrin α2 ITGA2 CD49b 
   
Integrin α2b ITGA2b CD41B, CD41 
   
Integrin α3 ITGA3 CD49c, VLA3a, VCA-2, GAP-B3 
   
Integrin α4 ITGA4 CD49d 
   
Integrin α5 ITGA5 CD49e 
   
Integrin α6 ITGA6 CD49f 
   
Integrin α7 ITGA7  
   
Integrin α8 ITGA8  
   
Integrin α9 ITGA9 RLC, ITGA4L, ALPHA-RLC 
   
Integrin α10 ITGA10  
   
Integrin α11 ITGA11 HsT18964 
   
Integrin αD ITGAD CD11d, αDβ2 
   
Integrin αE ITGAE CD103, HUMINAE 
   
Integrin αL ITGAL LFA-1 
   
Integrin αM ITGAM CD51 
   
Integrin αV ITGAV  
   
Integrin αX ITGAX CD11c 
 
Table 1-1 Nomenclature of Mammalian α Integrins 
This table summarises the 18 known mammalian integrin α subunits in terms of their protein 
name and abbreviated gene name. Many integrin subunits have been previously known by 
alternative names or synonyms, including different family classification systems. VLA = Very 
late activation antigen, CD = Cluster of differentiation/determinants antigen, VCA = Very 
common antigen, GAP = galactoprotein, RLC = regulatory light chain, LFA = lymphocyte 
function-associated antigen.     
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Protein Name Gene Name Synonyms 
 
Integrin β1 ITGB1 CD29, GPIIA 
   
Integrin β2 ITGB2 LFA-1, MAC-1 
   
Integrin β3 ITGB3 CD61, GPIIIa 
   
Integrin β4 ITGB4 CD104 
   
Integrin β5 ITGB5  
   
Integrin β6 ITGB6  
   
Integrin β7 ITGB7  
   
Integrin β8 ITGB8  
 
Table 1-2 Nomenclature of Mammalian Integrin β Subunits  
This table summarises the 8 known mammalian integrin β subunits in terms of their protein 
name and abbreviated gene name. GP = Glycoprotein, CD = Cluster of 
differentiation/determinants antigen, MAC = Macrophage antigen, LFA = lymphocyte function-
associated antigen.     
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Structure and Ligand Binding 
The 24 different combinations of α and β subunits (illustrated in figure 1-1) which 
produce a functional protein heterodimer confer ligand binding specificity to each 
individual integrin. Current work suggests that ligand specificity is highly dependent 
upon which α subunit is present (Mould et al., 2000), and that on this basis, the integrins 
can be divided into four main groups (as shown in figure 1-1), based upon their major 
ligand binding specificity and function; the laminin receptor integrins (those containing 
α3, α6 and α7), the collagen receptor integrins (those with an α1, α2, α10 or α11 
subunit) and the integrins which recognise a particular amino acid sequence known as 
RGD (Arg-Gly-Asp) found in ECM proteins such as fibronectin (Ruoslahti and 
Pierschbacher, 1987) i.e. those possessing an αIIb, α5, α8 or αV subunit. The remaining 
integrins (those which have an αL, αM, αX, αD, αE, α9 or α4 subunit) are those which 
are specifically expressed on cells of the haematopoietic system. Leucocyte-specific 
integrins are frequently involved in cell-cell adhesion, through molecules such as 
ICAMs and proteins found in blood plasma (van der Flier and Sonnenberg, 2001).  
The association of an α and β subunit creates an integrin heterodimer with a globular 
head domain; this is the region which binds ligands i.e. ECM components or cell 
surface molecules. The individual structural regions of a typical integrin heterodimer are 
shown in figure 1-2. Some of the integrin α subunits (α1, α2, α10, α11, αE, αD, αX, αM 
and αL) contain an additional insert within their extracellular head consisting of 200 
amino acids, which is not present in the other α integrins. This insert is known as the ‘I 
domain’(Colombatti et al., 1993), and it has been shown to contain a MIDAS motif 
(metal ion dependent adhesion site) which is able to bind Mg
2+
 ions (Lee et al., 1995). 
The I domain has been determined as having a key role in the ligand binding of those 
integrin heterodimers which include an I domain containing α subunit (Kanazashi et al., 
1997). All of the known mammalian integrin β subunits also contain a similar ‘I-like 
domain’ which features metal ion binding sites (Huang et al., 2000a) and is known to be 
an important part of the extracellular region of the heterodimer in terms of regulation of 
integrin activity (Takagi et al., 2002).  
The intracellular region of an integrin consists of a cytoplasmic tail. In most subunits, 
this region is relatively short (up to 50 AAs long), and it is through this that integrins 
are able to interact with the intracellular actin cytoskeleton via various β integrin 
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cytosplasmic-domain binding proteins (Liu et al., 2000) e.g. actin binding proteins such 
as talin or signalling molecules like FAK (focal adhesion kinase). The integrin β4 
subunit has a cytoplasmic tail which is considerably longer than that of other integrins, 
consisting of around 1000 AA (Tamura et al., 1990) . Integrin β4 is the only integrin 
subunit which interacts with intermediate filaments of the cytoskeleton, as opposed to 
actin filaments, and it is this longer tail region which allows this integrin subunit to 
interact with intermediate filaments at hemidesmosomes (Spinardi et al., 1993) as part 
of the α6β4 heterodimer.  
 
 
 
 
 
 
Figure 1-1 Mammalian Integrin Heterodimers and their Ligand Binding Properties  
Adapted from (Barczyk et al., 2010) The 24 known integrin heterodimers organised 
according to their ligand binding specificity. The integrin subunits which have previously 
been found in the mammalian inner ear are highlighted with references to these earlier 
studies. 
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Figure 1-2 Integrin Structure  
Adapted from (Barczyk et al., 2010). Schematic diagram of an integrin heterodimer showing 
the different domains within each of the subunits. The alpha subunit has a β-propeller at the 
top of the ‘thigh’ and ‘calf’ domains – together with the β subunit  hybrid (H) domain, PSI 
domain and four EGF repeats, these features of integrin structure make up the extracellular 
head region which binds ligands. The αI domain present in some, but not all, alpha subunits, 
is inserted between two of the blades of the β-propeller. Both the α and β subunits also have 
a short cytoplasmic tail region which intracts with intracellular integrin-binding proteins. 
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1.1.2 Integrin Activation: ‘Inside-Out’ Signalling 
The ability of a given integrin heterodimer to bind with a known ligand is dependent on 
several factors, including whether the integrin is active and its current affinity state for 
that particular ligand. Integrins can be both activated and deactivated according to the 
adhesive requirements of a cell at a particular time. The most well-known example of 
integrin activation is of integrin αIIbβ3 on blood platelets (Kieffer and Phillips, 
1990).This integrin is critical for the process of forming blood clots following vascular 
injury; deficiency in either integrin αIIb or β3 in humans due to genetic mutation results 
in a bleeding disorder called Glanzmann thrombasthenia (Hodivala-Dilke et al., 1999) .  
Under normal conditions, αIIbβ3 is present at the cell surface in an inactivated form and 
it is therefore unable to bind its usual soluble ligands in this state. This inactive state 
prevents platelet aggregation and the potential for thrombosis which would occur if this 
integrin were to be constitutively active. Only when blood platelets are stimulated i.e. in 
response to wounding, is integrin αIIbβ3 activated and then able to bind ligands such as 
fibrinogen in order for platelets to aggregate and form a clot at the site of the injury 
(Phillips et al., 1991). Activation of integrins is believed to be achieved through a 
conformational change which takes place in the extracellular region of the protein. This 
shape change results in the exposition of integrin ligand binding sites (O'Toole et al., 
1994). This activation is triggered intracellularly (as shown in figure 1-3); a process 
widely described as ‘inside-out’ integrin signalling.  
The affinity of an integrin for its ligand binding partners also represents a key way in 
which integrin adhesion and signalling may be regulated. Signals via other cell surface 
receptors are able to alter the affinity state of integrins for their respective ligands 
through the induction of a conformational change in the extracellular domain of the 
heterodimer. This so called ‘inside-out signalling’ is the primary method via which 
integrins are activated. Inside-out signalling of integrins represents a vital method of 
regulating integrin activity, preventing pathologies which could arise from unwanted 
binding of integrins to their ligands.  
The extracellular shape change exhibited by integrins on activation, has been 
determined as being induced by an initial alteration in the intracellular region of the 
integrin heterodimer. In the integrin receptor low-affinity state, the cytoplasmic tails of 
the α and β subunits are ‘clasped’ together (Vinogradova et al., 2002). Disruption of this 
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association, leads to ‘unclasping’ of the cytoplasmic tails which then become embedded 
in the plasma membrane (Kim et al., 2003; Vinogradova et al., 2004), and it is this 
intracellular event which is believed to be the trigger for the change in conformation 
exhibited by the extracellular head region.  
The extracellular head of an integrin has been shown to exist in one of three possible 
conformational states (Takagi et al., 2002) which are shown in figure 1-3. The low-
affinity state for inactive integrins on the cell surface is a bent state, where the globular 
head is in close proximity to the cell membrane (Xiong et al., 2002), a position which is 
not conducive to ligand binding. Inside-out and outside-in integrin signalling pathways 
are able to trigger a conformational change, resulting in both the extension of the head-
piece and also an ‘opening’ of the globular head domain to reveal ligand binding and 
recognition sites (Takagi et al., 2002). This structural rearrangement from a low to a 
high-affinity state is referred to as the ‘switchblade model’ of integrin activation (Xiong 
et al., 2003). 
The key intracellular integrin-binding protein which is involved in triggering these 
conformational changes is talin. In its active form, talin is able to bind the cytoplasmic 
tail of β integrins through its F3 domain (as shown in figure 1-3), and acts as the final 
molecule of intracellular signalling cascades which are responsible for the activation of 
integrins (Wegener et al., 2007).  More recently, additional integrin binding proteins 
known as kindlins have also been shown to be able to interact with integrin cytoplasmic 
tails in a similar manner to talin (Ma et al., 2008). Kindlins promote the effects of talin 
binding in the integrin activation process; the presence of talin alone is not sufficient to 
alter the extracellular conformation to that of the high affinity state (Moser et al., 2008). 
The changes observed in integrin affinity-state have been shown to be reversible; 
conformational changes in the extracellular structure of integrins therefore represent a 
key method for the regulation of their activity and ligand binding properties.   
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1.1.3 Integrin Signalling: ‘Outside-In’ 
The integrin family of cell surface receptors are capable of bi-directional signalling, 
forming a link between the extracellular and intracellular environment of a cell. In 
addition to inside-out activation of integrins, these proteins are also involved in many 
intracellular signalling pathways which are stimulated through extracellular binding of 
integrin ligands; referred to as ‘outside-in’ signalling. 
 
 
 
 
Figure 1-3 Integrin Conformational States: Inside-Out Activation 
Adapted from (Al-Jamal and Harrison, 2008; Wang, 2012).  When an integrin heterodimer 
is in its ‘inactive’ state, the extracellular head region is in a closed, ‘bent’ conformation; the 
integrin in this state has a low affinity for its ligand binding partners (Xiong et al., 2002). 
On delivery of an intracellular activation signal, the protein talin is able to bind to the 
cytoplasmic tail region of the integrin β subunit (Wegener et al., 2007).  Talin binding 
causes the integrin α and β tails to move further apart at the membrane and results in a 
conformation change in the integrin extracellular head. Activation of an integrin results in a 
‘switchblade’ like extension of the head region which also opens and exposes ligand binding 
sites (Xiong et al., 2003). In this conformational state, the integrin is said to be ‘act ve’ and 
has a high affinity for its ligand binding partners. 
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Outside-in signalling, whereby integrin ligand binding brings about changes in the 
intracellular environment of a cell, is involved in the remodelling of the cytoskeleton 
and formation of intracellular protein complexes. Integrins play a role in numerous 
cellular processes through this method of signal transduction; they are able to influence 
the cell cycle, modify cell morphology and alter the location of a cell through migration. 
For the purpose of this thesis, the intracellular responses induced by ligand binding are 
described in terms of the formation of cellular adhesion structures and cell shape 
changes, since these are of particular interest with regards to the potential role of 
integrins in the vestibular epithelium.  
1.1.4 Integrins and Cell Adhesion 
The integrin family of proteins is best known as being a group of cell adhesion 
molecules. Spanning the plasma membrane, integrins constitute a direct linkage 
between the extracellular environment e.g. the ECM or adjacent cells within a tissue, 
and the intracellular cytoskeleton, in particular actin filaments. The binding of integrins 
to ligands which are ECM components, such as collagens and laminins, triggers the 
formation of specialised adhesive structures known as focal adhesions.  
Focal Adhesions 
Focal adhesions are complex structures which provide a linkage between the 
extracellular matrix and the intracellular actin cytoskeleton, mediated by members of 
the integrin receptor family. In addition to acting as anchoring junctions, adhering cells 
to the ECM, focal adhesions are also linked to integrin-mediated ‘outside-in’ signalling 
pathways. The assembly of focal adhesions is shown in figure 1-4. 
 
At focal adhesions, integrin heterodimers which are bound to ECM ligands cluster at the 
plasma membrane (Cluzel et al., 2005). As described in 1.2, the cytoplasmic tail regions 
of integrins are able to associate with numerous intracellular integrin binding proteins 
such as talin (which may act as an inside-out activator of integrins); particular integrin α 
subunit tail regions associate with another integrin-binding protein, paxillin (Liu et al., 
1999). The linkage of the actin cytoskeleton to integrins may be directly mediated by 
some integrin-binding proteins which are also able to associate with actin filaments e.g. 
tensin (Lo et al., 1994; Miyamoto et al., 1995a).  
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Focal adhesion kinase (FAK) is another key constituent of focal adhesions – it is a 
tyrosine kinase which is recruited to the focal adhesion by associating with talin, and is 
thought to be activated via integrins (Chen et al., 1995). Clustering and activation of  
FAK triggers the recruitment of other downstream signalling molecules (Hanks and 
Polte, 1997)such as Src (Fincham et al., 2000), vinculin and α-actinin. This 
phosphorylation cascade leads to the activation of multiple signalling pathways i.e. 
ERK and JNK (Miyamoto et al., 1995b), in addition to interaction with the actin 
cytoskeleton. It is this integrin-dependent signalling cascade (illustrated in figure 1-5) 
which results in cytoskeletal remodelling and translocation of signalling molecules to 
the nucleus to effect further downstream changes within a cell – focal adhesion are thus 
able to act as an anchorage junction between a cell and the extracellular matrix, but are 
also important for in integrin-mediated ‘outside-in’ signalling pathways. Focal 
adhesions are highly dynamic structures, with as many as 50 proteins known to 
associate with the intracellular protein complex; they undergo constant changes of the 
downstream protein constituents. The dynamic nature of these adhesions is particularly 
important for cell migration, where new adhesive contacts are formed at the leading 
edge of the migrating cell, whilst the old anchorages dissociate, in addition to re-
modelling of the actin cytoskeleton.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-4 Assembly of Focal Adhesions  
Adapted from (Mitra et al., 2005).  This figure summarises some of the key constituents of 
focal adhesion complexes. (A) Binding of integrins to extracellular matrix ligands leads to 
clustering of integrin heterodimers. (B) Integrin binding proteins such as paxillin and talin  
(Chen et al., 1995) are able to associate with integrin cytoplasmic tails; these proteins are 
able to recruit focal adhesion kinase (FAK) (Hildebrand et al., 1995) . (C) FAK is a tyrosine 
kinase and its recruitment to focal adhesions initiates a phosphorylation cascade which in 
turn recruits further downstream proteins such as Src, vinculin and α-actinin. (D) Proteins 
such as α-actinin are able to bind actin filaments, thus forming a linkage between the ECM 
and the intracellular cytoskeleton via integrin receptors.   
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Hemidesmosomes 
The α6β4 integrin heterodimer is unique amongst the integrin receptors, since it 
interacts with intermediate filaments, as opposed to the actin cytoskeleton. This integrin 
is a key component of hemidesmosomes, specialised adhesive complexes (shown in 
figure 1-5), which are found in epithelial tissues such as the skin epidermis (Stepp et al., 
1990). The integrin β4 subunit, which binds extracellularly to laminin-5, is crucial for 
the initiation of hemidesmosome formation (Schaapveld et al., 1998), with plectin, 
BP230 and BP180 accessory proteins forming the link between the integrin heterodimer 
and intermediate filaments (Koster et al., 2003); the structure of hemidesmosomes is 
illustrated in figure 1-5. The skin blistering disorder junctional epidermolysis bullosa, 
which causes separation of the dermal and epidermal layers of the skin, has been linked 
to mutation and deficiency in the integrin β4 (Jonkman et al., 2002; Niessen et al., 1996) 
and α6 (Pulkkinen et al., 1997) subunits in humans, emphasising the importance of 
integrin α6β4 in hemidesmosome structure and function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-5 Structure of Hemidesmosomes in the Skin Epidermis 
From (Zahreddine et al., 2010). Hemidesmosomes are specialised adhesive complexes 
which are critical for maintaining the integrity of skin epidermis. Hemidesmosomes link 
laminin-5-containing extracellular matrix with intracellular intermediate filaments. Integrin 
α6β4 is the key transmembrane protein which binds laminin-5 extracellularly, and through 
recruitment of the accessory proteins plectin, BP180 and BP230, forms an intracellular 
linkage with the intermediate filaments of the cell cytoskeleton.  
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Integrin Adhesion: Proliferation and Cell Death 
Binding of the extracellular matrix by integrins has the ability to influence numerous 
cellular events by way of the downstream signalling pathways integrins are linked to i.e. 
proliferation, cell death, migration and phagocytosis. Proliferation of cells is a process 
which must be tightly regulated; many tumours result as a consequence of proliferation 
control defects. One way in which this event may be regulated is through cellular 
adhesion to the extracellular matrix. Ligand binding by numerous integrins has been 
described as activating a number of proliferative signalling pathways. They are known 
to act cooperatively with receptor tyrosine kinases (RTKs) to control signalling 
pathways that regulate G1 cell cycle phase cyclin-dependent kinases (CDKs) – loss of 
cell adhesion is known to halt the cell cycle at the G1 phase (Schwartz and Assoian, 
2001). Integrins are also believed to trigger activation of the PI-3K and MAPK cascades 
(Montcouquiol and Corwin, 2001). In addition to being involved in proliferation, 
integrins are also now thought to play a role in cell death, a process known as integrin-
mediated death (IMD). This process occurs as a result of un-ligated integrins being able 
to recruit and activate caspase-8 to induce apoptotic cell death (Stupack et al., 2001).   
1.1.5 Integrins in Repair, Regeneration and Wound Healing 
Due to their involvement in numerous cellular events such as proliferation, migration 
and adhesion, integrins have been shown to be important in numerous organ systems for 
the repair and regeneration of damaged tissue.  
Wound healing of lesions in the skin has been shown to involve several different 
integrin heterodimers in the process of wound closure. After initial blood clot formation 
and deposition of a provisional matrix rich in the protein fibronectin within the wound 
site (Clark, 1990), skin lesions undergo reepithelialisation, whereby keratinocytes 
migrate into the wound space. In order achieve this, basal keratinocytes at the periphery 
of the wound must dissolve their linkages with the adhesive structures which anchor 
them to the basal lamina e.g. hemidesmosomes (Litjens et al., 2006; Mercurio et al., 
2001). The mechanisms involved in this disassembly are not fully understood, but are 
thought to involve phosphorylation of integrin β4, the integrin β subunit constituent of 
hemidesmosomes (Germain et al., 2009; Kashyap et al., 2011). Several integrins are 
known to be expressed in normal skin tissue by keratinocytes, including α2β1, α3β1 and 
αVβ5 (Marchisio et al., 1991; Peltonen et al., 1989), in addition to the hemidesmosomal 
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integrin α6β4 as described in 1.1.2. The cellular mechanisms which underlie the 
migration of cells in the wounded region are complex and not fully understood, 
however studies have shown that integrin β1 is particularly crucial for proper migration 
of both keratinocytes and fibroblasts (Grose et al., 2002; Liu et al., 2010). Fibroblast 
migration into the wound site is important for wound contractility, a process which 
brings the wound edges closer together, facilitating the reepithelialisation process 
(Grinnell, 1994). 
Previous studies have shown that keratinocytes which lack the integrin β1 subunit show 
reduced migratory capability, believed to be the result of their inability to bind dermal 
matrix ligands deposited in the wound site. The function of integrin β1 in this process is 
believed to be dependent upon the TGF-β signalling pathway; TGF-β1 has been shown 
to be involved in the regulation of the reepithelialisation stage of cutaneous wound 
healing (Singer and Clark, 1999).The phenotype of mice with a fibroblast-specific 
deletion of  integrin β1 – these mice showed delayed reepithelialisation of skin wounds, 
was found to be rescued by the addition of exogenous active TGFβ1 (Liu et al., 2010). 
Epithelial integrins of the skin have also been shown to alter their expression and 
localisation during cutaneous wound healing.  Integrins α2, α3, α6 and β1 are localised 
to the basal layer of the skin in normal tissue, however, following injury, these integrins 
become detectable in the suprabasal layers of the epidermis during wound healing 
(Cavani et al., 1993; Hertle et al., 1992). It is this alteration in both the type of integrins 
expressed on basal keratinocytes and of their cellular localisation, which allows these 
cells to become migratory and to utilise fibronectin within the temporarily deposited 
wound site matrix to ‘crawl’ and reepithelialise the lesion (Cavani et al., 1993; Martin, 
1997).  
The epithelia of the cornea express a similar cohort of integrins as shown by the 
epithelial layers of the skin (Stepp et al., 1993) i.e. α2, α3 and β1. Wounding of the 
corneal epithelium is repaired in a similar way to that observed in skin lesions, and 
integrins such as α5β1 (Murakami et al., 1992) and α9 (Stepp and Zhu, 1997) have been 
shown to have increased expression in migrating  corneal epithelial cells as they move 
into the lesion.  
These findings support the idea that members of the integrin family are involved in this 
type of tissue repair involving proliferation and migration of cells into a lesion in 
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several epithelial tissues. Based upon this knowledge of the behaviour and capabilities 
of integrins in the regeneration of other epithelia, the work carried out in this thesis set 
out to investigate the expression of members of the integrin family within the vestibular 
epithelium of the mouse inner ear. 
1.2 The Mammalian Inner Ear 
Responsible for the detection of sound and movement, the specialised auditory and 
vestibular systems within the mammalian ear are capable of transmitting the 
information received through sound and motion stimuli as electrical impulses to the 
centres of the brain dedicated to the processing of such signals. This chapter will 
introduce and summarise the structure and function of the mammalian organ of Corti – 
the auditory epithelium, and will subsequently focus upon the vestibular sensory 
epithelium, principally the mammalian utricle and its capacity for hair cell regeneration, 
as the model tissue studied throughout this project. 
Both the auditory and vestibular structures of the ear utilise mechanosensory hair cells 
within a specialised sensory epithelium. Hair cells are present within the organ of Corti, 
the utricle and saccule (the two otolith organs of the vestibular system) and the cristae 
ampullaris located with the semi-circular canals of the labyrinth. 
1.2.1 The Mammalian Auditory System 
The mammalian auditory system is divided into three distinct regions; the outer ear, 
middle ear and inner ear. The outer ear consists of the ear canal and the external pinna 
or auricle which directs sound stimuli into the ear canal. Many mammalian species are 
able to manipulate the position of their pinnae, moving them independently of one 
another e.g. horses, cats and mice among others, in order to locate the source of the 
auditory stimulus. On reaching the ear drum, also known as the tympanic membrane, 
sound waves enter the structures of the middle ear. Oscillation of the tympanic 
membrane triggered by sound waves is conducted through the three tiny ear bones, the 
malleus, incus and stapes, to the fluid which fills the cochlea via the oval window. The 
inner ear constitutes both the auditory and vestibular organs. The organ of Corti, the 
specialised auditory epithelium, is found within the cochlea, a coiled, fluid-filled bony 
tube, which is divided by membranes into three separate compartments. 
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The organ of Corti is supported by the basilar membrane which lies beneath it; the 
organ of Corti is located within the central compartment of the cochlear duct – the scala 
media, which is situated between the scala vestibuli and the scala tympani as shown in 
figure 1-6. There are two types of mechanosensory hair cells within the auditory 
epithelium, known as inner and outer hair cells. They exist in the organ of Corti as a 
single row of inner hair cells and three rows of outer hair cells (as illustrated in figure 1-
7), surrounded by several types of supporting cells; such as the inner and outer pillar 
cells and Deiters’ cells (Lim, 1986). It is these supporting cells which are in direct 
contact at their basal surface with the basilar membrane. Both inner and outer hair cells 
possess structures known as stereocilia on their apical surfaces. Stereocilia are 
constructed of parallel arrays of actin filaments (Flock and Cheung, 1977; Tilney et al., 
1980), which are cross-linked to provide structural integrity by actin-bundling proteins 
such as fimbrin (Tilney et al., 1989) and espin (Sekerkova et al., 2011). Stereocilia are 
anchored at the hair cell apical surface within an actin-dense region known as the 
cuticular plate. In the organ of Corti, stereocilia are arranged in ordered rows on the 
apices of hair cells, forming a staircase-like arrangement whereby the rows of 
stereocilia are of increasing height; adjacent rows are connected by structures known as 
tip-links (Pickles et al., 1984).  Outer hair cell stereocilia rows are highly organised into 
a ‘V’ or ‘W’ shape on the apical surface, whilst inner hair cell stereocilia form rows 
which are straighter and appear less organised, exhibiting a gently curved, open ‘V’ or 
‘W’-shaped arrangement. (Hackney and Furness, 1995). Detection of auditory stimuli is 
conducted by inner hair cells; the function of outer hair cells lies with sound 
amplification (Ashmore, 1987) . 
The tectorial membrane, a structure which is made up of several types of collagen and 
other extracellular matrix proteins (Richardson et al., 1987) lies above the auditory 
epithelium and this plays a crucial role in the mechanosensory function of the organ of 
Corti; the tallest stereocilia of outer hair cells are embedded in the tectorial membrane at 
their tips (Kimura, 1966; Lim, 1972). When acoustic stimulation occurs, the 
propagation of sound waves by fluid motion through to the inner ear, causes oscillation 
of the basilar membrane upon which the organ of Corti sits. This oscillatory movement 
at the basilar membrane results in a shearing motion of the apical hair bundles against 
the tectorial membrane, and causes deflection of the stereocilia towards the tallest row 
in the staircase. Deflection of hair bundles results in the opening of mechanosensitive 
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ion transduction channels, allowing an influx of cations – primarily K+ ions of the 
endolymphatic fluid which bathes the hair cell apices. This influx is driven by the 
endocochlear potential of the endolymph – which has a high positive charge of around -
80 to 100mV in comparison to the potential of the perilymph. The high concentration of  
K
+
 ions within the endolymphatic fluid is actively maintained by the stria vascularis 
(Tasaki and Spyropoulos, 1959) through the presence of tight junctions and the K+ ion 
channel Kir4.1 (Marcus et al., 2002; Takeuchi et al., 2000). The cation influx driven by 
this ion concentration gradient results in a depolarisation of the hair cell membrane, 
which in turn, triggers the opening of baso-lateral voltage dependent Ca
2+
 channels. The 
opening of these channels leads to an influx of calcium into the hair cell, and results 
ultimately in the release of glutamate, a neurotransmitter at the base of the hair cell 
which is in contact with afferent auditory neurons. Action potentials are relayed via 
these nerve fibres to the auditory cortex of the brain for processing of the stimulus. The 
mechanotransductive capabilities of auditory hair cells are reviewed in depth by 
(Hudspeth, 2001)  
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Figure 1-6 Location of the Organ of Corti within the Cochlea  
The mammalian auditory epithelium, the organ of Corti, is found within the coiled cochlea 
of the inner ear. The cochlear duct is divided by membranes into three compartments (bold 
typeface); the scala vestibuli, the scala media and the scala tympani. The organ of Corti is 
situated on top of the basilar membrane within the scala media.  
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Figure 1-7 Structure of the Organ of Corti  
The organ of Corti lies on top of the basilar membrane and consists of one row of inner hair cells and three rows of outer hair cells. Both types of hair cell, 
which have a mechanosensory function, have hair-like projections on their apical surface called stereocilia. Hair cells are surrounded by several different 
types of supporting cell e.g. Dieters’ cells, which provide structural support, as well as having a key homeostatic function to maintain the optimum 
physiological environment for hair cells. Overlying the auditory hair cells is the tectorial membrane which is involved in the creation of mechanical 
shearing and deflection of stereocilia. The coloured regions highlight areas of the auditory epithelium where integrin proteins might be expected to be 
present e.g. blood capillaries (red), the basement membrane of the basilar membrane (green) and the interface with the base of supporting cells (yellow). 
Integrin αV was localised to supporting cell regions in contact with the basement membrane of the basilar membrane in the chinchilla cochlea (Tsuprun 
and Santi, 1999). 
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The mechanosensory hair cells of the mammalian inner ear are susceptible to damage, 
which may be induced by numerous factors including ototoxic drugs i.e. 
aminoglycoside antibiotics, in addition to ageing and noise exposure, resulting in both 
hearing and balance impairments. There are also numerous genetic mutations of 
proteins which are critical for the development and function of the inner ear which are 
the cause of many congenital hearing disorders e.g. mutations of multiple genes 
including cadherin 23 (Bolz et al., 2001) and myosin Viia (Weil et al., 1995) are known 
to underlie the deaf-blind disorder known as Usher’s syndrome. Unlike the auditory 
systems of birds and amphibians, the mammalian auditory epithelium is unable to 
regenerate lost hair cells and therefore humans and other mammalian species, are 
subject to permanent hearing loss. The mammalian vestibular epithelium has been 
shown to be capable of a limited degree of spontaneous hair cell regeneration, raising 
the question of what are the differences between auditory and vestibular hair cells and 
the epithelia within which they exists which allows vestibular hair cells to regenerate 
where auditory hair cells cannot.  
1.2.2 The Mammalian Vestibular System 
The mammalian vestibular system (illustrated in figure 1-8) consists of two main 
anatomical features; a system of semi-circular canals and several otolith organs. There 
are three semi-circular canals, the anterior, posterior and horizontal canals, each filled 
with endolymphatic fluid – they are involved in the detection of rotational movement. 
Each canal has a crista ampullaris at its base; cristae are covered in sensory hair cells, 
over which lies a structure known as the cupula. Sensory function is achieved as the 
movement of endolymph fluid within the semi-circular canal pushes on the cupula, 
which acts in a similar manner to the tectorial membrane in the organ of Corti, 
generating a mechanical shearing motion which results in the deflection of hair bundles 
of the cristae (Dohlman, 1969; Dohlman, 1981; Takumida, 2001). 
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Figure 1-8 Anatomy of the Mammalian Vestibular System 
Adapted from (Retzius, 1887). The mammalian vestibular system consists of three semi-
circular canals, the region of the vestibular system which detects rotational movement. At 
the base of each canal is an ampulla, containing a hair cell covered crista. The otolith 
organs, the utricle and saccule, both feature a sensory epithelium made up of vestibular hair 
cells and supporting cells, with the utricle being the larger of the two organs. The utricular 
and saccular maculae are responsible for the detection of linear acceleration and head tilts.  
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Collectively known as the otolith organs, the utricle and saccule are fluid-filled sacs, 
each with a specialised sensory macula. Overlying the sensory epithelia of these balance 
organs is the otolithic membrane, on the surface of which sit the otoconia – calcium 
carbonate crystals (Kachar et al., 1990). The otolith organs are both involved in the 
detection of linear acceleration and head tilts; the weight of the otoconia means that 
their movement due to gravitational effects creates mechanical shearing between the 
otolithic membrane and the macula beneath, resulting in deflection of vestibular hair 
bundles.    
The model tissue for the work carried out in this thesis was the adult mouse utricular 
macula. The utricular sensory epithelium is made up of two types of vestibular hair cells 
known as type I and type II hair cells (shown in figure 1-9). Type I vestibular hair cells 
are ‘bottle-shaped,’ and their cell body is completely surrounded by an afferent cup-like 
neural calyx. Type II hair cells have a more typically epithelial columnar shape and are 
innervated by bouton synapses at the base of the cell (Wersall, 1956). Surrounding the 
vestibular hair cells within the sensory epithelium are supporting cells; these cells are in 
contact with the basement membrane at their base and extend all the way to the apex of 
the epithelium. The apical surfaces of supporting cells are covered in microvilli.  
Vestibular hair cell stereocilia are arranged on the apical surface in rows of ascending 
height as also seen in auditory hair cells, but they are not organised in a ‘W’ or ‘V’ 
shape, instead appearing as a bundle which covers much of the apical surface of the cell. 
Vestibular hair bundles also have a kinocilium adjacent to the tallest row of stereocilia. 
The kinocilium, a special type of primary cilium, exhibits a typical ‘9+2’ arrangement 
of microtubules within its cytoskeletal core (Erkman et al., 1996). Type I hair bundles 
are typically taller than their counterparts on type II hair cells; there is also variation 
between bundles arrangement -  there are two formations, one ‘tight,’ the other ‘loose’ 
(Bagger-Sjoback and Takumida, 1988; Lapeyre et al., 1992). The utricular epithelial 
surface features a crescent-shaped region known as the striola. The striola represents the 
polarity of the vestibular hair bundles; in the utricle, stereocilia are oriented by way of 
their kinocilia (Denman-Johnson and Forge, 1999) facing towards the striola (shown in 
figure 1-10). This means that there is a change in the polarity of utricular hair cells 
dependent upon their location with respect to the striola – this enables the utricle to 
detect linear accelerations in different directions since some hair cells will be 
depolarised and others hyperpolarised according to the type of movement experienced.  
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Figure 1-9 Two Types of Hair Cell within the Utricular Sensory Epithelium  
Adapted from (Beckingham et al., 2005). There are two distinct types of vestibular hair cells 
within the utricular sensory epithelium. Type I hair cells (labelled ‘I’) are ‘flask’ shaped; 
their cell body is completely surrounded by an afferent neural calyx. In contrast, type II hair 
cells (labelled ‘II’) are a more typical columnar shape. The afferent synapses for type II hair 
cells are bouton synapses at the base of the cell body (Wersall, 1956). This figure indicates 
regions of the vestibular hair cells where integrin α8 was detected (green) in the late 
embryonic/early postnatal mouse (Littlewood Evans and Muller, 2000). The regions in red 
highlight areas of the vestibular epithelium where integrins would be hypothesised to 
localise e.g. the interface between the supporting cells and the basement membrane, in 
addition to that between the basement membrane and the mesenchymal tissue beneath the 
epithelium. EFF = efferent neuron, AFF = Afferent neuron. 
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1.2.3 Integrins and the Inner Ear 
A search of previously published literature reveals that relatively little is known about 
integrin expression in the inner ear, particularly with regards to the vestibular sensory 
epithelium. Much of the work carried out on integrins within the inner ear is related to 
changes in expression during mouse inner ear development at embryonic and very early 
postnatal stages, and does not examine integrin expression in the mature adult tissue. 
Changes in integrin expression during development are thought to be mediated by 
changes in cell-cell and cell-ECM adhesions. Previous work has investigated the 
Figure 1-10 Hair Cell Polarity and the Striola of Vestibular Otolith Organs 
Adapted from (Fitzpatrick and Day, 2004). The striola of the utricle divides the macula into 
two regions of opposing hair bundle polarity. In the utricle, stereocilia are oriented with 
their kinocilia (adjacent to the tallest row of stereocilia) facing towards the striola (Denman-
Johnson and Forge, 1999). In the other otolith organ, the saccule, hair bundles are instead 
oriented so that their kinocilia face away from the striola. This figure also illustrates how 
accelerative motion in one direct results in the movement of the otoconia in the opposite 
direction, leading to the deflection of the stereocilia towards the kinocilium. 
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alteration in expression of several integrin subunits, namely α6, α3 and β4 (Davies and 
Holley, 2002). Both α3 and α6 are expressed in the epithelial layers of the developing 
otocysts in E10.5 mouse tissue. The expression of α6 was shown to be concentrated in 
an atrioventral region of this epithelial layer, in addition to being expressed in cells 
which go on to form the cochlear ganglion. By E12.5, the expression pattern of both of 
these α integrin subunits is altered, with α6 becoming more restricted in distribution to 
pro-sensory regions of the epithelia and neural processes originating from the cochlear-
vestibular ganglion. Integrin α3 is at this stage expressed in regions of the epithelium 
adjacent to those which are pro-sensory and expressing α6. This expression pattern is 
then maintained from this stage onwards until birth, whereupon a second spatio-
temporal alteration in integrin expression occurs. Between birth and P6, α3 expression 
is up-regulated, whilst α6 expression is down-regulated in both the auditory and 
vestibular sensory epithelia. Immunolocalisation of β4, which did not show the same 
expression pattern changes as α6, being expressed in epithelial-mesenchymal borders 
throughout murine development, determined that the integrin heterodimer present must 
be α6β1. In the utricle at P0, β4 was expressed in cells underneath the sensory 
epithelium at the basement membrane-epithelium border, whereas α6 was also present 
in the supporting and hair cell layer (Davies et al., 2007). Integrins αV and β1 have been 
detected in the chinchilla cochlea at regions of supporting cell contact with the 
basement membrane (Tsuprun and Santi, 1999).  
Four integrin subunits, α6, αV, β1 and β3, have been detected by a previous study in 
OC2 cells (Brunetta et al., 2012), a cell line derived from immortalised inner ear cells 
from the E13 mouse (Rivolta et al., 1998). In this study, integrin β3 was shown to 
increase in expression level after OC2 cells were induced to differentiate (when they 
begin to express several hair cell marker proteins) by increasing the incubation 
temperature at which they were maintained in vitro. Over-expression of integrin β3 in 
these OC2 cells in their undifferentiated state was able to induce expression of myosin 
Viia. This result suggests that integrin β3 was able to induce OC2 cells to differentiate 
and potentially implicates a role for integrins in the cellular cues which underlie the 
signals required to induce a hair cell progenitor to proceed along a differentiation 
pathway towards becoming a hair cell. This previous work therefore suggests that there 
may be several different integrins present in auditory hair cells, and that integrins might 
be involved in the differentiation of hair cells during development.  
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One particular integrin heterodimer, namely α8β1, has been implicated as the cause of 
balance defects in a knock-out mouse model (Littlewood Evans and Muller, 2000). 
Mice which lack integrin α8 usually die shortly after birth due to kidney defects (Muller 
et al., 1997), but of those which survive, balance defect phenotypes have been observed. 
Electron microscopy of tissue from α8 knock-out mice with balance problems showed 
evidence of vestibular hair cells with cytoplasmic herniations and stereocilia 
abnormalities. Some normal stereocilia were also present, but often the kinocillium was 
observed to be fused with the surrounding stereocilia. In this previous study α8β1, FAK 
(focal adhesion kinase) and fibronectin have been shown to co-localise at the apical 
surface of hair cells in the utricular sensory epithelium of normal mice. Since a lack of 
integrin α8 results in stereocilia defects, it has been suggested that α8β1 may be 
responsible for organisation of the actin cytoskeleton at the hair cell apical surface, in 
conjunction with ECM components, such as fibronectin, thereby playing a role in the 
initiation of hair bundle formation (Littlewood Evans and Muller, 2000). This previous 
work also used in situ hybridization to look at the localisation of integrin α8 mRNA and 
several other subunits within the mouse utricle. Integrin α8 mRNA was observed to be 
localised at the apical surface of hair cells (immunohistochemistry was used to localise 
integrin α8 protein and showed similar apical localisation); mRNA for αV, α2 and β1 
was distributed throughout the hair cell body.  Immunohistochemistry was not carried 
out in this previous work however, to determine whether the mRNA distribution 
observed correlates with a similar pattern of integrin protein expression. This thesis 
aims to investigate the expression of integrins, including those such as α8 which have 
been previously found in the mammalian utricle, in order to determine the full cohort of 
integrin subunits expressed in the mature murine vestibular epithelium. 
1.2.4 Regeneration & Repair in the Mammalian Utricle 
Non-mammalian vertebrate species, such as birds, amphibians, reptiles and fish are 
capable of fully regenerating sensory hair cells which have been lost due to noise 
damage or exposure to ototoxic drugs. The sensory epithelia of the inner ear and the 
lateral lines of fish (Corwin, 1981)and amphibians (Corwin, 1985) are continuously 
renewed throughout the lifetime of the organism. In avian species, the auditory 
epithelium, populated with two different types of hair cell surrounded by supporting 
cells, is known as the basilar papilla. The mature avian auditory epithelium is capable of 
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regenerating hair cells, but only as a response to hair cell loss induced by acoustic 
trauma or exposure to ototoxic agents (Corwin and Cotanche, 1988; Oesterle et al., 
1993; Ryals and Rubel, 1988). In the avian vestibular system, the utricular macula has 
been shown to be capable of continuous turnover of hair cells (Jorgensen and 
Mathiesen, 1988; Roberson et al., 1992), in addition to its ability to regenerate 
vestibular hair cells where hair cell loss has been induced by noise damage or 
aminoglycoside ototoxicity (Weisleder and Rubel, 1993). Regeneration in the avian 
inner ear has been demonstrated to occur in two different ways. New hair cells may be 
produced through proliferation and mitotic division of the supporting cells and the 
differentiation of their progeny into sensory hair cells (Stone and Rubel, 2000; Warchol 
and Corwin, 1996). Alternatively, hair cells may be replaced via a direct phenotypic 
conversion, known as transdifferentiation i.e. a supporting cell re-differentiates as a hair 
cell without undergoing cell division (Adler and Raphael, 1996; Roberson et al., 1996). 
In contrast to the regenerative abilities demonstrated by the sensory epithelia of other 
vertebrates, the mature organ of Corti is unable to repair or replace dead or damaged 
hair cells. Within the mammalian vestibular system, however, the adult utricle has 
demonstrated that it is capable of a limited degree of hair cell regeneration in response 
to damage induced by exposure to ototoxic drugs. Studies of the mammalian vestibular 
epithelium and its regenerative capacity have been carried out in several species 
including chinchilla (Lopez et al., 1997), guinea pig (Forge et al., 1993), mouse 
(Kawamoto et al., 2009) and humans (Warchol et al., 1993). In vivo  studies have shown 
that following gentamicin treatment, few hair cells remain in the mouse utricular 
epithelium by 7 days post drug exposure (Kawamoto et al., 2009). 
Following exposure to ototoxic aminoglycosides, the vestibular sensory epithelium 
exhibits a high degree of hair cell loss, with epithelia treated in vivo typically showing a 
more complete loss of hair cells than cultured utricular tissue. Hair cell death in utricles 
maintained in vitro and exposed to aminoglycosides is believed to occur predominantly 
through apoptosis (Cunningham et al., 2002; Forge and Li, 2000; Lang and Liu, 1997); 
utricular cultures treated with aminoglycosides in the presence of a caspase inhibitor 
(caspases are proteases involved in apoptotic cell death) was able to prevent hair cell 
death by apoptosis (Forge and Li, 2000; Matsui et al., 2002). Supporting cells of the 
vestibular epithelium have been observed to undergo considerable shape change in 
damaged tissue – at sites of hair cell loss, neighbouring supporting cells (as many as 5 
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supporting cells have been shown to participate) extend apical processes which fill the 
space in the epithelium created by the loss of a hair cell, forming a scar (Meiteles and 
Raphael, 1994). Fragments of dead hair cells remaining within the hair cell layer of the 
epithelium may also be ‘sealed over’ by the spreading behaviour of supporting cells. 
Hair cells which have been irreparably damaged may also be removed intact from the 
epithelium by extrusion at the apical surface  (Li et al., 1995); tight junctions between 
the hair cell and the surrounding supporting cells maintain the cell being extruded 
intact, whilst the neighbouring supporting cell apical extensions close off the space 
which had been occupied by the hair cell. An additional method of removing dying 
vestibular hair cells has been observed in the mammalian utricle: supporting cells have 
demonstrated an ability to act as non-professional phagocytes which engulf apoptotic 
hair cells (Li et al., 1995).  
Regeneration of mammalian utricular tissue is typically detected at around 3 to 4 weeks 
post-aminoglycoside treatment (Forge et al., 1993; Forge et al., 1998; Kawamoto et al., 
2009; Lin et al., 2011), through the appearance of hair bundles which are comparable in 
morphology to short immature stereocilia observed during development, in addition to 
detecting increased numbers of cells positive for hair cell markers i.e. myosin Viia.   
Although regeneration of sensory hair cells has been shown to occur via two different 
mechanisms in non-mammalian vertebrates such as birds, it is thought that mammalian 
utricular hair cells are only regenerated by direct transdifferentiation of supporting cells. 
Studies aimed at detecting proliferation of supporting cells by mitotic division, as had 
been observed in the avian inner ear e.g. the incubation of damaged utricular tissue with 
mitotic trackers such as 
3
H and BrdU detected only a few labelled nuclei within the 
supporting cell layer. These results did not explain the numbers of regenerated hair cells 
which had been observed (Rubel et al., 1995; Warchol et al., 1993).  
Transdifferentiation, also known as phenotypic conversion, has been described in the 
vestibular epithelia of numerous other species including the newt (Taylor and Forge, 
2005), bullfrog (Baird et al., 2000), mouse (Lin et al., 2011) and guinea pig (Li and 
Forge, 1997), indicating that this is an ability of supporting cells which is conserved 
across a wide variety of vertebrate species. Morphological evidence for supporting cell 
transdifferentiation was observed at 4 weeks post-aminoglycoside treatment in guinea 
pig utricular macula which received in vivo exposure to gentamicin(Li and Forge, 
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1997). This previous study observed cells in the sensory epithelium which showed 
evidence of a small, immature apical hair bundle, but which remained attached to the 
basement membrane in the manner of a supporting cell. Cells with longer hair bundles 
which more closely resembled stereocilia were also observed; the attachment of these 
cells to the basement membrane was via a narrow, ‘foot-like’ process. This study also 
detected evidence of cells with hair bundles where the basal process was no longer in 
contact with the basement membrane. 
During the process of converting from a supporting cell to a hair cell, in addition to the 
development of an apical hair bundle, an important step in this regenerative pathway is 
the detachment of the cell from the basement membrane. Based upon previous studies 
of the function of integrins, it would be anticipated that there are integrin heterodimers 
expressed at the region of cellular contact of the basal region of supporting cells and the 
basement membrane of the utricle, as illustrated in figure 1-11. During 
transdifferentiation, it would therefore be necessary for such integrin-mediated adhesive 
links to the basement membrane to be broken in order for the basal process of the 
converting cell to retract. This might potentially occur in a manner which is similar to 
that described in 1.3 by keratinocytes during cutaneous wound healing, where they must 
sever their adhesive anchorages to the basal lamina and alter the type and localisation of 
their integrin receptors in order to migrate into a wound site. This thesis aims to 
investigate the presence of integrins in the normal mature murine utricle, with the 
hypothesis that these proteins would be expressed in regions such as the interface 
between the supporting cells and the basement membrane. It would therefore be of 
interest to investigate the effect of aminoglycoside-induced hair cell loss on the 
expression and localisation of the integrins due to the likelihood of their involvement in 
the cellular events which occur during transdifferentiation of supporting cells, the 
predominant mechanism of hair cell regeneration in the mammalian vestibular 
epithelium. 
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Figure 1-11 A Hypothesis for Integrin Involvement in Hair Cell Regeneration of the 
Mammalian Vestibular Epithelium  
Adapted from (Groves, 2010) and (Li and Forge, 1997). Following aminoglycoside -induce 
d hair cell loss, the mammalian utricle is able to regenerate some vestibular hair cells by 
transdifferentiation; a supporting cell converts into a hair cell. This thesis aims to investigate 
the hypothesis that integrins are expressed in the utricle – they would be expected to be 
localised to supporting cell contacts with the basement membrane. The process of 
transdifferentiation has been shown to involve the detachment of the supporting cell from 
the basement membrane, as shown by TEM (see insets) in gentamicin-treated guinea pig 
utricles at 4 weeks post-treatment (Li and Forge, 1997). It would be anticipated that this 
detachment from the basement membrane would involve breakdown of integrin-mediated 
linkages between this membrane and converting supporting cells, potentially resulting in 
changes in integrin expression and localisation within the vestibular epithelium. 
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1.3 Scope of the Thesis 
The sensory epithelium of the mammalian utricle has been shown experimentally to 
possess a limited capacity for spontaneous regeneration of hair cells lost due to 
exposure to ototoxic aminoglycosides. Both in vivo and in vitro studies have observed 
the emergence of new vestibular hair cells at 3 to 4 weeks post drug treatment, including 
the appearance of short stereocilia which resemble the morphology of immature hair 
bundles seen during development of the vestibular epithelium. Since the mammalian 
auditory epithelium, the organ of Corti, does not possess this same ability to regenerate 
lost hair cells, investigation as to which proteins and signalling pathways contribute to 
the regenerative capabilities of the utricle is of great significance. A comprehensive 
understanding of the regenerative process in the vestibular epithelium would be 
beneficial in terms of treating vestibular disorders or dysfunction related to ageing – 
mammalian vestibular regeneration has been shown experimentally as being by no 
means completely able to replace hair cells to replicate the numbers present in normal 
adult tissue. It would also be of interest to establish whether auditory hair cell 
regeneration could be induced in the organ of Corti via the same mechanisms e.g. gene 
therapy could be utilised to induce expression of key proteins for regeneration which the 
auditory epithelium lacks.  
Integrins, as cell surface receptors, are involved in a wide range of cellular processes 
including proliferation, differentiation and migration, in addition to their key role in 
cellular adhesion to both the extracellular matrix and neighbouring cells. In other organ 
systems, several integrin heterodimers have been implicated as being critical for tissue 
repair e.g. in the skin during the re-epithelialisation stage of wound healing. During 
regeneration of vestibular hair cells, numerous cellular changes occur in which integrins 
could be expected to be involved, including cellular spreading of supporting cells to seal 
the epithelium, proliferation of supporting cells and detachment from the basement 
membrane of supporting cells undergoing phenotypic conversion to become hair cells. 
The work carried out in this study is therefore based upon the hypothesis that integrins 
would be expected to be expressed within the tissue of interest, in particular at the 
region of contact between the supporting cells and the basement membrane, and that the 
expression and localisation of integrins could be anticipated to alter in response to 
aminoglycoside-induced hair cell loss based upon knowledge of the cellular processes 
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of hair cell death and spontaneous regeneration which occur in the vestibular epithelium 
of mammals.  
Prior to this work, the presence of integrins and their distribution within the mammalian 
utricle was largely unknown. This thesis aims to investigate the presence of the integrin 
family within the adult mouse utricle, in terms of which of the 18 α and 8 β integrin 
subunits are present normally in this tissue and their distribution within both the sensory 
epithelium and the underlying connective tissue. The first results section of this thesis 
focuses on the use of degenerate PCR (polymerase chain reaction) in order to identify 
the integrins expressed in normal utricular cDNA. In order to study integrins in a 
regenerating vestibular epithelium, the next section of this thesis describes in vitro 
culture experiments using utricles dissected from adult mice, and the progression of hair 
cell loss and subsequent regeneration at several time points following aminoglycoside 
treatment, establishing a model tissue for the study of integrin expression. The final 
results sections of this thesis centre around experiments using the organotypic culture 
model of vestibular hair cell loss and regeneration for immunolabelling of integrin 
subunits in order to investigate any potential changes in their distribution, and for 
quantitative PCR analysis to investigate changes in expression level during hair cell 
death and subsequent regeneration. Short discussion sections are included where 
appropriate immediately following the relevant results; however, discussion of the 
majority of the results of this work is within a dedicated discussion section as the last 
chapter of this thesis.  
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Chapter 2: Materials and Methods 
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All experimental work presented in this thesis was carried out by N. Stanley unless 
otherwise specified in this chapter. 
2.1 Animals 
Utricular maculae were obtained from adult, at least P21 (postnatal day 21), CBA/Ca 
mice, purchased from Harlan. Animals were sacrificed by CO2 inhalation and 
subsequent cervical dislocation in accordance with Schedule 1 of the United Kingdom 
Animals (Scientific Procedures) Act of 1986. 
2.2 Cryosectioning  
2.2.1 Inner Ear Sectioning  
Following sacrifice of the animals, auditory bullae were dissected from surrounding 
tissue. Cochleae and vestibular endo-organs were removed in Hanks Buffered Salt 
Solution (HBSS), with 10mM Hepes solution added (Sigma). Several perforations were 
made in the bony areas of each bulla using forceps to allow the fixative to perfuse 
throughout the entire cochlea and ensure thorough fixation of the inner ear tissues. Inner 
ears were fixed in 4% paraformaldehyde (PFA) for 1.5 hours and then decalcified in 
4.13% ethylenediamine tetraacetic acid disodium (EDTA) in phosphate buffered 
solution (PBS) for 48 hours at 4
o
C to allow frozen sectioning through the bony 
structures of the inner ear. In preparation for cryosectioning, cochleae were incubated 
overnight in 30% sucrose in PBS, to prevent damage from ice crystal formation. A 1% 
low-gelling temperature agarose gel containing 18% sucrose in PBS was used to embed 
the tissue in 35mm petri dishes. These dishes were then sealed with Parafilm® to 
prevent the samples from drying out and stored at 4°C until required.  
For cryostat sectioning, a block of agarose containing a single cochlea was cut out from 
the petri dish and mounted on a chuck using Tissue-Tek® OCT compound (Sakura). 
Mounted blocks were rapidly frozen by submerging in liquid nitrogen and were then 
placed inside the cryostat chamber at -25°C to equilibrate before sectioning. Frozen 
sections of 14µm were sliced through the entire inner ear using a Leica CM1900 
cryostat at -25°C until the utricular maculae was reached, whereupon these cryosections 
were picked up on poly-L-lysine coated slides (VWR); the coating on these slides 
enhances cellular adhesion to the glass surface, preventing sectioned tissue from being 
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lost during solution changes. Slides were then incubated in a 37°C oven for 30 minutes 
to dry before being stored at -20°C until required for immunohistochemistry. 
2.2.2 Sectioning of Organotypic Cultures 
Utricles which had been maintained in culture were fixed for 1 hour in 4% PFA. Fixed 
utricles were then prepared for cryosectioning by overnight incubation in 30% sucrose. 
The tissue was not removed from the filter paper on which it had been grown in vitro; 
small squares, each containing one utricle, were cut from the filter paper and these were 
then embedded in agarose. This approach allowed the orientation of the tissue to be 
more easily determined to obtain the required sections. Blocks of agarose containing 
each utricle were mounted and sectioned in the same way as previously described in 
2.2.1 for whole inner ear cryosectioning.   
2.3 Immunohistochemistry 
2.3.1 General Immunohistochemistry 
All tissue (wholemount and cryostat sections) was fixed for 1hr in 4% PFA as described 
in 2.2.1 and 2.2.2. 
A 72-well plate was used for wholemount utricle immunohistochemistry, with the 
required solutions placed in separate wells – this allowed the utricles to be transferred 
from well to well, reducing the likelihood of any tissue being removed with discarded 
solution. For cryostat sections on glass slides, a ‘PAP’ pen (Sigma) was used to create a 
hydrophobic barrier around the sections to contain solutions applied during 
immunostaining.  
Cryostat sections and wholemount utricles were incubated with 0.5% Triton X-100 
(TX-100), a non-ionic surfactant detergent used to permeablise cell membranes to 
facilitate the penetration of antibodies into cell bodies during immunostaining, for 20 
minutes. Samples were subsequently blocked for 1 hour with ‘block’ (consisting of 10% 
horse serum [in order to reduce the incidence of non-specific primary antibody binding] 
and 0.1% Triton in PBS). The use of serum as a block for immunohistochemistry 
experiments is based upon the principle of incubating a sample with a solution which 
contains a high concentration of large proteins and antigens. These antigens will 
therefore ‘block’ the tissue, preventing the primary antibody from binding non-
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specifically to the sample being immunolabelled, thus reducing the background signal. 
Samples were subsequently incubated with primary antibody in Lysine-PBS block 
(0.182g L-lysine in 10ml PBS) overnight at 4°C, unless otherwise stated for a specific 
primary antibody. The use of lysine, an amino acid, provides an additional block of non-
specific binding sites which could potentially interact with the primary antibody during 
incubation. Table 2-1 lists all primary antibodies used in this project. Following the 
removal of the primary antibody solution, specimens were washed for 5 minutes in PBS 
solution; this washing was repeated 3 times in order to remove any remaining unbound 
primary antibody. Samples were then incubated with an appropriate fluorescently 
tagged secondary antibody and/or phalloidin in Lysine-PBS block solution for 2 hours 
at room temperature. Table 2-2 lists all secondary antibodies and conjugated 
fluorophores used in this project. The samples were protected from light at this point in 
order to prevent photobleaching of the immunofluorescence. At the end of this 
incubation period, the secondary antibody solution was removed and the specimens 
were washed 3 times (for a period of 5 minutes per wash) with PBS solution to remove 
any remaining unbound antibody/fluorophore. 
Immunolabelled cryostat sections were covered with glass coverslips, after the addition 
of Vectashield™ mount with 4,6-diamidino 2-phenylindole (DAPI). DAPI is able to 
bind to A-T rich regions of double stranded DNA and is also capable of penetrating 
intact cell membranes. These properties mean that DAPI is able to selectively label cell 
nuclei. Wholemount utricles were removed from the 72-well plate and mounted on 
slides containing individual wells (C A Hendley) using Vectashield™ with DAPI and a 
glass coverslip. Coverslips were sealed to slides with nail varnish to prevent drying out 
and stored at 4°C until required for imaging. 
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 Protein Type; Host 
Species 
Concentration Supplier 
Integrins     
     
 α6 Monoclonal; 
Rat 
1:200 Serotec 
 αV Monoclonal; 
Mouse 
1:200 (with 
TSA 
amplification 
kit) 
BD Biosciences 
 β1 Monoclonal; 
Rat 
1:1000 BD Biosciences 
 β3 Polyclonal; 
Rabbit 
1:200 Novus Biologicals 
 β5 Polyclonal; 
Rabbit 
1:100 Millipore 
     
Hair Cell 
Markers 
    
 Myosin 
Viia 
Monoclonal; 
Mouse 
1:250 National 
Hybridoma Bank 
 Calretinin Polyclonal; 
Rabbit 
1:100 Chemicon 
     
ECM 
Proteins 
    
 Collagen 
Type IV 
Polyclonal; 
Rabbit 
1:1000 Abcam 
 
Table 2-1 Primary antibodies used for immunohistochemistry 
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Secondary 
Antibody/Conjugated 
Fluorophore 
Host Concentration Supplier 
    
Anti-Rabbit IgG TRITC 
 
Pig 1:500 Dako 
Anti-Rabbit IgG FITC 
 
Pig 1:500 Dako 
Anti-Rat IgG FITC 
 
Goat 1:500 Sigma 
Anti-Mouse IgG TRITC 
 
Rabbit 1:500 Dako 
Anti-Mouse IgG FITC 
 
Rabbit 1:500 Dako 
Phalloidin-FITC 
 
N/A 1:1000  
 
 
Table 2-2 Secondary antibodies and other conjugated fluorophores used for 
immunohistochemistry 
 
 
2.3.2 Antibody Amplification using a Tyramide Signal Amplification Kit 
The integrin αV antibody, subsequent to testing at a series of dilutions of both the 
primary and secondary antibody, required the use of an amplification kit in order to 
visualise the antibody sufficiently in inner ear tissue. It is possible that there was 
insufficient integrin αV antigen present in the tissue of interest, resulting in poor 
detection of this integrin using a standard immunohistochemistry protocol. Integrin αV 
is the alpha subunit able to form the most functional integrin heterodimers, therefore its 
presence would be expected in the inner ear. The use of a TSA amplification system can 
improve sensitivity without increasing the level of background staining observed. In this 
instance, a TSA amplification kit (TSA kit #4 with HRP, goat anti-mouse Ig and Alexa 
Fluor® 568 tyramide; Invitrogen, Paisley) was selected, since the integrin αV primary 
antibody being used was a mouse monoclonal antibody. 
In accordance with the product protocol, samples (either wholemount utricles or utricle 
cryosections) were permeablised with 0.1% Triton X-100 for 10 minutes. After rinsing 
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with PBS, the samples were then incubated in 1% blocking reagent (as supplied in the 
kit) for 1 hour at room temperature, before a further 1 hour incubation period with the 
integrin αV antibody diluted 1:200 in 1% blocking reagent. Following three 5 minute 
washes with PBS to remove any unbound primary antibody, the samples were incubated 
with a horseradish peroxidase (HRP) conjugate solution for 30 minutes. The TSA 
amplification system utilises an enzyme (in this case HRP) which is conjugated to a 
secondary antibody – in this case an anti-mouse secondary antibody in order to detect 
the mouse monoclonal integrin αV primary antibody. The HRP conjugate solution was 
removed from the samples by a further 3 washes with PBS and these were then 
incubated with an Alexa Fluor® 568 tyramide working solution (covered to protect the 
fluorophore from photobleaching), with the tyramide dye diluted 1:100 in amplification 
buffer (containing H2O2) for 10 minutes. In the presence of H2O2, HRP activates the 
tyramide coupled dye, resulting in the production of highly reactive, short lived 
tyramide radicals. These molecules are deposited in regions in direct proximity to the 
original HRP secondary conjugate bound to the primary antibody; in this way the signal 
is amplified, but with minimal loss of resolution and minimal background signal 
production.  The samples were again washed 3 times with PBS to remove the excess 
tyramide solution. Any further immunohistochemistry required on these samples was 
then carried out as previously specified.  
2.3.3 EdU Labelling 
In order to investigate proliferation within utricular cultures, a Click-iT™ EdU Alexa 
Fluor® 488 imaging kit, supplied by Invitrogen was used. This imaging method uses 5-
ethynyl-2’-deoxyuridine (EdU), a nucleoside analog of thymidine, which may be 
incorporated into DNA during the S-phase of cellular proliferation. EdU was used as an 
alternative to 5-bromo-2'-deoxyuridine (BrdU), since it does not require denaturation of 
the DNA by treatment with HCl in order to be detected. The HCl treatment required for 
BrdU labelling is liable to disrupt the tissue of interest, with the potential for the 
damage and destruction of antigen sites which could adversely affect any further 
immunohistochemistry experiments required to be carried out on EdU labelled samples. 
The EdU detection system with which cell proliferation experiments were carried out 
utilises a ‘Click’ reaction, a copper catalysed covalent reaction between an azide (the 
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Alexa Fluor® 488 dye) and an alkyne (the EdU), in order to visualise EdU within cell 
nuclei, as opposed to BrdU, which requires the use of anti-BrdU antibodies. 
 In accordance with the protocol provided by the manufacturer, utricles were cultured in 
the presence of a 10µM concentration of EdU. This was achieved by the addition of 
10µl of 10mM EdU stock solution to 10ml of culture medium. EdU was not added to 
the culture medium until after the cultures had been treated with gentamicin in order to 
only detect proliferation which occurred subsequent to damage and hair cell loss 
induced by the ototoxic antibiotic.  
Following fixation and/or cryostat sectioning, cultures incubated with EdU were washed 
with 3% bovine serum albumin (BSA) prior to permeablisation with 0.5% Triton-X-100 
in PBS for 20 minutes at room temperature. Whole utricles/utricular sections were then 
washed twice with 3% BSA to remove the permeabilisation solution and the Click-iT™ 
reaction cocktail prepared from the reagents supplied by the manufacturer; 215µl 1x 
Click-iT™ reaction buffer, 10µl CuSO4, 0.6µl Alexa Fluor® 488 azide and 25µl 
reaction buffer additive. The tissue to be labelled was incubated with the Click-iT™ 
reaction cocktail for 30 minutes at room temperature, whilst covered to protect the 
Alexa fluorophore from photobleaching. 3% BSA was used to wash the CIick-iT™ 
reaction cocktail solution off of the samples; any further immunohistochemistry 
required was then carried out as previously described. 
2.3.4 Confocal Microscopy 
Imaging of immunofluorescently labelled samples was carried out using a Zeiss Meta 
laser scanning confocal microscope using the x20 (dry) and x63 (oil) objectives. Z-
series stack images were taken at optimised intervals; maximal pixel intensity 
projections were created from these series by the LSM Image Browser software. For 
comparative imaging of integrin antibodies in tissue at different time points post-
gentamicin treatment, the same confocal settings were used throughout the imaging 
process. 
2.3.5 Cell Counts 
Quantification analysis of hair cell numbers was carried out from x63 magnification z-
stack confocal images of cultured utricles immunolabelled for the hair cell marker 
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myosin Viia. For the purposes of this study, hair cells were defined as those cells which 
were positive for the marker myosin Viia within their cell body. Each utricle studied 
was sampled 2-3 times; each sample consisted of a x63 image, with an area of 146.2µm 
x 146.2µm. Samples were randomly selected within the intact region of each individual 
utricle. Intact, well preserved regions of the tissue were assessed through examination of 
the quality of the fluorescent labelling of cellular junctions produced by phalloidin 
staining. Cell counts were carried out using Image J software. Hair cell counts from the 
samples of each utricle were averaged; these average counts were then normalised – this 
data is expressed as the number of hair cells per 1000µm2. Since the data collected from 
hair cell counts was taken from more than two groups, an analysis of variance 
(ANOVA) test was selected for carrying out statistical analysis, as opposed to a T-test. 
The ANOVA statistical test allows the means of multiple groups (in the case of the 
experiments carried out in this project, this represents the means hair cell counts at 
multiple time points following gentamicin treatment and non-treated control groups) to 
be compared. The null hypothesis of the ANOVA test is that the means of each of the 
groups are equal, representing random samples of the same population and that the 
experimental conditions applied to each group have no significant effect on the variable 
being measured i.e. hair cell numbers. 
A one-way ANOVA statistical analysis was used, since there was data from a single 
independent variable (hair cell number) to be compared across the groups investigated; 
this statistical test was carried out using GraphPad software. Post-hoc analysis of the 
ANOVA was then carried out using Tukey’s Test. This statistical test was used in 
conjunction with one-way ANOVA, in order to compare all possible pairs of cell count 
mean values, in order to determine which experimental conditions showed hair cell 
counts which were significantly different from one another. 
Quantification analysis of EdU labelled cell numbers was carried out in the same 
manner as described for hair cell counts. Utricular cultures incubated with EdU were 
stained with DAPI in order to visualise all cell nuclei. A Click-iT™ EdU Alexa Fluor® 
488 imaging kit was used to visualise all cell nuclei which had incorporated EdU into 
their DNA. Total cell counts e.g. all cells with DAPI-positive nuclei, in addition to 
counts of all nuclei positive for EdU were carried out using Image J software. Cell 
counts were averaged from the samples of each individual utricle studied and the data 
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normalised in order to be expressed as the number of nuclei/EdU-positive nuclei per 
1000 µm2. 
2.4 Scanning Electron Microscopy 
Cultured utricles to be analysed by scanning electron microscopy were removed from 
culture medium but remained attached to the nitrocellulose filter paper culture surface. 
Tissue was fixed in 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer pH 7.3 with 
3mM CaCl2 for 1.5 hours and then post-fixed with 1% OsO4 in 0.1M cacodylate. Post-
fixed tissue was then processed for SEM by a repeated thiocarbohydrazide-osmium 
procedure prior to dehydration of the samples through an ethanol series to 100% dry 
ethanol. Specimens were subsequently critical point dried from liquid CO2 and mounted 
on stubs using silver paint (Ted Palla) before being sputter coated with gold. Prepared 
specimens were viewed and digitally imaged using a JEOL JSM 6700F cold field 
emission instrument, operating at 5Kv. All digital images were adjusted for optimal 
contrast and brightness using Photoshop CS4 software. Processing of SEM specimens 
was carried out by G. Nevill and Prof A. Forge. 
2.5 Transmission Electron Microscopy 
Cultured utricles to be analysed by transmission electron microscopy were removed 
from culture medium but remained attached to the nitrocellulose filter paper culture 
surface. Tissue was fixed in 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer pH 
7.3 with 3mM CaCl2 for 1.5 hours and then post-fixed with 1% OsO4 in 0.1M 
cacodylate. Post-fixed tissue was then processed for TEM by partial dehydration to 70% 
ethanol and then en bloc stained in saturated uranyl acetate in 70% ethanol overnight. 
Dehydration was subsequently completed to 100% ethanol (samples require dehydration 
due to being placed into a vacuum for imaging by electron microscopy – if the samples 
were to contain water, this would evaporate when the sample was subject to a vacuum, 
potentially resulting in damage to the structural integrity of the tissue of interest) and 
specimens embedded in plastic. Initial thick sections (~1µm) were cut and stained with 
toluidine blue for examination under light microscope. Thin sections (80nm) were then 
cut and stained with uranyl acetate and lead citrate before being examined by a JEOL 
1200EXII fitted with a Gatan digital camera; the microscope was operated at 80 Kv. 
Processing and imaging of utricle cultures by TEM was carried out by G. Nevill and 
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Prof. A. Forge. All digital images were adjusted for optimal contrast and brightness 
using Photoshop CS4 software. 
2.6 Culture of Adult Mouse Utricles 
Adult mice were killed in accordance with Schedule 1 of the Home Office Animals 
(Scientific Procedures) Act 1986. Bullae were dissected from the animals by removal of 
the lower jaw and bisection of the head. Subsequent removal of the brain tissue from the 
bisected heads allowed access to dissect the entire bullae from the animal; the bullae 
were then transferred to petri dishes containing a Hanks Balanced Salt Solution 
containing 1M Hepes (4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid) buffer 
solution, whereupon the utricular maculae were dissected out from the whole inner ear 
using heat sterilised forceps. The otolithic membrane which overlies the utricle and the 
otoconia on the surface of the sensory epithelium were each carefully removed with 
forceps. Dissected utricles were removed of any extraneous tissue i.e. from attachment 
to the cristae of the vestibular system; it is often the case that during dissection the 
utricle will be removed with several cristae attached to it. It was the aim of these 
dissection methods to ensure that only the utricular sensory epithelium and the 
mesenchymal tissue directly beneath it were placed into culture. All dissection for 
organotypic cultures was performed under sterile conditions.  
Culture medium was made up under sterile conditions and stored at -20°C until 
required. 1ml of 1M Hepes buffer solution was added to 100ml of Gibco® 
GlutaMAX™ minimum essential medium containing Earles Salts (Invitrogen). 10ml of 
this solution was removed and stored in a 15ml Falcon tube; this media was used to 
make up laminin solutions. To the remaining 90ml of media, 10ml of sterile horse 
serum was added and the media aliquoted out into 15ml Falcon tubes, each containing 
10ml of media – this media (MEM + GlutaMAX™ + 1% Hepes + 10% Horse Serum) 
was used to maintain organotypic cultures.  
Two different methods for maintaining utricles in culture long-term were investigated in 
this work; the development of the culture technique is described in detail in 4.1. 
Initially, MatTek™ dishes (MatTek Corp) were coated with laminin (diluted at 1:75 
concentration with serum-free culture medium) by placing 200µl of laminin solution 
onto the glass bottom of the dish and allowing at least one hour before removing the 
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surplus solution. Dissected utricles were then placed onto the coated region and 
sufficient culture medium added to completely cover the tissue.  
The culture technique was refined during the initial stages of this project and a different 
culture surface selected. Round 13mm diameter 0.45µm micropore nitrocellulose 
membrane filters (Millipore) were placed into the wells of a 24-well plate and dissected 
utricles placed onto the filter paper in each well, before being covered with 450µl of 
culture medium. It was observed that within 24-48hrs of incubation, the tissue had 
adhered to the nitrocellulose surface, facilitating the changing of culture media without 
disturbing the tissue. 
During the culture time period, the tissue was maintained at 37°C in an incubator; 
culture medium was changed every other day. Where cultures were treated with 
gentamicin to induce hair cell loss, a solution of 2mM gentamicin diluted in normal 
culture medium was used over a 48hr incubation period. Tissue was then rinsed with 
medium to remove residual gentamicin and placed in fresh culture medium for the rest 
of the incubation period. 
2.7 Real-Time PCR (Polymerase Chain Reaction) 
2.7.1 Tissue 
Normal uncultured utricles were dissected from the whole inner ear using forceps in 
HBSS + 1M Hepes, in the same way as utricular maculae were dissected for 
organotypic culture experiments. Utricles were placed immediately into labelled 
Eppendorf tubes containing RNA Later (Invitrogen) to prevent RNA degradation and 
stored at -80°C until required. These utricles were used to obtain a cDNA sample to be 
used as the control (calibrator) sample for relative quantification analysis. 
Where PCR (polymerase chain reaction) experiments required RNA to be extracted 
from cultured tissue, utricles were maintained in vitro as described in 2.6 for the culture 
of adult mouse vestibular epithelium. Once the required culture time point was reached, 
utricles were removed from the nitrocellulose filter paper upon which they had been 
maintained, placed immediately into RNA Later and stored at -80°C. 
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Positive control tissue was obtained from adult mice; this tissue was lung, spleen and 
kidney. Each tissue was placed in RNA Later directly after dissection from the animal 
and stored at -80°C. 
2.7.2 RNA Extraction 
RNA extraction was performed using an RNeasy Mini kit (Qiagen) as detailed in the 
product protocol handbook. Tissue which had been stored at -80°C in RNA Later was 
allowed to defrost to room temperature. Each positive control tissue was cut and 
weighed in order to only use 30mg of tissue as recommended, and placed into 600µl 
buffer RLT containing β-mercaptoethanol (10µl/ml) to be disrupted and homogenised 
using a rotor-stator homogeniser. The addition of β-mercaptoethanol (β-ME) to the 
buffer provides additional protection against RNA degradation; β-ME reduces 
disulphide bonds and is therefore able to irreversibly denature any RNAses which might 
be present in the sample. Utricular tissue, due to its small size, was disrupted in 600µl 
buffer RLT containing β-ME by passing the tissue through a 20G needle attached to a 
sterile syringe twenty times. Subsequently, the utricular lysate was placed into a 
Qiashredder (Qiagen) spin column with a 2ml collection tube and centrifuged for 2 
minutes at full speed (13,000rpm). 
Tissue lysate was centrifuged at full speed for 3 minutes; the supernatant was removed 
by pipette and transferred to a fresh Eppendorf tube, taking care not to disturb any pellet 
which had formed during centrifugation. Each sample was subsequently processed by 
successive centrifugation steps as described in the kit protocol handbook. 
To aid in the complete removal of ethanol from the extracted RNA, following the final 
wash centrifugation, the Qiaspin columns were placed in a heat block at 55°C for 1 
minute.For the final elution step, 30µl of RNAse free water was used. 
The concentration of RNA obtained from the extraction for each sample was measured 
using a Nanodrop 1000 spectrophotometer (Thermo Scientific). 
2.7.3 Reverse Transcription of cDNA 
Reverse transcription of extracted RNA to cDNA was performed using a Sensiscript™ 
Reverse Transcription Kit (Qiagen) as directed in the protocol supplied with this kit.  
Additional reagents required for the use of this kit were primers for the reaction, for 
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which Oligo dT primers (which bind to the poly A tail of mRNA) were used 
(Invitrogen) and a mouse RNAse inhibitor (NEB) which was diluted to the specified 
final concentration using a 1x solution of the 10x Buffer RT (diluted in RNAse-free 
water). The reaction cocktail also contained a dNTP mixture supplied in the 
Sensiscript™ kit consisting of a 5mM concentration of each dNTP. An appropriate 
volume of RNA was added to each reaction based on the sample concentration (larger 
tissues e.g. spleen produced higher concentrations of RNA during the extraction process 
than utricular tissue; the kit protocol recommends that no more than 50ng of RNA 
should be used per 20µl reaction volume). 
Reverse transcription reactions were carried out by placing Eppendorf tubes containing 
the reaction mix into a heat block at 37°C for 1 hour. At the end of the reverse 
transcription reaction, the cDNA concentration of each sample was measured using a 
Nanodrop 1000 Spectrophotometer. cDNA samples were stored at -20°C until required. 
2.7.4 Degenerate PCR Primers 
Initial RT-PCR experiments were carried out using several sets of degenerate primers, 
the design process of which is discussed fully in the relevant results chapter.  Design of 
degenerate primers was carried out in collaboration with Dr. S. Dawson. Degenerate 
primers (Eurofins MWG Operon) were supplied in a lysophilsed state. Each primer was 
re-suspended in freshly autoclaved double-distilled H2O, to produce a 100µM primer 
stock solution. A working solution of 10µM was diluted from this stock solution for use 
in PCR reactions.  
In order to optimise the reaction conditions for each primer pair, initial PCR 
experiments were carried out on a temperature gradient to determine the optimal 
annealing temperature i.e. the temperature at which the primers will bind to the template 
DNA strand. Further refinements were applied as necessary; several primer pairs 
required an alteration to the concentration of MgCl2 used. The optimised RT-PCR 
reaction conditions for each set of degenerate primers is summarised in table 2-3. The 
thermal cycling process for degenerate PCR experiments was carried out by an 
Eppendorf Mastercycler Gradient PCR machine, using a 3-step PCR reaction i.e. one 
with individual denaturation (of the double stranded cDNA), annealing and extension 
(where the DNA polymerase extends the primers and synthesises a new strand of DNA) 
temperatures.  
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2.7.5 Integrin Subunit Specific PCR Primers 
A small set of specific PCR primers were designed to amplify each of a group of 5 
integrin subunits which were believed likely to be expressed in the tissue of interest, but 
which had not been successfully detected by degenerate PCR; α6, β1, β3, αV and α8.  
The primer sequence for each of these integrin subunits are as follows:  
Integrin α6 (Forward: 5’-CCTAACAGAATTGACCTCCGCCAGAAG-3’;  
Reverse: 5’-ACTGAACTCTCGATGACAACCCTGA-3’),  
Integrin αV (Forward: 5’-GCCAGACCCGTTGTCACTGTAAATGC-3’;   
Reverse: 5’-CGTCGGATGGCTCCCTTCTGCTTGAG-3’), 
Integrin α8 (Forward: 5’-CCTTCAAGCAAGCGCCCTCCTCTTCC-3’;   
Reverse: 5’-GCTTGCTGTGTAAACCTCTTGGGG-3’),  
Integrin β1 (Forward:  5’-GGAAACTCTAGTAATGTGATCCAGC-3’;   
Reverse:  5’-CACTTGGGACTGGCTGGGATGCCATG-3’) and  
Integrin β3 (Forward: 5’-GGGCTGATGACTGAGAAACTATCCCAG-3’; 
Reverse: 5’-CACGTACTTCCAGCTCCACTTTAGA-3’).  
Specific primers of a length of 22-25bp were designed, spanning across an exon-exon 
junction in order to prevent the amplification of any contaminating genomic DNA 
during the PCR reaction, for the detection individually of each of the selected integrins. 
The Tm of each forward and reverse primer was assessed using the OligoCalc online 
tool to ensure that these temperatures were within the optimum range. This tool was 
also used to check for potential self-complementarity, which would affect the efficiency 
of the primers and their ability to bind to the template DNA.  The specificity of these 
primers was confirmed by BLAST analysis (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
Specific integrin subunit primers (Sigma) were re-hydrated with ddH2O to produce a 
stock 100µM solution of each primer. Optimisation of reaction conditions was carried 
out as previously described, by using a temperature gradient to determine the optimum 
annealing temperature for each primer pair and subsequently altering the concentration 
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of MgCl2 in the reaction master mix. The optimised PCR conditions for each integrin 
subunit are summarised in table 3-5. 
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Forward Primer Reverse Primer PCR Conditions 
Intaall1F IntaxmdeR 3-Step RT-PCR 
  Annealing Temp = 55°C 
  MgCl2 concentration = 2mM 
  cDNA = 1µg 
   
Inta2110bF Intaall1R 3-Step RT-PCR 
  Annealing Temp = 55°C 
  MgCl2 concentration = 5mM 
  cDNA = 2µg 
   
Inta82b5vF Inta75v82bR 3-Step RT-PCR 
  Annealing Temp = 55°C 
  MgCl2 concentration = 5mM 
  cDNA = 2µg 
   
Inta673F Inta8673R 3-Step RT-PCR 
  Annealing Temp = 55°C 
  MgCl2 concentration = 4mM 
  cDNA = 2µg 
   
Inta49Fb Inta49Rb 3-Step RT-PCR 
  Annealing Temp = 55°C 
  MgCl2 concentration = 2mM 
  cDNA = 1µg 
   
Intb28F Intb28R 3-Step PCR 
  Annealing temperature = 55°C 
  MgCl2 concentration = 2mM 
  cDNA = 1µg 
   
Intb147F Intb147R 3-Step PCR 
  Annealing temperature = 55°C 
  MgCl2 concentration = 2mM 
  cDNA = 1µg 
   
Intb356Fb Intb356R 3-Step PCR 
  Annealing temperature = 55°C 
  MgCl2 concentration = 2mM 
  cDNA = 1µg 
 
Table 2-3 Summary of Optimised Reaction Conditions for Degenerate PCR Primers 
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2.7.6 Agarose Gel Electrophoresis of RT-PCR Products 
All RT-PCR products (whether amplified using degenerate or specific primers) were 
run on an agarose gel to determine whether the PCR had been successful and if the 
DNA fragments produced were of the size expected based on the amplicon designed to 
be produced by each primer pair; the use of an agarose gel allows DNA fragments of 
different sizes to be separated and identified using a DNA ladder as a reference point. 
Agarose gels were produced by adding the appropriate weight of agarose to 100ml of 
1xTAE buffer (2.0 M Tris, 1 M Glacial acetic acid, 50 mM EDTA, pH 8.0) in a conical 
flask. This solution was heated until the agarose had completely melted before being 
allowed to cool. In order to visualise the DNA under ultraviolet light, 2µl ethidium 
bromide was added to the agarose solution prior to pouring into a gel mould; plastic 
combs were used to create the required number of wells in the gel and this was left to 
cool and set for 30 minutes. Several different agarose % gels were used to run PCR 
products on, depending on the size of the expected DNA fragments, and in the case of 
latter experiments, whether multiple DNA fragments of different sizes required 
separation by gel electrophoresis. An appropriate DNA ladder (100bp or 1kb; 
NEB/Invitrogen) was used in order to estimate the size of the DNA fragments run on 
the gel. 
Gel electrophoresis was run by placing the gel in the apparatus filled with 1x TAE 
buffer and applying an electrical field of approximately -70mv for 30 minutes. DNA run 
on agarose gels was visualised by the use of a GelDoc-It 3UVTM Transilluminator 
Imaging system (Jencons-PLS) using the UV-B setting (302nm) and still images of the 
illuminated gels captured using Labworks (UVP BioImaging Systems) software. 
2.7.7 Extraction of PCR Products from Agarose Gel 
Since identification of the DNA fragments amplified by degenerate primers required the 
utilisation of cloning, PCR products which had been detected by gel electrophoresis 
required extraction from the agarose gel through which they had been run. Gel 
extraction was carried out using a QIAquick gel extraction kit (Qiagen). 
Each DNA band was cut from the agarose gel using a scalpel blade whilst being 
visualised on a UV lightbox and placed into a 1.5ml Eppendorf tube. Each gel slice was 
weighed using a digital balance and 3 volumes of Buffer QG from the kit added for 
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every 1 volume of agarose gel. For the purposes of this protocol 100mg of gel was 
equivalent to 100µl of buffer solution.  
The gel extraction process was carried out by microcentrifugation as described in the 
protocol supplied for this kit. In order to facilitate the removal of residual ethanol prior 
to the elution of the DNA fragments, the spin columns were placed on a heat block at 
55°C for 1 minute.  
2.7.8 Purification of PCR Products 
PCR products which were required for use in ligation reactions were first purified, in 
order to remove leftover primers and any other impurities which might adversely affect 
subsequent experiments carried out using these DNA fragments, by the use of a 
QIAquick PCR purification kit (Qiagen).   
The purification process was carried out by microcentrifuge as described in the protocol 
supplied with this kit. In order to facilitate the removal of residual ethanol prior to the 
elution of the DNA fragments, the spin columns were placed on a heat block at 55°C for 
1 minute. The final elution step was carried out using 30µl of RNAse-free water. 
2.8 Cloning of PCR Products Using the pGEM®-T Easy Vector System 
2.8.1 Ligation Reactions 
In order to clone the PCR products obtained from degenerate RT-PCR experiments, the 
DNA fragments were ligated into the plasmid vector pGEM®-T Easy (Promega). The 
use of cloning via a plasmid vector allowed the production of a larger volume of the 
PCR products generated from the degenerate PCR reactions carried out. This facilitated 
the analysis of the PCR products in order to determine which integrin subunit amplicons 
were present in each reaction sample. 
The pGEM®-T Easy vector used contains an ampicillin resistance gene, allowing for 
selection of bacteria which have taken up the vector by growing transformed cells on 
agar plates containing ampicillin. This plasmid also contains the lac operon, a collection 
of genes, including the enzyme β-galactosidase, and associated regulatory sequences 
required by bacteria in order to metabolise lactose. The cloning region of the pGEM®-T 
Easy vector is located within the lac operon, thus if a plasmid has successfully 
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incorporated a DNA fragment during the ligation stage of the cloning procedure, the lac 
operon sequence will be disrupted and non-functional. Successfully cloned bacteria 
maybe therefore be identified by growing cultures on agar plates which have had X-gal 
and IPTG added. IPTG (isopropylthio-β-galactoside) acts as an inducer of the lac 
operon, whilst X-gal (5-bromo-4-chloro-3-indolyl-beta-D-galacto-pyranoside) is an 
analog of lactose which can be metabolised by β-galactosidase. If no DNA fragment has 
been ligated into the plasmid, the lac operon will be fully functional, and the bacterial 
colony containing this vector will be able to produce β-galactosidase and metabolise X-
gal; this is detectable since unmetabolised X-gal is colourless, whilst the product of its 
cleavage by β-galactosidase are blue. Colonies which contain plasmids with a DNA 
fragment insert will therefore appear white, whilst those bacteria containing an 
unligated vector will appear blue, since they possess an uninterrupted lac operon.  
Each reaction was set up in a 0.5ml Eppendorf tube containing the following; 2.5µl 2x 
Rapid Ligation Buffer (Promega), 0.5µl pGEM®-T Easy vector, 0.5µl T4 DNA ligase 
(Promega) and 1.5µl of the purified PCR products. This gave a final reaction volume of 
5µl. The ligation reactions were carried out overnight at 4°C. 
2.8.2 Preparation of Agar Plates for Bacterial Culture 
LB-Agar was made up with 5 g tryptone,  2.5 g yeast extract,  5 g NaCl and  1.5% agar 
in 500ml distilled water and autoclaved for 45 minutes. LB-Agar was stored at room 
temperature until required; this medium was melted in a microwave and maintained in a 
water bath at 55°C prior to pouring. To this molten LB-agar 500µl Ampicillin, 500µl of 
X-gal and 500µl IPTG were added, swirling the bottle to mix before pouring into petri 
dishes and allowing to the plates to cool and set.  Plates were stored at 4°C until 
required. 
2.8.3 Cloning  
For the cloning of PCR products, XL10-Gold Ultracompetent cells (Stratagene) were 
used, which were stored at -80°C until required.  
14ml BD Falcon tubes were pre-chilled, one per ligation reaction, whilst the 
ultracompetent cells were thawed on ice. Each tube was aliquoted 50µl of cells, and 
then to each tube 2µl of β-mercaptoethanol (Stratagene) was added, swirling the tubes 
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gently to mix. The cells were kept on ice for 10 minutes, with swirling repeated every 2 
minutes. 1µl of ligation reaction was then added, swirling to mix and the tubes left to 
incubate on ice for 30 minutes. A 30 second heat-shock was given by placing the tubes 
into a water bath set at 42°C; following heat-shock the tubes were placed immediately 
back on ice for a further 2 minutes. To each tube 0.45ml of NZY+ broth which had been 
preheated to 42°C was added. NZY+ broth was made up as follows; 10g of NZ amine 
(casein hydrolysate), 5 g of yeast extract, 5g of NaCl and deionised water added up to 
1L.The pH was adjusted 7.5 using NaOH and the broth was then autoclaved. Filter-
sterilized supplements - 12.5 ml of 1 M MgCl2, 12.5 ml of 1 M MgSO4 and 20 ml of 
20% (w/v) glucose were added prior to use of the NZY+ broth. The cloning tubes were 
then placed in a shaker set at 250rpm/37°C for 1 hour.  
 
Following this incubation, each transformation reaction was plated onto an Amp/X-
gal/IPTG agar plate. Plates were incubated at 37°C overnight and then examined for 
colonies using blue-white screening (white colonies contain an insert into the pGEM®-
T easy vector, thus disrupting the Lac operon; blue colonies will not contain an insert). 
White colonies from each plate were ‘picked’ using a sterile pipette tip which was then 
dropped into a sterile bottle containing 5ml LB broth. LB broth was made up with 10g 
tryptone, 5g yeast extract and 10g NaCl. Distilled water was added to 1L, ensuring that 
the pH was around 7.0. The solids were dissolved in the water then the broth poured 
into bottles before autoclaving for 30-45 minutes. For each plate, in order to give a 
representative sample of the PCR product inserts which might have been cloned, 20 
colonies were ‘picked.’ The ‘picked’ colonies were grown overnight in a shaker at 
250rpm/37°C and the resultant bacterial culture stored at 4°C until required. 
In order to extract the plasmid DNA from the bacterial cells a QIAprep Miniprep kit 
(Qiagen) was used. A 1ml sample of the bacterial culture from each bottle was placed 
into individual 1.5ml Eppendorf tubes and these samples centrifuged at ≥8000rpm for 3 
minutes at room temperature. This produced a ‘pellet’ of bacterial cells from which the 
remaining medium (supernatant) could then be removed. The plasmid DNA extraction 
was carried out as specified by the microcentrifugation protocol described in the 
handbook for this kit. In order to facilitate the removal of residual ethanol prior to the 
elution of the plasmid DNA, the spin columns were placed on a heat block at 55°C for 1 
minute. 
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2.8.4 Restriction Digests of Plasmid DNA 
In order to establish which of the potential integrin subunits had been detected by each 
set of degenerate primers, restriction enzymes were selected for use based on restriction 
mapping, such that they would produce easily identifiable band patterns, when run on 
an agarose gel. For each of the expected amplicons for the α and β integrin subunits, a 
restriction map was produced using the Restriction Mapper online tool to identify all of 
the restriction sites present (http://www.restrictionmapper.org/). These restriction maps 
were then used to select appropriate restriction enzymes. The restriction digest strategies 
for identification of integrin subunits are provided in tables 2-5 and 2-6.  
Restriction digests were set up in 0.5ml Eppendorf tubes. The reaction mixture 
contained the following; 8µl autoclaved ddH2O, 2µl of the appropriate buffer for the 
enzyme, 2µl restriction enzyme and 8µl plasmid DNA, giving a total reaction volume of 
20µl. The reactions were incubated at a temperature appropriate for the enzyme being 
used for 1 hour. Table 2-4 summarises the restriction enzymes used and the conditions 
under which each reaction was performed. The products of the restriction digests were 
run on an agarose gel as previous described, on a gel weight appropriate for the 
expected fragment sizes required to be separated by electrophoresis. The resultant gels 
were viewed and imaged as described in 2.7.6. 
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Enzyme Buffer Reaction 
Temperature 
EcoRI Buffer 
H 
37°C 
RSAI Buffer 
C 
37°C 
HaeIII Buffer 
C 
37°C 
HaeII Buffer 
B 
37°C 
SalI Buffer 
D 
37°C 
HindIII Buffer 
E 
37°C 
BglI Buffer 
D 
37°C 
TaqI Buffer 
E 
65°C 
NcoI Buffer 
D 
37°C 
BamHI Buffer 
E 
37°C 
XhoI Buffer 
D 
37°C 
ApaI Buffer 
A 
37°C 
PstI Buffer 
H 
37°C 
SphI Buffer 
K 
37°C 
EcoRV Buffer 
D 
37°C 
 
Table 2-4 Summary of Restriction Enzymes and Digest Reaction Conditions 
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Forward 
Primer 
Reverse 
Primer 
Integrin 
Subunits 
Restriction Digest Strategy 
Intaall1F   IntaxmdeR αX,  αM, αD 
& αE 
BglI digest = 2 band patterns; αX/αD and αM/αE 
    
Inta2110bF   Intaall1R α1, α2, α10 
& α11  
BamHI digest = linearises if α1 amplicon, does not cut other amplicons or the plasmid vector                                                         
   XhoI = linearises if α2 amplicon, does not cut other amplicons or the plasmid vector 
   Rsa I digest = cuts all amplicons once except α10 
   SphI digest = linearises if α11 amplicon, does not cut other amplicons or the plasmid vector 
    
Inta82b5vF   
Inta75v82bR 
αV, αIIb, α5 
& α8 
Hae II digest = doesn't cut amplicon of αV or αIIb. Cuts α5/α8 amplicon once. Cuts vector 4 
times. 
   Apa I digest = linearises if αV, 2 cuts if αIIb  
   Pst I digest = linearises if α8, 2 cuts if α5 
    
Inta673F  Inta8673R α3, α6 & α7 EcoRV = linearises if α7, does not cut α3 or α6 
   Taq I digest = different banding patterns for α3 and α6. Taq I cuts vector 4 times.  
    
Inta49Fb   Inta49Rb α4 & α9 RSA I digest = 2 bands if α4 
   RSA I digest = 1 band if α9 
 
Table 2-5 Restriction Digest Strategies for Identifying α Integrins in Degenerate PCR Products 
Outline of the restriction digests to be used to identify different α integrin amplicons from degenerate PCR products based on restriction mapping.
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Table 2-6 Restriction Digest Strategies for Identifying β Integrins in Degenerate PCR Products  
Outline of the restriction digests to be used to identify different β integrin amplicons from degenerate PCR products based on restriction mapping.  
 
Forward 
Primer 
Reverse 
Primer 
Integrin 
Subunits 
Restriction Digest Strategy 
Intb28F   Intb28R β2 & β8 Stu I digest = linearised if β2 
   Nco I digest = 2 bands if β8 
    
Intb147F  Intb147R β1, β4 & 
β7 
RSA I digest = 2 bands if β1 
   Eco RI = 3 bands if β4 
   HindIII digest = linearised if β7 
    
Intb356Fb   ntb356R β3, β5 &β6 Kpn I digest = linearised if β3 
   Sal I digest = 2 bands if β5 
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2.8.5 DNA Sequencing 
As an additional confirmation of which integrin subunits had been detected by 
degenerate PCR, samples of the plasmid DNA created in the cloning experiments was 
sent for DNA sequencing (Source Bioscience); samples were sent for sequencing at a 
concentration of 100ng/µl. 
2.9 Quantitative PCR  
2.9.1 Utricular cDNA Samples for qPCR 
A sample of normal, uncultured adult mouse utricle cDNA was obtained in the same 
manner as that used for degenerate RT-PCR experiments. This sample consisted of the 
cDNA produced from a pool of 10 utricles dissected from 5 individual adult mice. The 
full process of RNA extraction from this tissue and reverse transcription to cDNA is 
described in 2.1.  
Three time points were selected for investigation of integrin expression levels using the 
utricular culture model developed in chapter 4; these were 4 days, 14 days and 21 days 
post-gentamicin. These time points were selected in order to represent the tissue at 
different stages in the process of hair cell death i.e. early on at 4 days where a large 
amount of hair cell death and then at 14 and 21 days, where there was believed to be a 
limited amount of regeneration occurring e.g. appearance of immature stereocilia 
bundles.  
Culture experiments were carried out as described in chapter 4, to produce a pooled 
sample of 8 – 10 individual utricles for each time point. At the end of the culture 
incubation period, the tissue was placed immediately into RNAlater. RNA extraction 
and reverse transcription to obtain cDNA was then carried out using the same methods 
as for normal utricular tissue samples.  
2.9.2 Integrin Screen with Custom TaqMan® Array 
Quantitative PCR was carried out using TaqMan® Custom 96 well plates (Applied 
Biosystems) containing TaqMan® assays for individual integrin subunits, in addition to 
two different endogenous controls and four hair cell markers; calretinin, myosinViia, 
Atoh1 and Pou4f3. Four replicates of each assay were present on each individual 96 
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well plate. A single 96-well plate was used per cDNA sample i.e. 4 separate array plates 
were run. The full plate layout is shown in figure 5-1. 
TaqMan® gene expression assay probes feature a reporter dye at their 5’ end, such as a 
FAM™ dye, and a non-fluorescent quencher at their 3’ end. In a qPCR reaction, the 
TaqMan® probe will bind specifically to a complimentary DNA sequence within the 
target gene for which the assay was designed. When intact, the fluorescence of the 
reporter dye is suppressed due to its proximity to the quencher dye, however, due to the 
activity of DNA polymerase during the extension phase of the PCR reaction, the 
reporter dye at the 5’ undergoes cleavage from the TaqMan® probe. The level of 
fluorescence within the assay is therefore increased as more reporter dye molecules are 
cleaved during each qPCR reaction cycle; thus detecting the amplification of the target 
gene within a given assay.  
All qPCR experiments were carried out on a SDS7500 real-time PCR System (Applied 
Biosystems) as described in the protocol provided for the customised 96-well plates. For 
each cDNA sample, a ‘cocktail’ containing 432µl of cDNA, 648µl of ddH20 and 1080µl 
of TaqMan® master mix (Applied Biosystems) was made up and mixed by pipetting. 
To each of the 96-wells of a single custom integrin gene expression plate, 20µl of this 
‘cocktail’ was added. Each plate was then sealed with MicroAmp® optical adhesive 
film (Applied Biosystems) and centrifuged to ensure the whole reaction volume had 
been brought to the bottom of the plate wells. 
Each plate was run using the following thermal cycling conditions summarised in the 
table 2-7.  
 
Hold Hold 
PCR (50 cycles) 
Melt Anneal/Extend 
50°C 95°C 95°C 60°C 
2:00 0:20 0:15 1:00 
 
Table 2-7 Thermal Cycling Conditions for qPCR Experiments 
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2.9.3 Relative Quantification of qPCR Experimental Data 
Relative quantification (RQ) analysis of the results of the qPCR experiments carried out 
during this project was performed using SDS1.2.1 software (Applied Biosystems). 
Relative quantification of this data used the comparative CT method to establish whether 
there was any change in the expression of the integrin genes screened for at several time 
points following gentamicin treatment.  
The comparative CT method of relative quantification calculates the amount of a given 
target gene e.g. itgb1, normalised to the expression of an endogenous control gene e.g. 
18S RNA, relative to a calibrator sample. In these experiments, the calibrator sample for 
each gene screened for was the expression level in utricular cDNA from tissue dissected 
from normal adult mice which had not been maintained in vitro. The RQ values 
obtained by using the comparative CT method are calculated using the formula RQ = 2
-
ΔΔC
T, where CT represents the fractional cycle number at which the amount of the target 
amplified during the PCR reaction reaches a set threshold level.  
Following initial analysis, the RQ studies carried out in this project were assessed in 
order to determine whether the baseline and threshold values generated by the SDS 
software were appropriate. Baseline values (the initial qPCR cycles where there is very 
little change in the detected fluorescence levels) for each detector were set such that the 
amplification curve began after the maximum baseline value. The threshold for each 
detector was set in the exponential phase of the amplification curve, since RQ analysis 
is only accurate within this phase.  
Gene expression plots were generated by the SDS software using the RQ values 
calculated, showing the fold-difference in expression of each target gene at a particular 
time point following gentamicin treatment, relative to the calibrator sample which had 
not been exposed to the ototoxic drug or maintained in vitro. Error bars for these graphs 
were calculated where there were two or more replicates with an RQ value for a given 
target; these error bars show the RQ maximum and RQ minimum levels. Confidence 
levels for the RQ maximum/minimum values for these gene expression plots were set at 
95%, therefore the error bars on all gene expression plots presented in this thesis show 
the upper and lower limits within which the true gene expression level of a given target 
is likely to occur, with 95% confidence. For a particular target gene, where the RQ 
values at two time points are different and the error bars indicating the RQ 
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maximum/minimum values do not overlap, the RQ values may be said to be 
significantly different from one another, with a significance level of 0.05. 
2.9.4 Optimisation of qPCR Reactions  
The protocol for the use of the customised integrin TaqMan® gene expression arrays 
recommends the use of 1-100ng of cDNA per 20µl reaction volume. In order to 
determine the optimal amount of cDNA required for these qPCR experiments with 
utricular cDNA, a series of control assays were carried out. Individual assays for 
myosin VI were initially carried out using 50ng cDNA per well. This qPCR run 
indicated that myosin VI began to be amplified in the cDNA samples from cultured 
utricles after between 33 and 39 cycles, as shown in figure 2-1 A.  
In order to allow amplification to begin at a lower cycle number, and therefore ensure 
more reliable results, a second control qCPR experiment was run using the cDNA at a 
higher concentration of 150ng/µl. Each well had 4µl of cDNA solution added – a total 
of 600ng of cDNA was therefore used per assay. Figure 2-1 B shows that under these 
conditions, myosin VI amplification began at around cycle 30 for cDNA from utricles 
maintained for 4 and 14 days post-gentamicin treatment. The cDNA sample from 
utricles maintained for 21 days post-gentamicin showed myosin VI amplification began 
at cycle 33. The use of 600ng of cDNA per assay was therefore selected for use on the 
customised integrin TaqMan® gene expression array plates.  
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Figure 2-1 Optimisation of the Amount of cDNA Required for qPCR Experiments 
(A) Myosin VI assays with each cDNA sample (4, 14 and 21 days post-gentamicin) 
using 50ng of cDNA per well. Amplification of myosin VI began between cycles 33 
and 39. (B) A larger amount of cDNA, 600ng per well, showed that amplification of 
myosin VI began earlier, at between cycles 30 and 33. Therefore, 600ng of cDNA 
per assay was selected as the amount to be used per reaction on the customised 
integrin TaqMan™ gene expression arrays.  
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2.9.4 Multiplexed Integrin Assays 
Individual integrin subunit multiplexed qPCR assays were carried out in 96-well plates 
(Applied Biosystems). 4μl of each cDNA sample (at a concentration of 150ng/μl) to be 
analysed was pipetted into individual wells. To each cDNA sample, 6μl of a reaction 
‘cocktail’ was added using a repeat pipettor (Eppendorf); the ‘cocktail’ consisted of 
0.5μl endogenous control (18S RNA) assay, 0.5μl target assay (e.g. an integrin subunit) 
and 5μl of TaqMan® master mix. All integrin assays and the 18S RNA assay were 
supplied by Applied Biosystems. The 96-well plates were sealed with MicroAmp® film 
and centrifuged to bring the reaction mixture to the bottom of each well.  
Individual multiplexed assays were run using the same thermal cycling conditions as for 
the custom gene expression assays as shown in table 2-7. Relative quantification 
analysis of the results of these qPCR experiments was performed using SDS1.2.1 
software as described in 2.9.3. 
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Chapter 3: Integrin Expression in the Normal Adult Mouse Utricle 
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3.1 Detection of Integrin Subunits Expressed in the Normal Adult Mouse Utricle 
by RT-PCR 
3.1.1 Objectives 
There have been few previous studies regarding the presence of members of the integrin 
family of proteins in the mammalian inner ear. Of these studies, most only describe the 
expression of a small number of integrin subunits within the embryonic or very early 
postnatal mouse (Davies, 2007; Davies and Holley, 2002; Littlewood Evans and Muller, 
2000) . The expression of integrins in the normal adult mouse utricle had not been 
investigated prior to the start of this project.  
In order to examine whether there are changes in the expression level or expression 
pattern of integrins in response to gentamicin-induced hair cell loss and any subsequent 
regeneration, it was first required to establish which of the 18 α and 8 β integrin 
subunits are present in the utricle in its normal, undamaged state.  
Due to the large number of integrin subunits which exist in mammals, it was determined 
that the design of degenerate RT-PCR primers would be the most appropriate method 
for conducting a ‘screen’ of the normal adult mouse utricle for all of the known murine 
integrins. Degenerate PCR was intended to be used as a primary screen of the tissue of 
interest. Using the information gathered by degenerate PCR, further experiments e.g. 
immunohistochemistry, could then be focused on exploring the expression pattern of 
those integrins found to be present in the utricle. The use of degenerate primers would 
be preferable to conducting individual RT-PCR experiments for each of the integrin 
subunits, since the latter would be more costly, in addition to being more time 
consuming. The integrin protein family is a large one; consisting of 26 α and β subunits 
in total. The use of degenerate primers, with the ability to detect multiple integrins 
within one PCR experiment would therefore be greatly beneficial. The initial aims of 
this section of the project were to design a set of functional degenerate PCR primers 
which would detect all of the known murine integrin subunits; one set of primers to 
detect the α subunits and a second set to screen for the β subunits.  
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3.1.2 Design of Degenerate Primers  
Previous work on the development and use of degenerate primers for detecting the 
integrins by PCR had been conducted (Pytela et al., 1994) predominantly using the 
human version of each of the subunits which had been identified at that time. The 
sequencing of the human genome had not yet been completed when this previous work 
was undertaken, thus it utilised the amino acid sequences of the known vertebrate 
integrins, rather than DNA sequences. Since this earlier study took place, a further four 
integrin subunits have been identified; α10, α11, αE and αD.  
The initial method  applied to the design of degenerate integrin primers was to use the 
Clustal W2 program (http://www.ebi.ac.uk/Tools/msa/clustalw2/) to perform sequence 
alignments of the murine DNA sequences of all 26 known integrin subunits when 
divided into two groups: the α subunits and the β subunits.  The results of this alignment 
analysis, however, proved to be unsuitable for the production of degenerate PCR 
primers. There was not a high enough degree of homology between all of the α subunits 
when aligned as a group, nor between all of the β integrins subunits. Producing 
degenerate primers from these sequence alignments would have required the 
incorporation of a large amount of ‘wobble,’ which would have compromised the ability 
of the primers to specifically amplify members of the integrin protein family.  
3.1.2.1 Division of the Integrins into Subgroups Based on DNA Sequence 
Homology 
Although often described as a “family,” the integrins may be further divided into 
subgroups based on several factors, including the ECM ligands to which they bind 
(Johnson et al., 2009).The α subunits may be divided into four subgroups as follows; the 
laminin binding subunits (α3, α7 and α6), the RGD sequence binding subunits (αIIb, 
αV, α5 and α8), and a small group consisting of α4 and α9. All of the remaining α 
subunits possess a domain known as the αI domain and thus form a large subgroup, 
which can be further divided into α subunits which are able to bind collagen (α1, α2, 
α10 and α11) and those which are expressed in leukocytes (αE, αM, αD, αX, αL).  
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Figure 3-1 A Degenerate PCR-based Approach for Identifying Integrin Subunits Expressed in Normal Adult Mouse Utricular Tissue 
This flow chart summarises the strategy used in this project in order to determine which integrin subunits are expressed in the normal adult mouse 
utricle.  Full details of the methods used in these experiments are provided in 2.7.  
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In order to design degenerate PCR primers, the α and β integrins required division into 
further subgroups depending on their degree of homology to one another. The 
ClustalW2 program was used to generate dendrograms in order to illustrate the 
relationships between the murine α and β subunits in terms of their DNA sequence. 
These resulting integrin ‘family trees’ are shown in figure 3-2.  
The α subunits (Figure 3-2 A) are divided into five main subgroups based on DNA 
sequence homology. These groups are similar to those described in terms of the 
evolution of the integrin family (Johnson et al., 2009). These groups also correspond to 
the ligand binding properties of the α integrins as described earlier in this chapter. It was 
possible to align the sequences of the α integrins within each group and obtain a high 
enough degree of homology in certain regions to be able to design degenerate primers. 
These regions (shown in figure 3-3) were similar to those consensus regions identified 
in previous work using the amino acid sequences of vertebrate integrin subunits (Pytela 
et al., 1994). The β integrin groups identified by the dendrogram produced based upon 
DNA sequence homology proved more difficult to use to design degenerate primers. 
The β integrins, although fewer in number, are considered to be more variable in terms 
of their DNA sequence e.g. integrin β4 has a cytoplasmic tail region which is far longer 
than any of the other β integrin subunits (Ewan et al., 2005). Further refinement of the β 
integrin groups was determined by running test alignments of variant combinations; this 
process resulted in 3 groups of integrin β subunits.  
The final groups to be used for degenerate primer design are shown in table 3-1. 
Integrin αL is not included in these groups; this subunit is shown in the dendrogram in 
figure 3-2 to be on a branch of its own in terms of DNA sequence homology. Since αL 
is a highly leucocyte-specific integrin (Berlin et al., 1995), and thus perceived as highly 
unlikely to be found in the tissue of interest, it was decided to omit this α subunit from 
the design of integrin degenerate PCR primers. 
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Figure 3-2 Homology of the Murine Integrin Subunit DNA Sequences 
Dendrograms produced using the ClustalW2 program based on the murine DNA sequences for all the known (A) α and (B) β integrin subunits. The α 
integrins are divided into five main groups based on their homology, whilst the β integrins are divided into 3 groups. This data was used to determine 
how many sets of degenerate primer pairs were required in order to screen normal utricular tissue for all of the known murine integrins. 
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Figure 3-3 Consensus Regions of the α and β Integrin Subunits 
(A) DNA sequence of an α integrin, i.e. α1, showing the location of 5 consensus regions (A1 – A5) used to design sets of degenerate PCR primers. The 
regions represented by grey boxes indicate regions where (Pytela et al., 1994)successfully designed degenerate primers based upon integrin amino acid 
sequences (direction of the arrows differentiates between forward and reverse primers). I domain = an integrin domain only found in some α integrin 
subunits. (B) DNA sequence of a β integrin, i.e. β1, indicating the conserved putative ligand-binding domain (blue box). Degenerate primers designed 
were located within this region (B1 indicates forward primers, B2 reverse primers). Previous work had also used two further regions (B3 & B4) for 
degenerate primer design. TM = transmembrane domain.  
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 Group Integrins  
Integrin α Subunits   
 Alpha A α1, α2, α10, α11 
   
 Alpha B αX, αE, αM, αD 
   
 Alpha C α3, α6, α7 
   
 Alpha D α5, α8, αV, αIIb 
   
 Alpha E α4, α9 
   
   
Integrin β Subunits   
 Beta 1 β1, β4, β7 
   
 Beta 2 β2, β8 
   
 Beta 3 β3, β5, β6 
 
 
 
 
  
 
 
 
 
Table 3-1 – Integrin α and β Sub-Groups for the Design of Degenerate PCR 
Primers 
This table shows the division of the integrin α and β subunits into groups; 5 for the αs and 3 
for the βs. These sub-groups were determined by using the dendrograms shown in figure 3-
2 based on DNA sequence homology.  
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3.1.2.2 Criteria for the Design of Degenerate Primers 
For each α and β sub-group, DNA sequence alignments were run using the Clustal W2 
program and consensus regions identified. The previous work of  (Pytela et al., 1994), 
demonstrated similar consensus regions to those identified by these alignments. Figure 
3-3 highlights the regions of the DNA sequence where degenerate primers designed for 
this project are located, in relation to those of this previous study. These consensus 
regions were then used to design a set of degenerate primers, based on a number of 
criteria. Each forward and reverse primer was required to be at least 23 base pairs (bp) 
in length. Additionally, an amplicon size of around 200bp was deemed optimal in order 
to allow for subsequent analysis of the PCR products by restriction digest; smaller 
amplicons would be more likely to produce small, difficult to detect fragments in such 
experiments.  
Degeneracy scoring was applied in order to select the best possible primers. This 
allowed the potential number of different primer sequences which could be produced 
based on the sequence alignments of the integrin subunits of a given group. For 
example, the INTAallF primer sequence of GGGCCAGATNGGVTCHTAYTTTGG, 
contains 4 sites at which degeneracy is required. N, Y & H represent sites at which there 
is 2-fold degeneracy and V a site at which there is 4-fold degeneracy. The degeneracy 
score for this primer is therefore calculated as 2 x 4 x 2 x 2 = 32. Degeneracy scores 
were required to be as low as possible, in order to maintain specificity to the integrin 
family of proteins. During the design process, the Oligo Calc online tool 
(http://www.basic.northwestern.edu/biotools/OligoCalc.html) was used to analyse 
potential primer sequences in order to assess their GC content, melting temperature (Tm) 
and to check for self complimentarity which might affect the efficacy of the primer. 
Where the Tm of a primer sequence was deemed to be lower than was preferable (which 
occurred in shorter primer sequences), GGC repeats were added to the 5’ end in order to 
raise the Tm. Figure 3-4 shows a summary of the degenerate primer pairs designed, 
including the sequences for both forward and reverse primers, the integrin subunits 
which each pair was designed to detect, the expected amplicon size and the positive 
control tissue used to test the efficacy of the primers. Each primer pair was also given 
an abbreviated name e.g. A1, for ease of reference in latter results of PCR experiments. 
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3.1.3 Testing of Degenerate Primers Using Positive Control Tissue 
Degenerate primer efficacy was verified by running PCR experiments using positive 
control tissue cDNA. Of the 12 degenerate primer pairs designed, 8 pairs produced PCR 
products of the expected amplicon size when run on an agarose gel. Figures 3-5 and 3-6 
show gel images of all successful RT-PCR reactions for the α (Figure 3-5) and β (Figure 
3-6) degenerate primers. 
Positive control tissue testing i.e. tissue known to express a given integrin subunit, was 
used to confirm whether each primer pair had the ability to detect each integrin subunit 
it was designed to, should that subunit be present in a given cDNA sample. Without this 
confirmation, it would be more difficult to establish in utricular cDNA whether a 
particular subunit was not present at all, or if it was in fact expressed, but not able to be 
detected effectively by the degenerate primers.   
Appropriate positive control tissues were selected using the NCBI Unigene 
(http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglist=Mm.263396) 
database to view the EST profile of gene expression within a range of tissues for each of 
the integrin subunits being detected.  The control tissue used for each primer pair was 
selected on the basis that it demonstrated a significant level of expression of each of the 
integrin subunits which the primer pair was designed to detect. The control tissues used 
for each set of primers are shown in figure 3-4.  
Some primers required optimisation of the PCR reaction conditions in order to function 
effectively e.g. alteration of the cDNA concentration, annealing temperature or MgCl2 
concentration. The optimal RT-PCR reaction conditions for each set of primer pairs are 
summarised in table 3-2. All of the PCR products from successful degenerate RT-PCR 
experiments shown in figures 3-5 and 3-6 were cut out of the agarose gel, to be used in 
cloning experiments to identify which integrin subunits were successfully amplified by 
each primer pair.  
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Primer Pair 
(Oligo Names) 
Abbreviated 
Primer Pair 
Name 
Forward Primer Reverse Primer Integrins 
to be 
Detected 
Control 
Tissue 
Amplicon 
Size (bp) 
       
INTAall1F + INTAxmdeR A1 ggcCAGATNGGVTCHTAYT
TTGG 
GGKGCMCCAATRGCCACATCY
G 
αX, αM, 
αD & αE 
Spleen 275 
INTAxmdeF + INTAxmdeR A2 ggcCAGATBGGSTCYTAYT
TTGGSKC 
GGKGCMCCAATRGCCACATCY
G 
αX, αM, 
αD & αE 
Spleen 275 
INTA2110bF + INTA2110R A3 ggcGTKGGRGCYTWTGACT
GGRRBGG 
ggcCCAAARTAKGAKCCDATCT
GVTC 
α1, α2, α10 
& α11 
Spleen 281 - 290 
INTA2110bF + INTAall1R A4 ggcGTKGGRGCYTWTGACT
GGRRBGG 
ggcCCAAARTADGABCCNATCTG α1, α2, α10 
& α11 
Spleen 281 - 290 
INTA673F + INTA8673R A5 GCHGTBTAYGTSTWCATK
AACCAG  
AKCCATCYTGGTTVAKRTCMCC α3, α6 & 
α7 
Spleen 
& lung 
127 - 130 
INTA82b5VF + INTA75V82bR A6 GGWGARCAGATGGCHKC
NTAYTT 
AKCCRTCYYGGTYSAGGTCHCC
CA 
α5, α8, αV 
& αIIb 
Spleen 
& lung 
259 - 268 
INTA82b5VF + INTA8673R A7 GGWGARCAGATGGCHKC
NTAYTT 
AKCCATCYTGGTTVAKRTCMCC α8 Spleen 
& lung 
262 
INTA49Fb + INTA49Rb A8 CTKGGCGACATTGAYRAT
GACGG 
CCTGAKATRGAYTGYCCAAAC
ATCC 
α4 & α9 Spleen 185 
       
INTB28F + INTB28R B1 ATACCCCRTKGATCTKTA
YTAYCT 
ATGGCATCMARMCCWCCYTCA
GG 
β2 & β8 Lung 348 
INTB356aF + INTB356R B2 GAYMTSTAYTACYTSATG
GACCTSTC 
GYAGCCTGSAKGAYBGCRTCAA
A 
β3, β5 & 
β6 
Kidney 
& 
spleen 
350 - 356 
INTB356bF + INTB356R B3 TSTAYTACYTSATGGACCT
STC 
GYAGCCTGSAKGAYBGCRTCAA
A 
β3, β5 & 
β6 
Kidney 
& 
spleen 
346 - 352 
INTB147F + INTB147R B4 ATACCCCRTKGATCTKTA
YTAYCT 
CTGCADRATKGCATCAAAGCCV
CCTTC 
β1, β4 & 
β7 
Lung 333 - 345 
 
 
Figure 3-4. Degenerate PCR Primers for the Detection of the Integrin α and β Subunits in the Normal Adult Mouse Utricle 
Summary table of the degenerate primers pairs used to detect integrins. Wobble was incorporated into the primer sequences as appropriate; Y = C or T, 
V = A or G or C, M = A or C, R = A or G, H = A or C or T, K = G or T and B = G or C or T. Lower case indicates where GGC repeats were added.  
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 Primer Pair Band Detected 
by RT-PCR 
(Positive 
Control) 
Integrin Subunits 
Successfully Amplified 
(Positive Control) 
Band Detected by RT-
PCR (Normal Utricle) 
Integrin Subunits 
Successfully 
Amplified (Normal 
Utricle) 
α Integrins      
 A1 Yes * αM &/or αE, *αX &/or 
αD 
No None 
 A2 No    
 A3 Yes α1 & α10 Not used Not used 
 A4 No    
 A5 Yes α7 Not used  Not used 
 A6 Yes **α8 and/or α5, αIIb 
and/or αV 
Not used Not used 
 A7 No    
 A8 Yes α4 & α9 Yes α4 & α9 
      
β Integrins      
 B1 Yes β2 & β8 Yes β8 
 B2 Yes β5 & β6 Yes β5 & β1 
 B4 Yes β7 & β1 Yes None 
Table 3-2 Summary of Integrin Subunits Detected by Degenerate Primers in Positive Control and Normal Utricle cDNA  
The results of the RT-PCR experiments using the integrin degenerate primer pairs are summarised to show which primers worked successfully (i.e. a 
band of the expected amplicon size was detected) and which subunits were identified through restriction digest/DNA sequencing as being present in these 
PCR products. */** indicates subunits with very similar restriction maps which prevented them from being distinguished from one another. Primers 
which did not show sufficient capabilities to detect their cohort of subunits are indicated as ‘not used’; these primers were not tested with utricular cDNA. 
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Figure 3-5 Integrin α Subunit Degenerate RT-PCR using Positive Control cDNA 
RT-PCR products run on an agarose gel stained with ethidium bromide. Bands consistent with the expected amplicon size were detected for the 
following primer pairs. (A) Primer pairs A1 (lane 1, 281-290bp), A2 (lane 3, 275bp), A7 (lane 10, 262bp) and A8 (lane 12, 185bp). (B) Primer pair A6 
(lane 7, 259-268bp). (C) Primer pair A4 (lane 4, 281-290bp). (D) Primer pair A5, using both spleen (lanes 1 & 3, 127-130bp) and lung (lanes 2 & 4, 
127-130bp) control cDNA.  La = 100bp DNA ladder (Promega).  
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Figure 3-6 Integrin β Subunit Degenerate RT-PCR using Positive Control Tissue 
cDNA 
RT-PCR products run on an agarose gel. Bands consistent with the expected amplicon 
size were detected with the following primer pairs. (A) Primer pair B1 (lane 1, 348bp), B2 
(lane 3, 350-356bp), B3 (lane 5, 346-352bp, with kidney cDNA) and B4 (lane 6, 333-
345bp). (B) Primer pair B3 (lane 2, 346-352bp) using spleen control cDNA.  La = 100bp 
DNA ladder (Promega). 
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3.1.4 Identification of Individual Integrin Subunits Detected in Control Tissue 
Individual integrin subunits successfully detected by each primer pair were identified by 
the cloning of RT-PCR products and restriction digest; full details of this process is 
given in 2.8. DNA sequencing was also used to confirm the identity of the detected 
integrins.  
A total of at least 15 integrin subunit genes were confirmed as having been detected by 
degenerate PCR; these were (as shown in table 3-2) Itga1, Itga4, Itga7, Itga9, Itga10, 
Itga8 and/or Itga5, Itga2b and/or Itgav, Itgam and/or Itgae, Itgax and/or Itgad, Itgb1, 
Itgb2, Itgb5, Itgb6, Itgb7 and Itgb8. 
Figure 3-7 shows an example of a restriction digest which successfully distinguished 
between two potential integrin gene amplicons within PCR products obtained using the 
A8 primer pair. An RsaI digest produced different DNA banding patterns depending 
upon whether the amplicon incorporated into cloned plasmid DNA was from Itga4 or 
Itga9 i.e. Itga9 would produce two DNA bands of 1898 and 1304 base pairs (bp) in 
length, whereas incorporation of Itga4 would result in a single cut of the DNA, 
linearising the plasmid and visible as a single DNA band when run on an agarose gel. 
Figure 3-7 shows 5 samples with a single DNA band of 3.1kb, indicating the presence 
of Itga4; the remaining 14 samples produced two DNA bands, thus were determined to 
contain the Itga9 amplicon. Restriction digests were utilised in this manner for all 
degenerate PCR products to identify individual integrins. The restriction digest 
strategies used are summarised in tables 2-5 and 2-6. Gel photos of these digests are 
provided in the appendix.  
Representative samples believed to have been identified as a given subunit, as well as 
samples which restriction digest had failed to conclusively identify, were sent for DNA 
sequencing (Source Bioscience). The DNA sequence data received was run as a BLAST 
alignment in order to confirm the identity of the integrin subunit detected.  
The process of attempting to determine which integrin subunits the degenerate primers 
designed were successfully able to detect was time consuming, due to the nature of the 
cloning experiments being carried out to generate sufficient DNA for restriction digest 
analysis. Colony numbers following transformation of competent cells with plasmids 
containing PCR product inserts were often very low, which made it difficult to obtain 
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enough samples so as to have a chance of finding a colony which had taken up each of 
the different possible amplicons each degenerate primer pair was designed to amplify.  
Additionally, some of the integrin amplicons displayed such a high homology to one 
another that their restriction maps were virtually identical, making it impossible to 
differentiate between some amplicons by restriction digest i.e. the Itgam and Itgae 
amplicons. The decision was therefore made to progress on to using the degenerate 
primers on normal adult utricular tissue despite not having the ability to detect all 26 
known murine integrins. 
3.2 Degenerate RT-PCR using Normal Adult Mouse Utricular cDNA 
Degenerate RT-PCR experiments using cDNA obtained from a sample of normal adult 
mouse utricles detected the presence of the following integrin genes; Itga4, Itga9, Itgb1, 
Itgb5 and Itgb8.  
The degenerate RT-PCR experiments using utricular cDNA with the following primer 
pairs, produced bands of the expected amplicon size when PCR products were run on an 
agarose gel; A8, B1, B3 and B4 (gel images shown in figure 3-8). Positive control 
reactions were run alongside those using utricular cDNA in order to show that the 
primers were functioning correctly under the reaction conditions. Primer pair A1 did not 
produce a DNA band with utricular cDNA; since the positive control reaction did detect 
PCR products, it was concluded that the utricular cDNA sample did not contain any of 
the integrins detected by the A1 primers.  
PCR products from these experiments were cloned and the resultant plasmid DNA 
subjected to restriction digest in order to identify individual integrins. Plasmid DNA 
transformed with PCR products produced using the A8 primer pair were digested with 
RsaI. This digest, when run on an agarose gel (Figure 3-9) produced one DNA band if 
the Itga4 amplicon had been ligated into the vector and two bands if Itga9. The results 
of this digest show that both Itga9 and Itga4 were detected in normal utricular cDNA. 
This result was confirmed by BLAST alignments run using DNA sequence data from 
samples believed to be Itga4 (3-10 A) and Itga9 (3-10 B). The sample identified as 
containing the Itga4 amplicon was found to have a homology of 96.79% with the Itga4 
DNA sequence across a length of 156bp (the expected Itga4 amplicon size was 185bp). 
The sample identified as containing the Itga9 amplicon was found to have a homology 
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of 98.38% with the Itga9 DNA sequence across the entire length of the amplicon 
(185bp). 
Plasmid DNA samples obtained through cloning of the PCR products produced by the 
B3 primer pair were digested with EcoRI (Figure 3-8 B) in order to identify which 
samples contained an amplicon within the vector. There is an EcoRI restriction site on 
either side of the region where amplicons are ligated into the P-GEM®T Easy vector. 
Colony numbers in these cloning experiments were low, thus all 8 plasmid DNA 
samples which proved to have an amplicon insert were sent for DNA sequencing. Using 
BLAST alignments of the DNA sequencing data, 4 of these samples were identified as 
Itgb5, with a homology of between 94.97 and 98.58% to the Itgb5 DNA sequence. A 
further 2 samples were identified as integrin Itgb1 with a homology of 92.67%. The B3 
primer pair was not originally designed to amplify the Itgb1 gene. The remaining 2 
samples did not correspond to any of the known murine integrin genes.  
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Figure 3-7 Restriction Digest of Cloned PCR Products from RT-PCR with the A8 
Degenerate Primer Pair 
RsaI digest of A8 cloned PCR products of reactions run using utricular cDNA. Lanes 5, 14, 
15, 16 and 18 show clones which contain the Itga4 amplicon (RsaI linearises the plasmid 
DNA producing a single 3.1kb band). The remaining lanes show clones which contain the 
Itga9 amplicon (RsaI cuts plasmids with this amplicon twice to produce two bands of 1898 
and 1304 bp). La = 1kb DNA ladder (Promega) 
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Figure 3-8 Integrin Degenerate RT-PCR using Normal Adult Mouse Utricular cDNA 
Gel photos of degenerate PCR reactions using utricular cDNA. Bands of the expected amplicon size were detected using the following primer pairs. 
(A) The A8 primer pair (185bp) with positive control (lane 1, spleen) and utricular (lane 2) cDNA. (B) The B4 primer pair (~340bp) for both positive 
control (lane 1, lung) and utricular (lane 2) cDNA, and the B1 primer pair (348bp) with both positive control (lane 4, lung) and utricular (lane 5) cDNA. 
(C) The B3 primer pair (~350bp) for both positive control (lane 1, spleen) and utricular (lane 3) cDNA. Cristae cDNA also produced a band with the B3 
primers (lane 2). La = 100bp DNA ladder (Promega). S = spleen, U = utricle, C = cristae & N = negative control (no cDNA). 
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Figure 3-9 Cloned Degenerate PCR Products from Utricular cDNA Analysed by 
Restriction Digest 
(A) Plasmid DNA produced using PCR products of the A8 primers digested with RsaI. 
Lanes 1 – 4 & 9 – 12 = Itga9 (two DNA bands of 1898 & 1304 bp). Lanes 5 – 8 = Itga4 
(single 3.1kb DNA band).  (B) EcoRI digest of plasmid DNA produced using PCR 
products of the B3 primers, lanes 2, 3, 5, 6 and 9 show those which have successfully up-
taken a plasmid with an amplicon insert; EcoRI ‘cuts out’ the amplicon from the vector = 
plasmid DNA band + B3 amplicon (~350bp).   (C) TaqI digest of plasmid DNA produced 
using PCR products of the B3 primers. This digest produced several different banding 
patterns when run on a gel; lanes 1, 2, 4, 7, 8 & 10 appear similar (P1), as do lanes 3, 6 & 9 
(P2). A third banding pattern (P3) was observed in lane 5. Representative samples of each 
banding pattern were sent for DNA sequencing to conclusively identify individual 
integrins. La = 1kb DNA ladder and 100bp DNA ladder (Promega). 
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Figure 3-10 DNA Sequencing and BLAST Analysis to Confirm Identification of Subunits Successfully Amplified by Degenerate RT-PCR 
Samples from cloning experiments which had undergone restriction digest were sent for DNA sequencing to confirm the identity of the integrin 
amplicons. Samples believed to be Itga4 and Itga9 were sequenced and this data used to perform a Blast alignment. (A) Sample identified as having 
96.79% homology with Itga4 over a length of 156bp. (B) Sample  identified as having 98.38% homology with Itga9 over a length of 185bp. 
Alignment length and percentage identity are highlighted with bold text. Chromosome diagrams indicate the location of the Itga9 and Itga4 genes and 
the sequence homology found by BLAST (red bar). 
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Cloning experiments with PCR products of the B4 primer pair produced very few 
colonies despite repeating the experiment (both the ligation stage and the transformation 
of competent cells). The only plasmid DNA sample obtained for this primer pair was 
found not to contain an integrin subunit amplicon when DNA sequence data was 
subjected to BLAST alignment. B1 primer pair PCR product transformations also 
demonstrated low colony numbers. Four plasmid DNA samples were obtained for this 
primer pair; these were all identified as Itgb8 by BLAST alignment of the DNA 
sequence. A homology of between 95.11 and 99.71% was recorded for these samples.  
3.3 RT-PCR with Specific Integrin Primers 
3.3.1 Positive Control cDNA 
Integrin subunits which had not been detected by degenerate PCR primers in control 
tissue were evaluated as indicated in figure 3-1. Through consultation of published 
literature, a group of 5 integrin subunits which were believed likely to be expressed in 
utricular cDNA was identified. This group was comprised of several highly abundant 
subunits, as well as integrins which had been detected in inner ear tissue in previous 
studies; αV, α8, β1, β3 and α6. Individual specific PCR primers were therefore designed 
to detect each of these integrins; this design process is described in 2.7.5. Primer 
sequence data for these specific integrin subunit RT-PCR primers is provided in table 3-
3.  
As with the degenerate primers, specific integrin subunit primers were tested for 
efficacy using cDNA from an appropriate positive control tissue; spleen for integrins 
αV, α8 and β3, and lung for α6 and β1. Bands of the expected size were detected using 
control tissue with the primers for integrin α6, β1, β3 and αV. The results of these RT-
PCR experiments are shown in figure 3-11 where PCR products were run on an agarose 
gel. The integrin α8 primer pair was not observed to produce any PCR products, despite 
several different reaction conditions being tested.  Table 3-4 summarises the optimised 
reaction conditions at which each of the specific primer pairs functioned most 
effectively. 
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Integrin 
Subunit 
Forward Primer Tm (Salt 
adjusted) 
Reverse Primer Tm (Salt 
adjusted) 
 
Amplicon 
Size 
 
α6 
 
ATCACAGTGACTCCTAACAGAATTG 
 
63°C 
 
ACTGAACTCTCGATGACAACCCTGA 
 
66°C 
 
143bp 
      
β1 CTCTCTTTCTTCAGAAGTCATT 56°C ATTTATTAGCAGTTATGCTAATTTC 56°C 134bp 
      
β3  TGCAGTGACTGAAAATGTCGTCAGC 66°C CACGTACTTCCAGCTCCACTTTAGA 66°C 108bp 
      
α8 GGACAGGTCTACTTGTACCTTCAAG 66°C CATTGTAAATGAGGACTTTACCTCG 63°C 149bp 
      
αV CTGGCCTTGAAGTGTACCCTAGCAT 67°C TGCTTGAGTTTATCCAGTAGAAGCT 63°C 128bp 
 
 
 
 
 
 
Table 3-3 Integrin Subunit Specific RT-PCR Primers 
A summary of the 5 integrin subunits selected for the design of specific RT-PCR primers. The forward and reverse primer sequences are provided, as 
well as their Tm, as determined by the OligoCalc online tool. These integrin subunits were selected based upon their abundance in functional 
heterodimers (integrin αV and β1 are the two most ‘promiscuous’ integrin subunits) and have been previously identified in inner ear tissue in previous 
work. 
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3.3.2 Utricular cDNA 
All four integrin genes for which the specific integrin primer pairs were functional 
(Itga6, Itgav, Itgb1 and Itgb3) detected a band of the expected size when used in RT-
PCR reactions with utricular cDNA. Itga6 and Itgb3 were also detected in cDNA from a 
sample of cristae. The results of these RT-PCR experiments are shown in figure 3-12 
where PCR products were run on an agarose gel. 
The same RT-PCR reaction conditions determined by using positive control tissue were 
applied to experiments using utricular cDNA. Some primer pairs required further 
optimisation by alteration of the MgCl2 concentration to detect integrins in utricular 
cDNA effectively. Table 3-4 summarises the reaction conditions required for RT-PCR 
using utricular cDNA in comparison to those required for positive controls.  
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Figure 3-11 Testing of Specific Integrin Subunit RT-PCR Primers using Positive Control cDNA 
PCR products from specific integrin subunit primers and positive control tissue run on an agarose gel. (A) 2mM MgCl2 and an annealing temperature 
of 55°C produced bands of the expected size for Itga6 (lane 1 = lung cDNA) and Itgb3 (lane 9 = spleen cDNA). (B) 2mM MgCl2 and an annealing 
temperature of 60°C produced a band of the expected size with the Itgav primer pair (lane 3 = spleen cDNA). (C) 3mM MgCl2 and an annealing 
temperature of 62°C produced a band of the expected size with the Itgb1 primer pair (lane 3 = lung cDNA). The Itga8 primer pair did not function 
successfully under these conditions (lane 2). La = 100bp DNA ladder (Promega). L = lung, S = spleen & N = negative control (no cDNA). 
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Figure 3-12 Specific Integrin RT-PCR using cDNA from Normal Adult Mouse Utricles 
Specific RT-PCR primers detected Itga6 (A - lane 3), Itgb3 (A – lane 7), Itgav (B – lane 3) and Itgb1 (C – lanes 3 & 4) in utricular cDNA. Itga6 (A – 
lane 2) and Itgb3 (A – lane 6) were also detected in a cristae cDNA sample. Itgav (B – lane 2) and Itgb1 (C – lane 2) were not detected in cristae 
cDNA. Positive controls (using cDNA from an appropriate tissue) and negative controls (no cDNA) were run alongside inner ear cDNA RT-PCR 
reactions for each set of primers. S = spleen, L = lung, U = utricle, C = cristae & N = negative control. La = 100 bp DNA ladder (Promega). 
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Specific RT-PCR Primers PCR Reaction Conditions (Positive Control cDNA) PCR Reaction Conditions (Utricular cDNA) 
α6 Lung cDNA = 2µg Utricle cDNA = 2µg 
 Annealing temperature = 55°C Annealing temperature = 55°C 
 MgCl2 concentration = 2mM MgCl2 concentration = 2mM 
   
αV Spleen cDNA = 2µG Utricle cDNA = 2µg 
 Annealing temperature = 60°C Annealing temperature = 60°C 
 MgCl2 Concentration = 2mM MgCl2 concentration = 1mM 
   
α8 Not successful N/A 
   
β1 Lung cDNA = 2µg Utricle cDNA = 2µg 
 Annealing temperature = 65°C Annealing temperature = 65°C 
 MgCl2 concentration = 4mM MgCl2 concentration = 4mM 
   
β3 Spleen cDNA = 2µg Utricle cDNA = 2µg 
 Annealing temperature = 55°C Annealing temperature = 55°C 
 MgCl2 concentration = 2mM MgCl2 concentration = 1mM 
   
 
 
 
Table 3-4 Summary of Optimised Reaction Conditions for RT-PCR Experiments with Specific Integrin Subunit Primers 
Optimised RT-PCR reaction conditions for the specific integrin subunit primer pairs are shown for both positive control tissue and utricular cDNA. In 
some instances, conditions which worked for positive control cDNA did not function as efficiently with utricle cDNA. The α8 primer pair was tested 
with multiple reaction conditions using control cDNA (up to 5mM MgCl2 & an annealing temperature of 68°C) but no PCR products were detected. 
These primers were therefore not used with utricular cDNA. 
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3.4 Discussion 
3.4.1 The Homology of the Integrin Family of Proteins and Its Implications for 
Degenerate PCR 
In order to design a set of degenerate PCR primers which would be able to detect all of 
the known murine integrin subunits, an approach based on the homology of DNA 
sequences for these proteins was adopted. An initial attempt to design two sets of 
degenerate primers (one for detection of the α integrins and one for the βs) proved 
unsuccessful due to the lack of homology within these groups. Consensus regions 
sufficient for the design of an effective set of degenerate primers were not present 
amongst the α or the β integrin subunits.  
The dendrograms shown in figure 3-2, created using the murine DNA sequence 
information for the integrin subunits, represent the relationships between the α and β 
integrins in terms of their DNA sequence homology. The α subunits are divided into 5 
groups, which may be compared to previous studies on the evolution of the integrin 
subunits. Phylogenetic studies involving the comparison of integrin α subunits from 
numerous species including humans, mice and invertebrates such as Drosophila 
melanogaster, place these subunits into groups which correspond to those shown in 
figure 3-2 A (Hughes, 2001; Huhtala et al., 2005; Johnson et al., 2009). Each of these 
studies indicates that those α integrins which possess an I-domain form two separate 
groups; the collagen receptor integrins (α1, α2, α10 and α11), and the leucocyte 
integrins (αL, αM, αD, αE and αX). These previous studies describe a further two 
groups, known as the PSI and PSII integrin ‘families’ which feature Drosophila 
homologues. The PSI α integrins are α3, α6 and α7, as well as the Drosophila αPSI. 
These integrins (including the invertebrate homolog) are known laminin receptors 
(Belkin and Stepp, 2000). The PSII α integrins are α5, αV, αIIb and α8, plus αPSII from 
Drosophila. This group once again is linked by their ligand binding attributes; PSII α 
integrins are those capable of recognising and binding a particular RGD amino acid 
sequence in the ligands with which they interact. The mammalian integrins α4 and α9 
form the final α subgroup. Previous studies, however, also described an additional group 
– the PSIII integrins, of which there are no mammalian members, only invertebrate 
proteins (Johnson et al., 2009). It has been suggested that at some point in their 
evolutionary history, vertebrates lost this family of α integrins, whilst diversification 
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occurred within the other families in order to produce the numerous α subunits known 
today (Hughes, 2001). The α integrin groups defined in this work for the purpose of 
creating degenerate PCR primers are therefore supported by previous studies and 
investigation of the evolutionary origins of the integrins.  
During this project, the β integrins were divided into three groups based on a 
dendrogram of their DNA sequence homology (figure 3-2 B) which was refined by 
running test alignments and investigating these for appropriate consensus regions. 
Previous work (Hughes, 2001; Huhtala et al., 2005) divides the β integrins into two 
main subgroups; the β1 group – containing β1, β2  and β7 and the β3 group – containing 
β3, β5 and β6. The two remaining β integrins (β4 and β8) are described as each being a 
‘group’ of their own (Holmes and Rout, 2011), although integrin β8 is also described as 
being more closely related to the β3 group integrins (Hughes, 2001). Integrin β4, a 
considerably larger protein than the other β subunits, has been recently postulated as 
being the original ‘primordial’ β integrin (Holmes and Rout, 2011). Studies involving 
the integrins of organisms such as the invertebrate Ciona intestinalis, have shown that 
this proteostome possesses an integrin which is an orthologue of vertebrate β4 (Ewan et 
al., 2005), supporting the theory that the β4 integrin subunit had evolved prior to the 
divergence of vertebrate and ascidian species such as C. intestinalis.  
The dendrogram produced in this work using the mouse DNA sequences of the 8 
mammalian β integrins, differs somewhat from previous studies. Although figure 3-2 B, 
groups the ‘β3’ integrins together as in previous work, it places β1 and β8 together as a 
group, with the remaining subunits (β2, β4 and β7) forming a third group; this third 
group is most similar to the previously described ‘β1’ group, with β1 having been 
replaced by β4. Following initial examination by DNA sequence alignment, these 
groups were revised and whilst the ‘β3’ group remained unchanged, the two other 
groups were altered so that one consisted of β2 and β8, the other β1, β4 and β7.  
That the grouping of β integrin subunits does not completely agree with previous 
phylogenetic studies may be attributed to their high level of divergence in terms of 
DNA sequence which has been previously described. It has been observed that there is a 
far greater degree of homology between the sequences of one β subunit when compared 
across its homologs in other species, than there is amongst all of the β integrins from a 
single species (Pytela et al., 1994). The result observed in this project for the β integrins 
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is therefore likely to represent the way in which the DNA sequences of the 8 β subunits 
diverge which is specific to the mouse version of each gene.  
3.4.2 Integrin Subunits Detected in the Normal Adult Mouse Utricle by RT-PCR 
The results of the degenerate RT-PCR experiments on utricular cDNA carried out in 
this project indicate the presence of five integrin genes; Itga4, Itga9, Itgb1, Itgb5 and 
Itgb8. The use of specific integrin PCR primers on the same cDNA sample detected the 
presence of a further three subunits, namely Itga6, Itgav and Itgb3, and supported the 
finding that Itgb1 had been detected in the tissue of interest by the degenerate PCR 
primers.  Of these eight integrin subunits detected in the normal mouse utricle using this 
type of PCR, there are several potential heterodimers. All four of the α subunits detected 
can form a heterodimer with integrin β1, the most ‘promiscuous’ of the β subunits (it is 
present in a total of 12 known mammalian integrin heterodimers). Integrins α4 and α6 
can also associate with β7 and β4 respectively, although these integrins were not 
detected in the cDNA sample by RT-PCR. Integrin αV, the most ‘promiscuous’ α 
integrin, could also potentially associate with the β3, β5 and β8 subunits which were 
positively identified in these experiments.  
The degenerate PCR primers designed during this project were not proven to be able to 
detect all of the integrin subunits for which each primer pair was intended. This may 
potentially be attributed to certain integrin subunits not being expressed at a high 
enough level in the control tissue they were tested on. Where a primer pair was 
potentially able to detect any of four different subunits, it may have been possible that 
the control tissue selected contained some subunits at a higher expression level than 
others, making their detection more likely than those expressed in much lower 
quantities. Cloning experiments used to identify which subunits were present in the RT-
PCR product samples often produced low bacterial colony yields. Therefore, even if as 
many as 20 clones were examined, if a given subunit had been present in the cDNA at 
higher levels than others, this subunit would be more likely to be present in the cloned 
plasmid DNA. Based upon the results obtained during this project, degenerate PCR 
would not be considered the most effective method for conducting a screen of utricular 
cDNA for a protein family as diverse as the integrins. Had the full extent of the lack of 
homology amongst the α and β subunits been known, an alternative experimental 
approach for integrin screening would have been selected e.g. the use of a DNA 
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microarray, which could have been utilised to provide information on expression levels 
of integrins, in addition to their presence or absence from the murine utricle. It would 
also have been possible to begin this study with a selected cohort of integrin subunits 
most likely to be expressed in the tissue of interest based upon a search of the literature, 
as was carried out after the capabilities of the degenerate PCR primers had been 
exhausted.  
The integrins represent a group of proteins which are described as a ‘family,’ but which 
lack the degree of DNA sequence homology which might be expected of such a family 
of molecules. In the current era of genomics, with entire genomes for an ever-growing 
number of organisms being sequenced, it would seem unlikely, based upon the findings 
of this project, that by analysis of DNA sequence data alone, the 26 integrin subunits 
described in mammals would be considered homologous enough to warrant the term 
‘family.’ It might be conceivable that some of the integrin subgroups identified in this 
thesis show the degree of homology that might now be expected of a protein family i.e. 
those α integrins which possess an I domain. Whilst they do not exhibit such largely 
conserved DNA sequences as shown by other protein families, the integrins do share a 
great deal in terms of their protein structure and cellular functions. All integrins are 
comprised of an α and β subunit to form a heterodimer, creating an adhesion molecule 
which provides a link between the surroundings of a cell (be it the extracellular matrix 
or the surface of a neighbouring cell) and its intracellular environment. The integrin cell 
surface receptors, which might be considered unlikely to be identified as a protein 
family were their individual members discovered today with the weight of genomic data 
available, remain linked as a highly divergent family group through their shared 
functional role as adhesion molecules.  
In order to provide a more conclusive ‘screen’ of the normal adult mouse utricle and 
further establish which of the integrin α and β subunits are expressed in this tissue, a 
quantitative PCR based approach was deemed most appropriate. Using specific gene 
expression assays for each integrin subunit would remove the potential bias shown by 
the degenerate RT- PCR and cloning based strategies towards subunits expressed at a 
higher level in a given cDNA sample. Further discussion of the individual integrins 
detected in utricular cDNA in these degenerate and specific primer RT-PCR 
experiments is given in chapter 7, in order to provide a comparison with the results of 
subsequent qPCR analysis.   
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Chapter 4:  Organotypic Culture of Mouse Utricles 
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4.1 Development of Organotypic Adult Mouse Utricle Culture Techniques  
4.1.1 Objectives 
The adult mouse utricle was selected as the tissue culture model for the work to be 
undertaken during this project. There have been numerous studies carried out using 
mature mammalian vestibular sensory epithelium, maintaining this inner ear tissue in 
vitro for considerable time periods. Previous work has shown how mammalian utricular 
tissue maintained in culture can be damaged and hair cell loss induced by treatment with 
aminoglycoside antibiotics (Warchol et al., 1993). This tissue, both in vivo and in vitro, 
has also been shown to partially recover, with the observation of immature stereocilia 
bundles appearing on the apical surface which gradually develop a more mature 
morphology(Bermingham et al., 1999; Forge et al., 1993; Lin et al., 2011).  
Through the use of an in vitro culture system, it would be possible to alter the culture 
conditions of the tissue in order to successfully induce hair cell loss. The addition of an 
ototoxic drug i.e. gentamicin, to the culture medium would provide an easy method of 
manipulating the tissue as opposed to the systemic administration of antibiotic required 
for an in vivo approach. 
In order to establish a sustainable model, experiments were initially carried out using 
methods previously practised by the research group for the culture of mammalian 
vestibular tissue (Forge and Li, 2000; Li et al., 1995). With these techniques as a 
starting point, experiments were carried out to investigate how adult mouse utricular 
tissue responded when cultured in this way, leading to the refinement and adaption of 
the methods and culture conditions as was required to produce a degree of hair cell loss 
sufficient for use in later experiments and to maintain the tissue for a substantial length 
of time whilst retaining manipulative capacity. 
4.1.2 Use of MatTek™ Dishes Coated With Laminin 
Initially, organotypic cultures were grown on MatTek™ dishes. These dishes have a 
glass bottom surface, allowing high resolution images to be taken directly. To this glass, 
a coating of the extracellular matrix protein laminin (Sigma) was added. A laminin 
solution at concentration of 1µg/75µl in serum-free culture medium and a thin layer of 
this solution was spread over the glass. The solution was air dried for one hour and the 
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remaining excess liquid removed by pipetting to leave a thin coating of laminin on the 
bottom of the dish.  
Following dissection of the utricular tissue from the animal, a small volume of culture 
medium was added to the glass well of the MatTek™ dish on top of the laminin coating, 
and the tissue introduced with forceps, gently manipulating it in such a way that the 
utricles laid flat on the glass bottom, with the sensory epithelium uppermost. Culture 
medium was changed every other day, by removing and replacing half the total volume 
(200µl) of medium in order not to remove any essential secreted growth factors or other 
molecules. 
When attempting to maintain organotypic cultures in this manner for longer time 
periods, the tissue became noticeably thinner and flatter, with cells ‘growing out’ from 
the utricle. On reaching 21 days in culture and beyond, the tissue had become extremely 
thin. This change in morphology made subsequent manipulation of the cultured tissue 
i.e. immunohistochemistry of wholemounts, difficult and it would have proved to be an 
even greater challenge to use these utricles for cryosectioning.  
Initial experiments involved treatment of cultures with 2mM gentamicin for 24 hours 
only. This treatment failed to induce a significant degree of hair cell loss, when the 
tissue was labelled with hair cell markers (data not shown) to check for the presence of 
hair cells. Subsequently, all cultures were treated with 2mM gentamicin for a period of 
48 hours. This aminoglycoside treatment was administered 24 hours after the initial 
tissue dissection and the start of the culture time period in order to allow the dissected 
tissue time to stabilise in the in vitro environment. 
Although this approach successfully induced a sufficient degree of hair cell loss to be 
considered suitable for the study of the potential effects of hair cell loss on the integrin 
family, culturing on glass coated with laminin was not believed to be the optimal 
method of growing these cultures. The level of outgrowth seen and the difficultly this 
introduced into the use of the cultured tissue in subsequent experiments meant that an 
alternative surface on which to maintain the utricles was required. Laminin is an 
extracellular matrix protein and is therefore a potential ligand with which some integrin 
subunits are able to bind and interact; there were therefore concerns that using a laminin 
substrate could in itself have an effect on the expression and distribution of integrins 
during the culture process. 
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4.1.3 Use of Nitrocellulose Filter Papers 
As an alternative surface on which to maintain organotypic utricle cultures, the use of 
13mm diameter 0.45µm micropore nitrocellulose membrane filters (Millipore) was 
investigated. A single filter was added per individual well within a sterile 24-well plate 
(BD Falcon). Dissected utricles were carefully transferred onto the surface of these 
membrane filters with the sensory epithelium uppermost and covered with culture 
medium (400µl). Allowing a 24 hour period after dissection for the cultures to ‘settle’ 
prior to any gentamicin treatment, it was observed that the tissue appeared to settle 
quicker upon this surface and was therefore less inclined to be dislodged during 
subsequent changes of media.  
In comparison to observations of utricles grown on laminin-coated glass, utricles 
maintained on nitrocellulose filters exhibited less outgrowth and did not become as thin 
and flattened when kept for longer time periods as had previously occurred. This 
allowed easier removal of the utricles from the membrane filter surface for use in 
subsequent immunohistochemistry experiments than had previously been possible. 
Additionally, the membrane filters were used to an advantage when cultures required 
cryosectioning. By keeping the tissue in situ on the membrane filter and cutting out a 
small square of the filter around each utricle, the filter could be used as a guide when 
embedding the tissue in agarose to achieve the required orientation for sectioning and to 
ensure that the tissue remained flat. Since the filter paper could clearly be seen within 
the agarose block when mounted on a cryostat chuck, and also within cut sections, the 
filter paper could be used to accurately judge when sectioning the tissue that the 
required point in the agarose block had been reached. This enabled the maximum 
amount of cryosections from each utricle to be acquired. If culture explants grown on 
laminin had been used for this purpose, they would have been extremely difficult to 
visualise and there would have been a far greater risk of missing the tissue entirely 
whilst using the cryostat.  
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4.2 Gentamicin Treatment Induces Hair Cell Loss In Adult Mouse Utricular 
Cultures 
4.2.1 Organotypic Utricle Culture Morphology Under Transmission Electron 
Microscope 
To examine the ultrastructure of utricular culture tissue, control tissue which had been 
maintained in vitro for a total of 7 days and had not undergone gentamicin treatment 
was fixed and prepared as described in 2.5 for viewing by transmission electron 
microscopy.  
TEM sections of control utricles at this time point exhibit similar morphology to that 
expected within normal vestibular tissue. The sensory epithelium was well populated 
with hair cells which appeared to be viable, surrounded by supporting cells. The 
cytoplasm of hair cells has a lower electron density than that of supporting cells 
allowing these two cell types to be easily distinguished. Bundles of stereocilia are 
present on the apical surface of hair cells (Figure 4-1) whilst supporting cells have 
numerous microvilli apparent at their apices (Figure 4-2). A clearly defined basement 
membrane can be seen, dividing the distinct and separate regions of the organotypic 
culture tissue; the sensory epithelium (containing vestibular hair cells and supporting 
cells) and the underlying mesenchymal tissue (Figure 4-2). 
Many of the vestibular hair cells in these TEM sections appear in good condition; 
several different types of organelle can be discerned at high magnification within the 
hair cell bodies. Mitochondria of a healthy size and shape (shown in Figure 4-1) are one 
indicator which supports the data obtained from the immunohistochemistry experiments 
carried out in this project; a large number of vestibular hair cells continue to populate 
the sensory epithelium of the utricle when cultured for 7 days without the addition of 
gentamicin. Additional features of sensory hair cells visible in higher magnification 
images of these cell bodies include the golgi apparatus or golgi body (Figure 4-3) and a 
lamellar body towards the base of the cell. Lamellar bodies consist of sheets of lamellae 
which resemble rough endoplasmic reticulum in appearance - their presence has been 
previously documented in sensory hair cells (Saito, 1983) . 
In supporting cells, the cell cytoplasm is richly populated by vesicles (Figure 4-3) that 
appear to be full of an electron dense material, suggesting that they may be transport 
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vesicles in the process of conveying synthesised protein to the cell surface. This 
observation is supported by the results of subsequent imaging of utricular cultures under 
the scanning electron microscope (data presented in 4.2.4). It is possible that the 
vesicles observed by TEM could contain material synthesised within the supporting cell 
and that they are in the process of transporting this material to the apex of the cell to be 
secreted. This would also be an indicator of the health and survival of utricular tissue in 
culture using the techniques developed during this work. 
Although the vestibular sensory epithelium appears generally healthy, there is some 
evidence of a limited amount of hair cell death occurring in tissue which has not been 
exposed to the ototoxic antibiotic. Cellular debris (figure 4-2) is visible outside of the 
epithelium above the apical surface of the cells. From the observed size and shape of 
this debris, it would appear to have originated from a hair cell which has undergone cell 
death and been extruded from the epithelium. It would be expected that despite the best 
efforts during dissection and the culture period, some cell death might be inevitable due 
to the removal of the tissue from its natural environment. The immunohistochemistry 
studies carried out earlier in this project, however, would support the belief that hair 
cells survive well using the culture techniques developed and that the majority of the 
hair cell damage and loss observed in gentamicin treated utricles is as a direct result of 
the ototoxic drug and not a product of the culture process itself. 
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Figure 4-1 TEM of the Utricular Macula at 7 Days In Vitro  
TEM section of a control utricle maintained for 7 days in culture without gentamicin 
treatment. ‘Hc’ indicates a vestibular hair cell, whilst ‘sc’ denotes the surrounding 
supporting cells, which have cell bodies that are considerably more electron dense than 
those of hair cells. Mitochondria (mt) and an apical stereocilia bundle (st) are also shown in 
this section of the epithelial layer of the tissue. Bar = 2µm. 
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Figure 4-2 TEM of Utricular Sensory Epithelium and Underlying Mesenchyme at 7 
Days in vitro 
Utricular culture tissue maintained in vitro for 7 days without treatment with gentamicin 
viewed under TEM. The two main layers of the utricle; the sensory epithelium populated 
with hair cells ‘hc’ and supporting cells ‘sc’ and the underlying mesenchyme (‘me’) are 
separated by the clear border of the basement membrane ‘bm.’ Supporting cells have 
numerous microvilli (mv) projecting from their apical surface. Cellular debris (‘d’) is also 
visible outside of the epithelium in this section of tissue. Bar = 5µm. 
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Figure 4-3 TEM of Hair Cells and Supporting Cells in Utricular Tissue at 7 Days in 
vitro 
Utricular tissue cultured for 7 days in normal medium viewed by TEM. Supporting cell (sc) 
bodies are filled with vesicles (v) which appear to be filled with an electron dense material. 
An electron dense region at the apex of this supporting cell indicates an area of actin 
filaments (ac). Within the hair cell (hc) body, the golgi body (gb) and a lamellar body (lb) 
are both apparent within the cytoplasm. Bar = 1µm. 
sc 
hc 
v 
gb 
lb 
ac 
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4.2.2 Immunohistochemistry of Adult Utricles Treated With Gentamicin  
Utricular Cultures at 4 Days Post-Gentamicin Treatment 
Organotypic utricle cultures which had been subjected to 48 hours incubation with 
2mM gentamicin and had been fixed as described in 2.2.2, were labelled with 
fluorophore tagged phalloidin, in this case FITC-tagged (Fluorescein isothiocyanate). 
Phalloidin binds to f-actin and is used to visualise the actin cytoskeleton. In this tissue, 
Phalloidin-FITC labelled stereocilia bundles on the apices of vestibular hair cells and 
cell junctions. Utricles were also labelled with a hair cell marker; antibodies against 
either myosin Viia (which specifically labels the cytoplasm and hair bundles of sensory 
hair cells (Hasson et al., 1995)) or calretinin (a calcium binding protein which has also 
previously been used to label post-mitotic hair cells  (Erkman et al., 1996)) were used to 
visualise vestibular hair cells. Calretinin is known to label only type I vestibular hair 
cells which are innervated by afferents which form calyces (Holmes and Rout, 2011). 
Utricular tissue maintained in culture for a total of 5 days, incubated in culture medium 
only, showed extensive coverage of the sensory epithelium with vestibular hair cells 
labelled with an antibody for myosin Viia (Figure 4-4 A). Hair cells also showed 
evidence of stereocilia still present on their apical surface following a 5 day period in 
culture, when labelled for actin filaments with a phalloidin-FITC fluorophore (Figure 4-
4 Aii) 
In comparison, utricles which had undergone 48 hours exposure to gentamicin show a 
considerable decrease in the number of cells positively labelled for the hair cell marker 
antibody to myosin Viia (Figure 4-4 Bi & Ci). Hair cell counts of gentamicin treated 
utricles at 2 days post-gentamicin showed a 42% decrease in hair cell numbers in 
comparison to control counterparts maintained in vitro for the same length of time 
(Figure 4-8), indicating that the decrease in hair cell numbers is attributable to 
aminoglycoside exposure and not purely a side-effect of the culture conditions. One-
way ANOVA analysis of hair cell count data calculated a P value of 0.0012, indicating 
that the variation of the mean hair cell counts of the groups (in this case the groups 
consisted of 2, 14 and 28 days post-gentamicin utricles, with control counterpart groups 
at 2 and 28 days), is significantly higher than would be expected to occur by chance 
through random sampling. However, the use of the post-hoc Tukey’s test (shown in 
table 4-1) to compare the mean hair cell numbers at 2 days post-gentamicin and in 
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control counterparts cultured for the same time period calculated a P value > 0.05, and 
therefore could not be considered statistically significant. Myosin Viia positive hair 
cells in such cultures were also seen to lack stereocilia (Figure 4-4 Dii), whilst their 
control counterparts cultured for the same length of time overall maintained their apical 
bundles, suggesting that this observed difference was also a result of the gentamicin 
treatment. Gentamicin treated utricles at 4 days post-gentamicin also showed evidence 
of cellular debris within the sensory epithelium; (Figure 4-4 Di, arrows) irregular 
plaques of myosin Viia positive labelling can be seen at the same level as vestibular hair 
cells which have survived the drug exposure. There is also evidence of scar formation, 
where supporting cells have spread in order to close the breach in the epithelium caused 
by loss of hair cells, indicated by the labelling of cell junctions by Phalloidin-FITC 
(Figure 4-4 Dii, arrow).  
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Figure 4-4 Utricular Cultures at 4 Days Post Gentamicin Treatment 
Wholemount utricular cultures labelled with phalloidin-FITC (green) and antibody to 
myosin Viia as a marker for hair cells (red). (A) Control tissue cultured for 5 days without 
gentamicin treatment. (B & C) Utricles after 4 days recovery following gentamicin 
treatment. (D) Utricle from (B) imaged at x63. (Di) Arrows = myosin Viia positive plaques 
within the epithelium. (Dii) Arrow = scar formation. 
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Utricular Cultures at 10 and 14 Days Post-Gentamicin Treatment 
Control utricles maintained in vitro for 13 days (in parallel with gentamicin treated 
tissue which was fixed and labelled 10 days after the cessation of gentamicin 
incubation) continued to survive after this length of time in culture. Hair cells positive 
for myosin Viia were abundant (Figure 4-5 Ai) across the sensory epithelium. These 
hair cells also continued to maintain an apical bundle of stereocilia as shown by 
labelling with phalloidin-FITC (Figure 4-5 Aii). 
Gentamicin treated utricles cultured for the same time period, showed markedly fewer 
hair cells positive for myosin Viia (Figure 4-5 Bi). It is also possible to observe atypical 
irregular plaques of myosin Viia positive immunolabelling which appear to be the 
‘debris’ from hair cells which have been disrupted by the aminoglycoside treatment, as 
was observed at 4 days post-gentamicin. This debris is visible within the sensory 
epithelium itself. Of those hair cells which have survived, Phalloidin-FITC indicates 
that the majority do not have intact stereocilia at their apices (Figure 4-5 Bii).  
Immunofluorescent labelling of control cultures grown for 17 days, in parallel with 
utricles which were gentamicin treated and maintained for a further 14 days afterwards, 
demonstrates the ability of adult utricular tissue to survive well using the culture 
technique which has been developed during this work. Control tissue at this time point 
is highly populated with vestibular hair cells with a large number of cells labelled 
positively for the hair cell marker calretinin (red) (Figure 4-3 Ai). Hair cell counts 
(sampled from utricles labelled with myosin Viia as the hair cell marker) reveal that 
there is a further 65% decrease in hair cell numbers between utricles cultured for 2 days 
post-gentamicin in comparison to those maintained for 14 days post treatment (Figure 
4-8).  Comparison of the mean hair cell counts at 2 and 14 days post-gentamicin using 
Tukey’s test did not calculate the difference in hair cell numbers between these 
experimental conditions as being statistically significant (P > 0.05).  
Gentamicin treated utricles at 14 days post drug exposure, appear very similar to those 
fixed at 10 days post-gentamicin treatment. The sensory epithelium shows a distinct 
reduction in hair cells positively labelled with myosin Viia (Figure 4-6 Bi); hair cell 
counts show an 80% decrease in hair cells which are myosin Viia positive (Figure 4-8) 
compared to hair cell numbers in control utricles cultured for 5 days. When the mean 
hair cell count at 14 days post-gentamicin was compared to that of the 2 day-post 
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gentamicin control counterpart group, Tukey’s test calculated a P value of <.0.01; the 
difference in the mean hair cell numbers of these two groups can therefore be 
considered statistically significant.  Phalloidin labelling also shows the presence of scars 
formed on the epithelial surface (Figure 4-6 Bii, arrow).  
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Figure 4-5 Utricular Cultures at 10 Days Post Gentamicin Treatment  
Wholemount organotypic utricular cultures labelled with phalloidin-FITC (green) and for 
the hair cell marker myosin Viia (red). (A) A control utricle maintained for a total of 13 
days in vitro without being subject to gentamicin treatment. The outlined region is believed 
to be an area in which the epithelial surface of the tissue was damaged during the dissection 
process. (B) Gentamicin treated utricular tissue fixed following a 10 day recovery period. 
‘D’ indicates irregular plaques of myosin Viia positive labelling believed to be cellular 
debris.  
cellular debris. Bar = 50µm. 
  
127 
 
 
 
 
Figure 4-6 Utricular Cultures at 14 Days Post Gentamicin Treatment  
Wholemount organotypic utricular cultures labelled with phalloidin-FITC (green) and for 
the hair cell marker myosin Viia (red). (A) Control tissue cultured for a total of 17 days 
labelled with the hair cell marker calretinin (red). DAPI (blue) labels cell nuclei. (B) 
Gentamicin treated utricular tissue fixed after a 14 day recovery period labelled with the 
hair cell marker myosin Viia (red). Arrowheads indicate scarring on the epithelial surface 
where Phalloidin-FITC labelled actin filaments are present at cellular junctions.  
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Utricular Cultures at 28 Days Post-Gentamicin Treatment 
The longest time period for which adult mouse utricles were maintained in vitro during 
these studies was 31 days. Control tissue cultured for this time period continued to 
survive well under these experimental conditions; the sensory epithelium of these 
utricles exhibits dense population with myosin Viia positive vestibular hair cells (Figure 
4-7 Ai). Bundles of stereocilia, visualised by Phalloidin-FITC staining, are both 
apparent and abundant (Figure 4-7 Aii), although not present on every myosin Viia 
positive hair cell.  
Gentamicin treated utricles which were maintained for the same total length of time i.e. 
grown for 28 days post-gentamicin treatment, show a marked reduction in hair cell 
numbers when immunofluorescently labelled with a hair cell marker (Figure 4-7 Bi) 
When compared to gentamicin treated utricles fixed at 14 days post antibiotic exposure, 
there is not a large visible difference in the degree of hair cell loss. Hair cell counts 
show an 82% decrease in hair cell number in utricular tissue at 28 days post-gentamicin 
when compared to hair cell numbers in control counterparts maintained in vitro for the 
same time period (Figure 4-8). Tukey’s test calculated a P value of < 0.01 when 
comparing the mean hair cells counts of these two groups, therefore the difference 
observed between control and gentamicin-treated utricles at this time point can be 
considered statistically significant. This data also demonstrates that control utricles 
cultured for a total of 31 days show an 18% decrease in hair cell numbers in comparison 
to control utricles cultured for 5 days. However, Tukey’s test calculated a P value > 
0.05 when comparing the mean hair cell numbers of control utricles maintained in vitro 
for 5 and 31 days, showing that the difference between these two groups is not 
statistically significant. This finding supports the observations of immunolabelling on 
long term control cultured utricular tissue, that vestibular hair cells survive well under 
these experimental conditions, and that the observed hair cell loss in gentamicin treated 
tissue is not purely a side effect of the culture technique used.  
When viewed at higher magnification (x63 objective) what appear to be small immature 
hair bundles (Figure 4-7 Cii & Dii, insets indicated with arrows) can be seen in these 
utricular cultures, which are positively labelled with Phalloidin-FITC. As previously 
described in birds during regeneration (Cotanche, 1987) and mammals – e.g. in 
regenerating guinea pig utricles (Forge et al., 1998) and in mouse utricles during 
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development (Denman-Johnson and Forge, 1999), cells bearing these short hair bundles 
also appear to have a smaller surface area than would be expected of a mature hair cell, 
suggesting that they may potentially be regenerated cells. A sampling of 4 utricles 
calculated these immature bundles to be present at an average of 0.42 bundles/1000μm2 
(to 2 d.p.). This suggests there is some limited degree of regeneration occurring within 
the vestibular sensory epithelium after 4weeks in vitro following gentamicin-induced 
hair cell loss. 
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Figure 4-7 Utricular Cultures at 28 Days Post Gentamicin Treatment 
Wholemount organotypic utricular cultures labelled with phalloidin-FITC (green) and for 
the hair cell marker myosin Viia (red). (A) Control tissue maintained for a total of 31 days 
in vitro without receiving gentamicin treatment. (B) Gentamicin treated cultured utricular 
tissue fixed after a 28 day recovery period. (C & D) Gentamicin treated utricles viewed with 
the x63 objective. (Cii & Dii insets) Arrows indicate the presence of small immature 
stereocilia bundles on the apical surface of some cells. 
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HC/1000μm2 
(to 2 d.p.) 
N (No of 
utricles) 
SD  
(to 2 d.p.) 
SEM  
(to 2 d.p.) 
Control (2 DPG) 5.99 2 0.66 0.46 
2 DPG 3.46 4 1.19 0.59 
14 DPG 1.23 4 0.47 0.24 
Control (28 
DPG) 
4.91 3 2.58 1.49 
28 DPG 0.87 4 0.55 0.28 
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Figure 4-8 Hair Cell Loss in Gentamicin Treated Cultured Utricles 
Hair cell counts (i.e. cells positive for myosin Viia) from utricles cultured for several 
incubation periods following gentamicin treatment (and untreated controls). HC numbers 
were counted from x63 magnification confocal images using Image J software. Controls 
were maintained for the same length of time as their gentamicin treated counterparts, but 
were cultured in normal medium only. Each utricle was sampled 2-3 times and HC counts 
averaged, before being normalised to give hair cell numbers as a value of HCs/1000µm
2
.   
(A) Comparison of HC numbers at different time points in culture. Error bars show standard 
error. Percentage decrease of hair cell numbers given in chapter 4 were calculated using the 
HC/1000µm
2 
values shown in table (B). 
B 
A 
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Comparison Mean 
Difference 
q P Value 
    
Control (2 D) vs Gent (2 DPG) 2.53 3.239 ns 
P>0.05 
Control (2 D) vs Gent (14 DPG) 4.761 6.095 ** 
P<0.01 
Control (2 D) vs Control (28 D) 1.08 1.312 ns 
P>0.05 
Control (2 D) vs Gent (28 DPG) 5.116 6.55 ** 
P<0.01 
Gent (2 DPG) vs Gent (14 DPG) 2.231 3.498 ns 
P>0.05 
Gent (2 DPG) vs Control (28 D) -1.449 2.104 ns 
P>0.05 
Gent (2 DPG) vs Gent (28 DPG) 2.586 4.055 ns 
P>0.05 
Gent (14 DPG) vs Control (28 D) -3.681 5.343 * 
P<0.05 
Gent (14 DPG) vs Gent (28 
DPG) 
0.3551 0.5568 ns 
P>0.05 
Control (28 D) vs Gent (28 DPG) 4.036 5.858 ** 
P<0.01 
 
Table 4-1 One-way ANOVA Statistical Analysis; Post-Hoc Analysis by Tukey’s Test 
This table shows the results of the Tukey’s test carried out on the hair cell count data 
collected from utricles maintained for multiple time periods following gentamicin 
treatment and control counterparts. Each pairwise comparison of mean hair cell count 
values analysed by the Tukey’s test is shown, in addition to the resulting P value; this 
statistical analysis indicates whether the differences in the mean values for each pair of 
experimental conditions are significantly different from one another. The following 
abbreviations are used by the GraphPad software to denote significance; ns = not 
significant, * = significant (P = 0.01 – 0.05), ** = very significant (P = 0.001 – 0.01). 
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4.2.3 EdU Labelling of Organotypic Utricular Cultures to Measure Cell 
Proliferation 
In order to investigate the level of cell proliferation taking place in the utricular culture 
model system, 5-ethynyl-2´-deoxyuridine (EdU) labelling was utilised to allow the 
visualisation of all cells which had undergone mitosis during the culture period. EdU, an 
alternative to 5-bromo-2'-deoxyuridine (BrdU), is a nucleoside analog of thymidine, 
which can become incorporated instead of a natural nucleoside during the DNA 
synthesis process; DNA synthesis is a required phase for any cell which is undergoing 
mitotic division (Hynes, 2004). EdU is good alternative to BrdU, since it does not 
require the same treatment with hydrochloric acid (HCL) that BrdU necessitates in order 
to detect labelled cells, and thus the potential for damage to the tissue and other antigens 
which may be required for antibody labelling is reduced. Utricular tissue was cultured 
in the presence of 10µM EdU in normal culture medium solution. EdU-containing 
medium was only used for culture experiments after the 48 hour gentamicin treatment 
had been completed; thus limiting the cells detected to those which had undergone 
mitotic events occurring after ototoxic drug exposure. This would focus results on the 
behaviour of the tissue during its period of hair cell loss and potential recovery. A 
‘Click-IT’™ kit (Invitrogen) was used to visualise any EdU labelled nuclei after 
fixation of the culture tissue. As described in the kit protocol, the detection of EdU is 
based on a click reaction, a copper catalysed covalent reaction between an azide (the 
Alexa Fluor® 488 dye) and an alkyne (the EdU).  
EdU Labelling in Cultured Utricles at 3 Weeks Post-Gentamicin Treatment 
Cultured tissue maintained in vitro for 3 weeks post-gentamicin treatment (i.e. a total of 
24 days), was labelled with a hair cell marker and for EdU to visualise any cells which 
had incorporated the EdU supplied to them whilst in culture into their genetic material 
during DNA synthesis. Using the LSM image browser software, it was possible to 
analyse z-stack confocal images of wholemount utricles by orthogonal sections, which 
visualised the location of EdU positive cells within different layers of the utricular 
tissue. 
A control utricle (Figure 4-9) maintained in vitro for the same time period, but which 
was not exposed to the ototoxic drug, showed that cell proliferation occurs in these 
organotypic cultures irrespective of drug induced hair cell death. There are a high 
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number of hair cells present on the sensory epithelium of this utricle (Figure 4-9 B) 
which are positively labelled with the hair cell marker calretinin, as seen in previous 
immunohistochemistry experiments examining the culture model system development. 
Orthogonal sectioning of this image (Figure 4-9 A) shows that EdU positive cells 
(labelled in green) are localised to the mesenchymal tissue underlying the sensory 
epithelium (Figure 4-9 A, far right). There are no cells visible which show co-
localisation of the hair cell marker and EdU. There are also no supporting cell nuclei 
which are EdU positive, indicating that none of the cells of the sensory epithelium have 
undergone mitotic division. It would appear that the cell proliferation observed by this 
EdU labelling is mostly confined to the area of the cultured tissue which is involved in 
the outgrowth of the original tissue on the nitrocellulose filter surface upon which the 
cultures are maintained.  
Organotypic cultures which received 48hrs gentamicin treatment and were then allowed 
a further 3 week recovery period in vitro (Figure 4-10) showed evidence of cell 
proliferation when labelled for EdU. Cell counts of DAPI positive nuclei and EdU 
positive nuclei (data presented in figure 4-11) from the entire utricle, indicate that 
approximately 27% of cell nuclei were positive for the mitotic marker, although, as with 
control utricles, there was no evidence of cells positive for EdU (labelled in red) also 
being positive for the hair cell marker calretinin. This would suggest that any 
regenerated hair cells present at this time point are not the product of supporting cells 
re-entering the cell cycle and dividing mitotically. The use of orthogonal sections to 
assess z-stack images of gentamicin treated cultures at this point allows visualisation of 
the level at which EdU positive nuclei are present and how this corresponds to the level 
where hair cell bodies are located. 
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Figure 4-9 Proliferation in Cultured Utricle Tissue at 24 Days In Vitro Without 
Gentamicin Treatment 
Organotypic utricular cultures immunolabelled as wholemount tissue using DAPI (blue) to 
label cell nuclei, calretinin (red) to label vestibular hair cells and the Click-IT™ reaction 
system with Alexa Fluor® 488 to label EdU positive nuclei. (A) Z-stack image of control 
tissue maintained in vitro for 24 days without gentamicin treatment, viewed by orthogonal 
sectioning. The location of EdU positive nuclei within the cell layers of the utricle is 
visualised in this way. (B) Maximal projection of the same z-stack used for orthogonal 
sectioning in (A). 
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Figure 4-10 EdU labelling of Cultured Utricles at 21 Days Post Gentamicin Treatment  
Organotypic utricular cultures immunolabelled as wholemount tissue using DAPI (blue) to 
label cell nuclei, calretinin (green) to label vestibular hair cells and the Click-IT™ reaction 
system with Alexa Fluor® 488  to label EdU positive nuclei (red). (A) Z-stack confocal 
image of a utricle cultured for 21 days post gentamicin treatment, viewed by orthogonal 
sectioning to show the relative location of hair cells and EdU positive nuclei within the 
cultured tissue. (B) Maximal projection of the z-stack image used for analysis by orthogonal 
sectioning in (A). 
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Figure 4-11 Proliferation in the Adult Mouse Utricle at 21 Days Post-Gentamicin  
Cell counts were carried out on z-stack confocal images of utricles cultured for 21 days post-
gentamicin in the presence of the mitotic marker, EdU. Total nuclei (those positive for DAPI) 
and EdU positive nuclei were counted using Image J on random samples of a total of 8 utricles; 
each utricle was sampled 2-3 times. SD = Standard deviation. SEM = Standard error. (A) Cell 
count data was used to calculate the percentage of nuclei that were EdU positive. (B) Graph 
compares the numbers of DAPI positive nuclei to those also positive for EdU. Error bars show 
standard error. 
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4.2.4 Organotypic Utricle Culture Morphology Examined Under the Scanning 
Electron Microscope 
Utricular Tissue Cultured for 5 Days Post-Gentamicin and Control Counterparts 
Scanning electron microscopy was utilised to provide further morphological evidence as 
to how the appearance of the vestibular sensory epithelium alters in response to ototoxic 
drug treatment.  
Control utricles, cultured for a total of 8 days, appear healthy and demonstrate an intact, 
regular, sensory epithelial surface which is widely populated with hair cells and 
supporting cells (Figure 4-12 A). When viewed at a higher magnification, there is 
widespread persistence and maintenance of stereocilia bundles on the apical surface of 
vestibular hair cells (Figure 4-12 B) as seen previously by labelling cultured utricles 
with phalloidin. These stereocilia appear normal in their morphology and organisation.   
In addition to the cells of the epithelium, the presence of a fibrilar substance which 
extends across much of the surface of the epithelium is visible. From the structural 
appearance of this material, it is believed to be otolithic membrane which has been 
produced by the supporting cells, acting as a potential indicator that the supporting cells 
survive well in the tissue under these culture conditions. That this membrane is still in 
the process of being actively synthesized by these cells is supported by evidence of 
vesicles which appear to be full of material, being present in the supporting cell 
cytoplasm when viewed by TEM. 
In comparison, tissue maintained for the same total number of days, but which was 
subjected to a 48 hour gentamicin treatment, shows a marked decrease in the number of 
hair cells visible on the surface of the epithelium (Figure 4-13 A) and there are large 
areas of the tissue where supporting cell scars have formed to maintain an unbroken 
epithelial layer. Despite the large decrease in the number of vestibular hair cells in this 
tissue, some have retained stereocilia (Figure 4-13 B). Many of these hair cells are 
located towards the periphery of the tissue, suggesting that perhaps hair cells in this 
region are less sensitive to the ototoxic drug. There are hair cells present which maintain 
apical hair bundles with a more normal morphology (Figure 4-14 B), whilst stereocilia 
in varying stages of disarray and disorder are also visible; including those which have 
become fused (Figure 4-13 B and Figure 4-15 A). Additional observation shows what 
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appears to be an immature bundle with a kinocilium (Figure 4-13). From these SEM 
images, it is not possible to determine whether this stereocilia structure has been created 
by regeneration of the tissue in response to gentamicin-induced hair cell loss, or 
whether this was a hair cell that was not fully mature at the time the tissue was dissected 
from the animal. 
In addition to hair cells with fused, disorganised stereocilia, which are likely to be in the 
process of dying, there is evidence of vestibular hair cells which are further ahead in the 
cell death process. Numerous incidences across the damaged epithelial surface (Figure 
4-16 B) of dying hair cells being extruded from the tissue at the apical region may be 
seen, as supporting cells expand and seek to remove the dead hair cell and close any 
consequent breakage in the epithelial layer.  
In gentamicin-treated utricles at this time point the epithelial surface is covered with 
material that resembles otolithic membrane (Figure 4-15 A). This membrane has a 
distinctive ‘honeycomb’ like appearance and its continued presence indicates that the 
supporting cells have not been affected by the ototoxic drug exposure. It is possible to 
see healthy looking microvilli protruding from the apical surfaces of the supporting 
cells underneath the otolithic membrane structure.  
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 Figure 4-12 Control Utricular Tissue Maintained in Culture for 8 Days Viewed by 
Scanning Electron Microscopy 
The surface of the sensory epithelium from utricle cultures maintained in vitro for 8 days 
with no gentamicin treatment. (A) An overview of the surface of the entire utricle. Bar = 
100µm. (B) Stereocilia of the vestibular hair cells. There is a fibrilar, membranous material 
which has covered much of the epithelium; this is obscuring the apices of the supporting 
cells. Bar = 1µm. 
  
141 
 
 
 
 
 
  
Figure 4-13 Utricular Cultures at 5 Days Post Gentamicin Viewed by Scanning 
Electron Microscope 
The surface of the sensory epithelium from utricle cultures maintained in vitro at 5 days post 
gentamicin treatment. (A) An overview of the entire utricle surface shows the decrease in 
hair cell numbers in comparison to control cultures. Bar = 100µm. (B) Some stereocilia are 
still present on the apical surface (black arrowheads), however, others are in disarray or 
have become fused (white arrowhead). What appears to be an immature bundle ‘I’ is visible 
on the surface of one hair cell. Bar = 10µm. 
 
B 
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Figure 4-14 Vestibular Hair Cells of Utricular Tissue at 5 Days Post Gentamicin 
Viewed by SEM 
The surface of the sensory epithelium from utricle cultures maintained in vitro at 5 days post 
gentamicin treatment. (A) The ‘honeycomb-like’ structure of the fibrilar material present on 
the surface of the sensory epithelium. (B) A surviving vestibular hair cell with a normal 
stereocilia bundle; the supporting cells surrounding it have apices covered in microvilli. Bar 
= 1µm.  
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Figure 4-15 Hair Cell Death in Utricular Cultures at 5 Days Post Gentamicin Viewed 
by SEM 
The surface of vestibular hair cells and supporting cells in utricle cultures maintained for 5 
days post gentamicin treatment. (A) Remaining stereocilia often appear fused (white 
arrowhead) and disorganised. Bar = 1µm. (B) Remnants of a vestibular hair cell (centre) are 
extruded from the epithelium after undergoing cell death. Bar = 1µm. 
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Utricular Tissue Cultured for 14 Days Post-Gentamicin Treatment Viewed by 
Scanning Electron Microscope 
Following a two week period of recovery after 48 hours gentamicin exposure, utricles 
viewed by SEM appear, similar to those studied at 5 days post-gentamicin treatment, to 
have fewer vestibular hair cells (Figure 4-16 A). The process of vestibular hair cell loss 
is ongoing, with stereocilia present in various disorganised formations as the cell death 
cycle progresses (Figure 4-16 B), and very long kinocilia also visible. These hair cells 
are often found towards the periphery of the utricle, as seen in the tissue at 5 days post-
gentamicin treatment. This would appear to support the idea that the vestibular hair cells 
at the periphery of the sensory epithelium are those which are most resilient, but not 
completely resistant, to ototoxic drug induced hair cell loss. Dead hair cells also 
continue to be extruded from the utricle at this time point (Figure 4-17 A).  
Evidence of cellular proliferation occurring in the underlying mesenchyme of cultured 
utricles was observed by EdU labelling of these tissues, as described in 4. Further 
evidence of this proliferation and remodelling of the utricular connective tissue is also 
visible under SEM. Figure 4-17B shows the surface morphology of tissue which has 
‘grown out’ from the original utricle after being maintained in culture. This outgrowth 
across the surface of the nitrocellulose filter paper appears ‘stretched’ and sheet-like, 
with an apical surface populated by numerous microvilli. From their surface appearance 
it might be expected that the cells of these ‘outgrowths’ are of a fibroblast-like nature. 
Despite the continuation of the response of the tissue to gentamicin treatment in terms 
of hair cell loss, at 14 days post-gentamicin potential evidence of regeneration occurring 
begins to appear. The emergence of short, but highly organised bundles (Figure 4-18, 
inset) which resemble the morphology of an emerging, immature stereocilia bundle on 
the apex of a hair cell can be observed. It is not possible to determine with scanning 
electron microscopy as to whether a complete regenerative event has occurred i.e. that 
this immature bundle is developing from a hair cell which itself is entirely new and 
regenerated, rather than from a hair cell which lost its original stereocilia formation due 
to the gentamicin treatment and has been subsequently stimulated to produce a new 
bundle.  
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Figure 4-16 SEM of Utricular Tissue at 14 Days Post Gentamicin Treatment  
The epithelial surface of utricles maintained in vitro for 14 days post gentamicin treatment. 
(A) An overview of the entire surface of a single utricle demonstrates the decrease in hair 
cell numbers seen at this stage. Bar = 100µm. (B) Disorganised stereocilia and long 
kinocilia (arrowhead) on the surface of the tissue which shows a marked decrease in 
vestibular hair cell numbers at this time point. Bar = 1µm. 
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 Figure 4-17 SEM of Hair Cell Death at 14 Days Post Gentamicin and Explant 
Outgrowth 
The surface of utricles cultured for 14 days post gentamicin treatment viewed by scanning 
electron microscopy. (A) A vestibular hair cell (arrowhead) is extruded from the sensory 
epithelium. Bar = 1µm. (B) The morphology of the ‘outgrowth’ of cells from the original 
utricular tissue. Bar = 1µm. 
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Figure 4-18 SEM of the Potentially Regenerating Vestibular Epithelium at 14 Days 
Post Gentamicin  
The surface of a utricle cultured for 14 days post gentamicin viewed under the scanning 
electron microscope. At this time point, structures which resemble an immature stereocilia 
bundle (arrowhead, inset) are seen on the apical surface of the sensory epithelium. Bar = 
1µm. 
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Chapter 5: Integrin Expression in Response to Hair Cell Loss in the Adult Mouse 
Utricle 
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5.1 Quantitative PCR for the Investigation of Integrin Expression During Hair 
Cell Loss and Regeneration 
5.1.1 Objectives 
Through the use of RT-PCR with both degenerate and specific PCR primers, 8 
individual integrin subunits were identified as being expressed in the normal adult 
mouse utricle. The degenerate PCR primers designed for this project were not proven to 
be able to detect all of the known murine integrin subunits. It was therefore not possible 
to screen utricular cDNA for all of the α and β subunits using this method.  
In order to both conduct a full screen of normal adult mouse utricular cDNA for 
members of the integrin family, and to investigate the relative expression levels of 
particular integrin genes in response to hair cell loss, a set of quantitative PCR 
experiments was carried out. The abbreviated gene names of all known mammalian 
integrin subunits are summarised in table 1-1 and 1-2. 
5.1.2 Design of Custom TaqMan™ qPCR Gene Expression Array Plates 
Commercially available gene expression arrays for integrin subunits used the human 
version of the gene and thus could not be guaranteed to detect the genes for each of the 
murine integrins in mouse utricular cDNA samples. It was therefore decided to create a 
custom array, using the 96-well plate TaqMan® array system from Applied Biosystems.  
Figure 5-1 shows the layout of the selected assays within a single 96-well plate - each 
gene assay was replicated four times per plate.   Gene expression assays for a total of 18 
integrin α and β subunits were used in customised array. Rn18s and Gapdh assays were 
included in order to provide two endogenous controls. Gene assays for four hair cell 
markers were also included on the plate; Myo7a (myosin Viia), Pou4f3, Calb2 
(calretinin) and Atoh1. Each gene assay was repeated four times per array plate. It was 
anticipated that utricular cDNA samples from organotypic utricle cultures harvested at 
several time points following treatment with gentamicin would demonstrate changes in 
the expression level of these markers.  Significant hair cell loss had been observed in 
these cultured utricles by immunohistochemistry;  myosin Viia-positive hair cell 
numbers were observed to decrease in the utricle following gentamicin treatment and it 
would therefore be expected that the expression of Myo7a would be lower in utricular 
cDNA obtained from such cultures, in comparison to untreated controls. 
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Through a search of previously published literature, several integrins were identified as 
being unlikely candidates for expression in the utricle, due to their known cell type 
specificity e.g. Itga2b is specifically expressed by platelets as a key adhesion molecule 
in the platelet aggregation events which occur during the process of forming blood clots 
(Ruegg et al., 1992).  The following integrin subunits were therefore omitted from the 
customised qPCR gene expression array; αIIb, αX, αM, αE, αD, αL, α10 and β2. 
5.2 Relative Quantification of Custom Integrin TaqMan™ Gene Expression Array 
qPCR Data 
A successful qPCR run of the integrin gene expression array was achieved with each of 
the four utricular cDNA samples. The four samples tested were cDNA from normal 
utricular tissue which had not been maintained in vitro (0 DC) and cDNA from utricular 
cultures harvested at the following  time points post-gentamicin treatment; 4 days (4 
DPG), 14 days (14 DPG) and  21 days (21 DPG). A gene was determined as being 
‘detected’ in a given cDNA sample if it had been successfully amplified by at least 3 of 
the 4 replicate assays for that gene. Of the 18 integrin genes screened for, 11 α and β 
subunits were detected in normal utricular cDNA; Itga3, Itga6, Itga8, Itgav, Itgb1, 
Itgb3, Itgb4, Itgb5, Itgb6, Itgb7 and Itgb8.  The remaining integrins (Itga1, Itga4, Itga5, 
Itga7, Itga9 and Itga11) were not detected in normal utricular cDNA. These subunits 
were also not found in any of the gentamicin-treated utricular cDNA samples analysed.  
Relative quantification (RQ) analysis of the data from these experiments was carried out 
using SDS software (Applied Biosystems) as described in 2.9.3. Gene expression plots 
showing the RQ values for the α integrins are shown in figure 5-4 and those for the β 
integrins in figure 5-5.The array plate run using cDNA from normal adult mouse 
utricles which had not been cultured (0 DC) was used as the calibrator for this RQ 
study, in order to investigate the gene expression levels of integrins and hair cell 
markers in gentamicin treated tissue, relative to their expression in the normal, 
undamaged utricle. Error bars (figures 5-4 and 5-5) indicate the minimum and 
maximum RQ values based on the four replicate assays for each individual gene per 
array plate. Where error bars do not overlap i.e. when comparing the expression of a 
gene in normal tissue, to utricular tissue at 4 days post-gentamicin, the difference in 
expression level observed may be described as being significant with 95% confidence.  
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1 2 3 4 5 6 7 8 9 10 11 12
A Rn18s Rn18s Rn18s Rn18s Gapdh Gapdh Gapdh Gapdh Itga1 Itga1 Itga1 Itga1
B Itga2 Itga2 Itga2 Itga2 Itga3 Itga3 Itga3 Itga3 Itga4 Itga4 Itga4 Itga4
C Itga5 Itga5 Itga5 Itga5 Itga6 Itga6 Itga6 Itga6 Itga7 Itga7 Itga7 Itga7
D Itga8 Itga8 Itga8 Itga8 Itga9 Itga9 Itga9 Itga9 Itga11 Itga11 Itga11 Itga11
E Itgav Itgav Itgav Itgav Itgb1 Itgb1 Itgb1 Itgb1 Itgb3 Itgb3 Itgb3 Itgb3
F Itgb4 Itgb4 Itgb4 Itgb4 Itgb5 Itgb5 Itgb5 Itgb5 Itgb6 Itgb6 Itgb6 Itgb6
G Itgb7 Itgb7 Itgb7 Itgb7 Itgb8 Itgb8 Itgb8 Itgb8 Myo7a Myo7a Myo7a Myo7a
H Calb2 Calb2 Calb2 Calb2 Atoh1 Atoh1 Atoh1 Atoh1 Pou4f3 Pou4f3 Pou4f3 Pou4f3
Figure 5-1 Layout of Custom TaqMan™ Gene Array for Integrin qPCR Experiments 
This figure shows the design of a single 96-well plate gene expression array for 18 individual integrin subunits. Each gene assay was replicated four 
times on a single plate. Rn18s and Gapdh were selected as endogenous control assays. Four hair cell marker gene assays were also included; Myo7a, 
Calb2, Atoh1 and Pou4f3. qPCR experiments were run on these customised arrays using one 96-well plate per cDNA sample. 
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Figure 5-2 Omission of 21 DPG qPCR Data from RQ Analysis 
The qPCR data from the array plate run using 21days post-gentamicin cDNA was omitted from the RQ study; it was observed that the 21 DPG sample 
contained less cDNA than those of the other time points investigated. (A) With 0 day control (0 DC) cDNA, the Rn18s endogenous control began to be 
amplified at around 18 cycles, whilst Itga3 (C) began to be amplified at around 34 cycles. Using 21 DPG cDNA, Rn18s amplification (B) started at 
around 20 cycles; Itga3 (D) did not begin to be detected until as late as 38 cycles.   
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5.2.1 Expression Changes in Hair Cell Markers 
Changes in the expression level of each of the four hair cell markers which were 
included in the custom array plate were observed (shown in Figure 5-3). Atoh1, Calb2, 
Myo7a and Pou4f3 were all detected in normal utricular cDNA (0 DC). 
Hair Cell Associated Proteins 
Myo7a and Calb2 showed a significant decrease in gene expression at 4 DPG in 
comparison to the level detected in the 0 day control sample; Myo7a expression had 
decreased to an extent that it was undetectable at 4 days post-gentamicin.  At 14 DPG, 
Calb2 expression continued to be significantly lower than that observed in normal 
tissue, but did not differ significantly from the level of expression detected at 4 DPG. 
Myo7a was detected at 14 days post-gentamicin, at a level of gene expression which 
was still significantly lower than had been detected in the 0 day control cDNA sample.  
Hair Cell Transcription Factors 
Atoh1 and Pou4f3, both transcription factors which are involved in hair cell 
differentiation, each show a significant increase in gene expression at 4 DPG in 
comparison to the level seen in normal utricular cDNA. Pou4f3 in particular, 
demonstrates a large (approximately 5-fold) increase in expression at 4 DPG; the 
expression level of this transcription factor  decreases significantly by 14 DPG, to a 
level which is significantly lower than  that observed in normal tissue. Atoh1 levels also 
show a significant decrease at 14 DPG, compared to the elevated gene expression seen 
at 4 DPG, however, at 14 DPG, Atoh1 gene expression had returned to a level which 
was not significantly different to that observed in the normal utricle.  
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Figure 5-3 Changes in Hair Cell Marker Gene Expression Levels in Response to Gentamicin-Induced Hair Cell Loss 
Relative quantification (RQ) analysis of the gene expression of four hair cell markers; Atoh1, Myo7a, Pou4f3 and Calb2. Data from the array plate run 
using cDNA from normal adult mouse utricles which had not been maintained in vitro (0 DC) was used as a calibrator in order to investigate gene 
expression levels at 4 (4 DPG) and 14 days post-gentamicin treatment (14 DPG) in comparison to expression in normal tissue. Error bars indicate 95% 
confidence intervals for RQ values.  
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5.2.2 Increased Expression of Integrins in Utricular cDNA Post-Gentamicin 
Treatment 
Five integrin subunits demonstrated an increase in gene expression level in utricular 
cDNA at 4 and 14 days post-gentamicin; Itga3, Itgav, Itgb1, Itgb5 and Itgb8. Each of 
these integrins was detected in normal utricular cDNA.  
Itga3 and Itgb5 gene expression shows an increase at 4 DPG compared to normal tissue, 
however, this increase was only calculated as being significant for Itga3. At 14 DPG, 
the expression of these two integrins was higher than that observed at 4 days, although 
neither increase was found to be significant.  
Itgav, Itgb1 and Itgb8 also exhibited increased gene expression at 4 DPG; this increase 
was significant for Itgav (an approximately 7-fold increase) and Itgb1 (an 
approximately 10-fold increase), but not for Itgb8.  All three subunits show a 
subsequent decrease in gene expression at 14 DPG compared to the level observed at 4 
DPG. This decrease was only found to be significant for Itgb1; this subunit was also the 
only subunit in this group to show a level of expression at 14 DPG which was 
significantly higher than that detected in normal utricular cDNA.   
5.2.3 Integrins Only Expressed in Normal Utricular cDNA 
Of the 18 integrins screened for, two subunits, namely Itgb7 and Itga8 were only 
detected in the normal utricular cDNA sample (0 DC). It is possible that  these genes 
were either not present at all in cDNA from gentamicin treated utricles, or that they 
were expressed at such a low level as to be undetectable by qPCR.  
5.2.4 Integrins Not Detectable at 4 Days Post-Gentamicin 
Integrins Itgb6 and Itga6 were detected in both normal utricular cDNA and at 14 DPG, 
but were undetectable in the 4 DPG cDNA sample. The gene expression of Itga6 was 
higher at 14 DPG in comparison to the level observed in normal tissue, however, this 
difference was not calculated as significant. Integrin Itgb6 expression showed a 
significant, but small decrease at 14 DPG in relation to expression level of this gene in 
normal utricular cDNA 
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5.2.5 Integrins Not Detectable at 14 Days Post-Gentamicin  
Integrins Itgb3 and Itgb4 were found to be present in normal utricular cDNA; each of 
these subunits also demonstrated a significant increase in gene expression at 4 DPG in 
comparison to that observed in normal tissue. These expression level increases were 
relatively large in comparison to other changes observed in integrin expression – Itgb3 
showed an approximately 11-fold increase in gene expression, and Itgb4 expression was 
approximately 12-fold higher than that of normal utricular cDNA. Neither integrin was 
detected in the 14 DPG cDNA sample – therefore Itgb3 and Itgb4 could be considered 
as being expressed at such a low level as to be undetectable by qPCR at this time point, 
or to be absent from this cDNA sample altogether.  
5.2.6 Integrins Not Detectable in Normal Utricular cDNA but Present in 
Gentamicin-Treated Tissue 
Of the 18 subunits screened for, only integrin Itga2 was undetectable in the normal 
utricular cDNA (0 DC) sample, but was then found to be expressed at both 4 and 14 
DPG. Expression of Itga2 was observed to be lower at 14 DPG than at 4 DPG, although 
this difference was not found to be significant.  
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Figure 5-4 Changes Integrin α Subunit Gene Expression in Response to Gentamicin-Induced Hair Cell Loss 
Relative quantification (RQ) of integrin α subunit qPCR data from gene expression array plates run using cDNA from normal adult mouse utricles which 
had not been cultured (0  DC) and utricular cultures harvested at 4 (4 DPG) and 14 days post-gentamicin treatment (14 DPG). Error bars indicate the 95% 
confidence intervals for each RQ value. 
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Figure 5-5 Changes in Integrin β Subunit Gene Expression in Response to Gentamicin-Induced Hair Cell Loss 
Relative quantification (RQ) of integrin β subunit qPCR data from gene expression array plates run using cDNA from normal adult mouse utricles which 
had not been cultured (0  DC) and utricular cultures harvested at 4 (4 DPG) and 14 days post-gentamicin treatment (14 DPG). Error bars indicate the 95% 
confidence intervals for each RQ value.  
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5.3 Multiplexed Individual Integrin Subunit qPCR Assays 
Following the RQ study of qPCR data obtained from the customised TaqMan™ integrin 
gene expression arrays, several subunits were selected for further investigation using 
multiplexed assays in order to confirm the results of the initial screen. Subunits to be 
included in these individual assays were selected on a basis of those which 
demonstrated larger changes in integrin expression level that were calculated as being 
significant. The five integrin subunits which were chosen for multiplexed qPCR assays 
were integrin α2, αV, β1, β3 and β4. The results of the RQ analysis of these assays are 
shown in figure 5-6. The same cDNA samples run on the array plates were also used for 
these individual assays.  
5.3.1 Relative Quantification  
All five integrin genes investigated using multiplexed assays were found to be 
expressed in normal utricular cDNA. These subunits had all been detected in normal 
utricular tissue by the initial qPCR screen, except for integrin Itga2.  
5.3.2 Increased Expression of Integrins in Utricular cDNA Post-Gentamicin 
Treatment 
Integrins Itgav, Itgb1 and Itgb3 all show a trend towards their gene expression being 
increased at 4 DPG, although differences between the levels detected at 4 days and in 
normal control tissue were not significant. These three subunits had all previously 
shown an increase in gene expression at 4DPG compared to normal utricular cDNA in 
the initial integrin qPCR screen. Integrin Itgav shows a subsequent decrease in 
expression at 14 DPG which was not calculated as being significant, but was higher 
than the level observed for this integrin in normal tissue. The changes in gene 
expression exhibited by Itgav follow the same trend as those observed for this subunit in 
the initial qPCR screen.  
Integrin Itgb3 also maintained a level of gene expression at 14 DPG which was higher 
than that detected in normal tissue, although this difference was not significant; integrin 
Itgb3 was not detected in the 14 DPG cDNA sample in the initial qPCR screen, but had 
shown increased expression at 4 DPG. This integrin exhibited a higher level of gene 
expression at 14 DPG than was detected at 4 DPG by multiplexed assay. 
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Integrin Itgb1, following an increase in gene expression at 4 DPG, shows a subsequent 
decrease in its expression level at 14 DPG. The expression of the Itgb1 gene appeared to 
show a small decrease from that observed in normal utricular cDNA, however, its 
expression at 14 DPG was not calculated as being significantly different from that 
detected in the 0 DC sample. Examination of the raw data from these multiplexed ssays 
indicates that integrin Itgb1 is likely to be present at a higher level than the other 4 
subunits investigated by these multiplexed assays; integrin Itgb1 expression begins to be 
detected after approximately 30 PCR reaction cycles in normal utricular cDNA, earlier 
than any of the other integrins in this sample. 
5.3.3 Integrin Multiplexed Assays Not Consistent with the Initial qPCR Screen 
Multiplexed assays for integrins Itga2 and Itgb4 detected these subunits in all 3 cDNA 
samples tested; Itga2 had not been detected in the 0 DC sample in the initial qPCR 
screen and Itgb4 had previously been undetectable at 14 DPG. Based upon the raw data 
from these assays, these two integrins are likely to be expressed in lower quantities in 
normal utricular cDNA compared to the other integrins for which multiplexed assays 
were carried out; Itgb4 does not begin to be detected until 35PCR reaction cycles and 
the start of Itga2 amplification occurs even later at around 37 cycles.  
Integrin Itgb4 shows a trend towards a decrease in gene expression at 4 DPG compared 
to its expression in normal utricular cDNA. This is the opposite of the trend observed in 
the initial qPCR screen, where Itgb4 was shown to increase significantly between the 0 
DC and 4 DPG samples. Itga2 gene expression displays a trend towards an increase at 
4DPG when compared to the 0 DC sample, and towards a further increase at 14 DPG. 
The significance of these RQ values cannot be calculated from the data obtained in 
these experiments; expression of these subunits being detected by only one of the three 
replicate assays carried out for each cDNA sample (with the exception of Itga2 in the 0 
DC sample). It was therefore not possible to calculate RQ maximum and minimum 
values for these assays, thus the RQ analysis for these subunits lacks 95% confidence 
intervals.  
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Figure 5-6 Multiplexed Individual Integrin Gene Expression Assays 
RQ analysis of individual multiplexed gene expression assays for five integrin subunits; Itga2, Itgav, Itgb1, Itgb3 and Itgb4.  Rn18s was used as the 
endogenous control. Data from assays run using the 0 DC (normal, uncultured utricle) cDNA sample were used to calibrate the expression of each 
integrin at 4 and 14 DPG relative to its expression in normal tissue. Error bars indicate 95% confidence intervals. Where no error bars are shown, RQ 
values were obtained from only one assay. 
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5.3 Discussion 
The custom integrin TaqMan ™ gene expression arrays carried out during this project 
detected the gene expression of 11 integrin subunits in normal adult mouse utricular 
cDNA. These arrays were also able to identify a group of 10 subunits which showed 
changes in their gene expression level in cDNA from utricles cultured for 4 and 14 days 
post-gentamicin treatment i.e. utricular tissue undergoing hair cell loss. Additionally, a 
subset of the integrins screened for in these qPCR experiments were identified as being 
undetectable in either normal or gentamicin utricular tissue. The changes exhibited by 
the gene assay carried out in this project, both integrins and hair cell markers, are 
summarised in table 5-1. 
A full discussion of those integrins determined as showing significant changes in gene 
expression in gentamicin treated utricles is given in chapter 7, in order to analyse these 
results in conjunction with the those obtained by degenerate RT-PCR (chapter 4) and 
subsequent immunohistochemistry experiments (chapter 6) and explore the implications 
of the presence of these integrins in the mammalian utricle.  
5.3.1 Limiting Factors for Integrin qPCR Experiments Using Utricular cDNA 
The cDNA samples utilised for both the custom integrin gene expression array plates as 
well as the individual multiplexed integrin assays represent the gene expression of a 
single ‘pool’ of utricular tissue; the cDNA from between 8 to 10 utricles from 4 to 5 
individual animals. Due to the size of the tissue of interest, pooling of tissue was 
necessary in order to obtain sufficient cDNA to run the number of assays carried out. 
However, this also introduces a greater variability of the genetic makeup of the cDNA 
within the sample, further complicating the investigation of changes in gene expression 
level by qPCR. In order to investigate this further, it would be necessary to carry out 
integrin gene expression assays with multiple ‘pools’ of cDNA, to assess whether the 
how replicable the results of the initial qPCR array plate screen are e.g. to reduce the 
potential for a single a-typical utricle within a given pool distorting the outcome of the 
results.  
The individual integrin subunit multiplexed assays carried out were limited by the 
amount of cDNA which was available after the initial screen had been carried out. 
Integrins selected for further investigation by multiplexed assay were chosen based 
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Genes Not Expressed in 
Normal or Gentamicin-
Treated Utricles 
 
Genes Only Expressed In 
Normal Utricle 
 
Genes Showing Increased 
Expression in Gentamicin-
Treated Utricles 
Genes Showing 
Decreased Expression 
in Gentamicin Treated 
Utricles 
 
Itga1 Itga8 Itga2 Myo7a 
Itga4 Itgb7 Itga3 Calb2 
Itga5  Itga6  
Itga7  Itgav  
Itga9  Itgb1  
Itga11  Itgb3  
  Itgb4  
  Itgb5  
   Itgb8  
  Pou4f3  
  Atoh1  
Table 5-1 Summary of Gene Expression Changes Detected by qPCR in the Utricle Following Gentamicin Treatment  
This table summarises the findings of the qPCR gene expression arrays carried out using cDNA from both normal and gentamicin treated utricle. 
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upon which subunits had shown a significant change in gene expression in the initial 
qPCR screen. Repeating the investigation of integrin gene expression in normal and 
gentamicin-treated tissue through the use of these multiplexed assays was carried out 
with the aim of establishing how replicable (and therefore how reliable) the results of 
the initial qPCR arrays were. Multiplexing of a target assay with an endogenous control 
limits the error that was potentially introduced into the array plate results - the assays on 
the customised integrin TaqMan™ gene expression arrays were not multiplexed. By 
having the endogenous control assay in the same well as each integrin target assay, their 
relative expression levels would be more directly comparable due to being subject to the 
same reaction conditions i.e. reagent and cDNA quantities and well position within the 
plate (wells which are nearer the edges of the 96-well plate are more susceptible to 
evaporation during the qPCR thermocycling process). It is possible that due to the 
samples used being the very last of the cDNA samples for each time point, that this may 
have caused pipetting errors and differences in the PCR reaction mixtures, which 
resulted in only one of the three replicate assays detecting the presence of integrins 
Itga2 and Itgb4 in the majority of the cDNA samples examined. It may also have 
contributed to the size of the error bars seen in figure 5-6 and explain why the results of 
the multiplexed assays show gene expression changes which generally follow the same 
trend as was observed in the initial screen, but which were not calculated as being 
significant. If qPCR experiments carried out in this project were to be attempted again, 
it would be important to obtain utricular tissue in greater quantities, both from normal 
control tissue and from gentamicin-treated utricle cultures, in order to ensure that the 
amount of cDNA being used was not a limiting factor. Since the cDNA samples used in 
this study were from pools of 8 – 10 individual utricles, it would be preferential to 
harvest at least double this amount of tissue for each time point being investigated.  
Quantitative PCR is a sensitive molecular technique, which results in studies such as 
this work which uses cDNA from a pool of tissue, being subject to subtle variations of 
individual utricles and therefore ultimately making significant expression level changes 
more difficult to establish. It is also possible that any changes in integrin expression 
which occur after gentamicin exposure are inherently small and more difficult to detect. 
RQ analysis in this project was only carried out comparing two time points (utricular 
cultures at 4 and 14 days post-gentamicin treatment) to normal utricular cDNA. cDNA 
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from utricles at 21 days post-gentamicin was also run on an TaqMan™ gene expression 
array, however there was insufficient cDNA in this sample for the data collected to be 
reliable and it was therefore omitted from the relative quantification study. It may 
therefore be the case that more significant changes in integrin expression occur in 
between the time points studied and up-regulation or down-regulation events at their 
most significant levels have been missed.   
5.3.2 Changes in the Expression of Hair Cell Markers in Gentamicin-Treated 
Utricular Tissue 
Pou4f3, a transcription factor expressed in sensory hair cells (also known as brn3c/brn-
3.1) exhibited a significant increase in gene expression at 4 days post-gentamicin in 
comparison to its expression in normal utricular cDNA. Pou4f3 has been previously 
identified as being involved in hair cell maturation and survival in the inner ear (Xiang 
et al., 1998)  in both auditory and vestibular hair cells. Mutation of this transcription 
factor causes deafness and vestibular deficiency in Pou4f3-deficient mice; animals 
lacking the Pou4f3 gene do not develop hair cells within their sensory epithelia (Erkman 
et al., 1996; Xiang et al., 1997). Pou4f3 mutation has also been linked to a type of 
progressive hearing loss in humans (Vahava et al., 1998). Research into understanding 
the downstream targets of Pou4f3 and the hair cell survival pathways in which they are 
involved is on-going. The observation of an increase in Pou4f3 gene expression in 
utricular cDNA at 4 days post-gentamicin would lend support to the current 
understanding that this transcription factor is important for hair cell survival as part of 
the damage responses triggered within sensory hair cells by aminoglycoside ototoxicity 
(Towers et al., 2011).   
Atoh1 is another hair cell associated transcription factor, which is known to be critical 
for the development and differentiation of sensory hair cells (Bermingham et al., 1999). 
The qPCR data from this project shows that Atoh1 (also known as math1) is present in 
the normal adult utricle and exhibits an increase in gene expression at 4 days-post-
gentamicin. This result is consistent with the findings of previous studies (Wang et al., 
2010) where Atoh1 mRNA was shown by qRT-PCR to be increased in the mouse utricle 
following aminoglycoside-induced hair cell loss. It would be anticipated, since Atoh1 is 
involved in the differentiation of hair cells, that the organotypic utricle culture model 
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used during this project i.e. a tissue known to exhibit a limited regenerative capability, 
would require up-regulation of the Atoh1 gene in order to induce the transdifferentiation 
of supporting cells into new hair cells. Adenoviral transfection with the Atoh1 gene has 
been shown to induce hair cell regeneration, above the level of spontaneous 
regeneration, in the aminoglycoside-damaged murine vestibular system (Schlecker et 
al., 2011).   
Immunohistochemistry using antibodies against the hair cell markers myosin Viia and 
calretinin in this project demonstrated that hair cells positive for each of these proteins 
are depleted in gentamicin-treated utricular tissue by 4 days post-gentamicin. The 
decrease in gene expression shown by Calb2 and Myo7a in this study by qPCR in 
cDNA from cultured utricles harvested at 4 days post-gentamicin follows the same 
trend as would be expected. That the expression of these hair cell markers subsequently 
begins to recover by 14 days post-gentamicin would support the known ability of the 
utricular epithelium to regenerate vestibular hair cells. A full discussion of the process 
of regeneration in the mammalian vestibular system is included in chapter 7. 
5.3.3 Summary 
The integrin qPCR gene expression assays carried out in this project served as an initial 
screen of utricular tissue for integrin subunits present in normal tissue and for changes 
in integrin gene expression within organotypic utricular cultures undergoing 
aminoglycoside-induced hair cell loss. The results of this qPCR study of integrin 
expression in the adult mouse utricle highlighted a group of integrin subunits which will 
be the subject of further analysis into a potential role for these cell surface receptors in 
hair cell loss and spontaneous regeneration in the vestibular sensory epithelium.  
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Chapter 6: The Expression Pattern of Integrins in Response to Gentamicin- 
Induced Hair Cell Loss 
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The development of an in vitro mouse utricle culture model provided a method of 
studying the effect of gentamicin-induced hair cell loss (and any subsequent 
regeneration) upon the expression of the integrin family of proteins. Immunofluorescent 
labelling of individual integrin α and β subunits was used to investigate both their 
presence in the murine vestibular sensory epithelium and their expression pattern.  
Primary antibodies against individual integrins subunits were initially used to label 
cryostat sections of adult mouse utricles which had not been maintained in culture, to 
investigate the ‘normal’ expression of each subunit in control tissue. Where necessary, 
the dilutions required for the use of the primary antibodies were determined by the use 
of an appropriate positive control tissue.  
A series of in vitro culture experiments were carried out to provide the tissue required 
for time series immunolabelling for several integrin subunits. Three time points at 
which to observe the tissue of interest were selected; 4, 14 and 21 days post-gentamicin 
treatment. These time points were chosen based on the findings of previous work 
(Berggren et al., 2003; Forge et al., 1998; Kawamoto et al., 2009). An early time point 
of 4 days post-gentamicin treatment was selected to show the tissue in a damaged state 
with surface scarring and substantial hair cell loss. The latter time points of 14 and 21 
days post-gentamicin were selected due to these previous studies indicating that 
regenerative events began to be observed at 14 days and were more evident at 21 days 
after ototoxic drug damage. 
 A ‘group’ of utricles (a group was defined as the dissection of 5 animals i.e. 10 
individual utricles) were dissected from adult mice and placed into culture on the same 
day, with one control utricle and two gentamicin-exposed utricles being maintained for 
each of the three time points, This process was then repeated in triplicate. The use of 
such an experimental approach provided three groups of tissue, with each time point 
represented by both control and gentamicin treated utricles. This tissue underwent 
cryostat frozen sectioning. Immunolabelling was carried out on a section of tissue from 
each group at each time point, for both control and gentamicin-treated utricles. 
Immunofluorescent labelling was therefore repeated in triplicate with control and 
gentamicin-treated cultured tissue, in order to allow for any potential variation occurring 
within the in vitro culture set up and subsequent incubation period.  
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All cryostat sections in these immunohistochemistry experiments were labelled with 
primary antibodies against an integrin subunit and a hair cell marker (either a mouse 
monoclonal myosin Viia antibody [dilution of 1:250] or a polyclonal rabbit calretinin 
antibody [dilution of 1:100]). A full description of the methods used for 
immunohistochemistry is provided in 2.3; tables 2-1 and 2-2 give full details of the 
primary and secondary antibodies used during this project. 
6.1 The Expression of Integrin β1 in the Adult Mouse Utricle 
6.1.1 Expression of Integrin β1 in the Normal Adult Mouse Utricle 
Cryostat sections of normal, uncultured adult mouse utricular tissue, fixed immediately 
after dissection from the animal, were immunofluorescently labelled for integrin β1 
(green) using an integrin β1 (CD29) goat anti-rat primary antibody (BD Biosciences) at 
a dilution of 1:1000. The hair cell marker calretinin (red) was also used to label these 
sections in order to visualise vestibular hair cells within the sensory epithelium. 
In the normal adult utricle, integrin β1 appears to be expressed at the border between the 
vestibular sensory epithelium and the basement membrane (Figure 6-1 Ai & Bi). There 
is no co-localisation of integrin β1 and calretinin, indicating that this integrin is not 
present in mature vestibular hair cells. Calretinin is also a neuronal marker, and labels 
the nerve fibres which innervate the utricle (Figure 6-1 Bii, arrow). There is no integrin 
β1 labelling in this region. In addition to its localisation at the basement membrane, the 
other main region of significant integrin β1 positive labelling is located within the 
mesenchymal tissue underlying the epithelium. In particular, blood capillaries found in 
the mesenchyme demonstrate punctate integrin β1 expression along their length (Figure 
6-1 Ci, arrow).  
6.1.2 Co-labelling of Normal Adult Utricular Tissue with Integrin β1 and Collagen 
Type IV 
To confirm that integrin β1 expression occurs at the basement membrane border in the 
normal adult mouse utricle, cryostat sections were co-labelled for integrinβ1 (green) and 
collagen type IV (red). Collagen type IV is the main constituent protein found in basal 
lamina  (Kefalides, 1973) and it was selected for use as a basement membrane marker. 
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The collagen type IV anti-rabbit primary antibody (Abcam) was used at a dilution of 
1:1000. 
As expected, collagen type IV (red) positively labels the basement membrane upon 
which the sensory epithelium of the utricle lies (Figure 6-2 Aii). This marker also labels 
capillaries within the mesenchyme (Figure 6-2 Bii), since the endothelia of these blood 
vessels also possess a basement membrane (Kramer et al., 1985). Integrin β1 co-
localises with collagen type IV both within the blood capillaries (Figure 6-2 Biii, arrow) 
and at the epithelial-basement membrane border (Figure 6-2 D). At higher 
magnification, integrin β1 labelling is punctate in appearance across the length of this 
border.  Integrin β1 expression in the capillaries of the mesenchyme appears to be in 
closer proximity to the luminal surface of the vessels, in comparison to that of collagen 
type IV, which appears to label the outer region of these structures.  
6.1.3 Integrin β1 Expression in Gentamicin Treated Utricles 
Cryostat sections of utricular tissue cultured for 4, 14 and 21 days post-gentamicin were 
labelled for integrin β1 (green) in conjunction with a hair cell marker myosin Viia (red). 
Control tissue was grown in vitro for the same total time period (i.e. 7 days in the case 
of control counterparts of 4 day post-gentamicin utricles) without receiving 48 hours 
antibiotic treatment.  
In control tissue, the expression pattern of integrin β1 is similar to that seen in normal, 
uncultured adult mouse tissue.  Integrin β1 expression occurs at the epithelial-basement 
membrane border (Figure 6-3 Ai). There also appears to be integrin β1 positive 
labelling, similar to that observed in non-cultured tissue, in blood capillaries of the 
mesenchyme (Figure 6-3 Bi, arrowhead). This labelling is not as clearly defined as 
previously seen, appearing as irregular β1-positive plaques as opposed to the finer 
punctae observed in normal tissue. This could be attributed to the likelihood that these 
blood vessels die away following tissue dissection. The hair cell marker myosin Viia 
indicates that vestibular hair cells are abundant in control tissue at this time point in 
vitro (Figure 6-3 Aii). This pattern of β1 labelling was observed in all control utricles at 
each of the 3 time points examined (Figure 6-4A & 6-5A). A general observation of 
cultured utricles which have been maintained for this length of time in vitro is their 
tendency to show a greatly flattened appearance, which is especially evident when 
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examining sections through this tissue as opposed to wholemounts. The mesenchyme 
underlying the epithelium is demonstrably thinner than that of uncultured tissue.  
At 4 days post-gentamicin, β1 expression is very similar to that observed in the normal 
utricle. Despite the loss of vestibular hair cells indicated by the decreased number of 
cells labelled positive for myosin Viia (Figure 6-3 Bii) integrin β1 expression remains 
most evident at the epithelial-basement membrane border (Figure 6-3 Ci). As observed 
in control tissue which spent the same length of time under culture conditions, integrin 
β1 labelling of the blood vessels within the mesenchyme is sporadic and not as clearly 
defined as that seen in normal tissue (Figure 6-3 Ci); the capillaries are expected to have 
degenerated in vitro and thus the labelling seen is likely to be residual debris from these 
structures. 
At 14 (Figure 6-4) and 21 (Figure 6-5) days post-gentamicin, few vestibular hair cells 
positive for myosin Viia (Figure 6-4 Bii & 6-5Bii) are visible. Integrin β1 expression at 
these two latter time points does not appear to differ greatly from that observed at 4 
days post-gentamicin treatment. Integrin β1 is expressed at the basement membrane 
throughout the process of hair cell loss and any subsequent tissue recovery for the entire 
time period investigated (Figure 6-4 Ci & Figure 6-5 Ci). Irregular integrin β1 positive 
plaques also continue to be observed in gentamicin treated tissue within the underlying 
mesenchyme at all three time points.  
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 Figure 6-1 Integrin β1 Expression in the Normal, Uncultured Mouse Utricle 
Cryosections of normal mouse utricle which had not been cultured immunolabelled for integrin β1 (green) and calretinin (red). DAPI labels cell 
nuclei blue. (A & B) Vestibular hair cells are positive for calretinin (red) which also labels the neurons which innervate this tissue (Bii, arrow). (C) 
The same section as in B at higher magnification in a region where there are both neurons and blood capillaries visible (Ci, arrow).  
 
 
  
173 
  
 
 
  Figure 6-2 Co-labelling of Normal Adult Utricles for Integrin β1 and Collagen Type IV 
Cryosections of a normal uncultured adult mouse utricle labelled for integrin β1 (green) and 
collagen type IV (red). DAPI labels cell nuclei blue. (A & C) Overview of the entire utricle. 
(B) The same section as in A is viewed under higher magnification, focussing on a region 
containing several blood vessels (Biii, arrow). (D) Co-labelling of integrin β1 and collagen 
type IV, both in the underlying mesenchyme and at the epithelial-basement membrane 
border (arrow).  
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Figure 6-3 Integrin β1 Expression in Control and Gentamicin Treated Tissue at 4 Days Post-Gentamicin Exposure 
Cryostat sections of utricular tissue cultured for 4 days post-gentamicin labelled for integrin β1 (green) and myosin Viia (red). DAPI labels cell 
nuclei blue. (A & B) Control tissue cultured for a total of 7 days, without receiving 48 hours antibiotic treatment. Irregular integrin β1 positive 
plaques (arrow) are thought to be due to degradation of the blood vessels in vitro.  (C) Aminoglycoside treated tissue at 4 days post gentamicin 
treatment. 
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Figure 6-4 Integrin β1 Expression in Control and Gentamicin Treated Utricular Tissue at 14 Days Post-Gentamicin 
Cryostat sections of utricles cultured for 14 days post gentamicin treatment labelled for integrin β1 (green) and myosin Viia (red). DAPI labels cell nuclei 
blue. (A) Control tissue maintained in vitro for a total of 17 days without receiving gentamicin treatment. (B & C) Gentamicin treated utricular sections at 
14 days post gentamicin treatment. There is little remaining mesenchyme tissue at this time point. Plaques positive for integrin β1 (Ciii, arrowhead) 
correlated to the region where the blood capillaries of the tissue would have been located. 
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Figure 6-5 Integrin β1 Expression in Control and Gentamicin Treated Utricular Tissue at 21 Days Post-Gentamicin 
Cryostat sections of utricles cultured for 21 days post gentamicin treatment labelled for integrin β1 (green) and myosin Viia (red). DAPI labels cell 
nuclei blue. (A) Control tissue maintained in vitro for a total of 24 days without being treated with gentamicin. In this section the tissue is still 
sitting on the filter paper on which it was cultured. (B & C) Gentamicin treated utricular sections at 21 days post gentamicin exposure. 
Mesenchymal tissue is greatly reduced in these sections after 24 days in culture.  
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6.2 The Expression of Integrin αV in the Murine Vestibular Epithelium 
6.2.1 Integrin αV Expression in the Normal Adult Mouse Utricle 
Cryostat sections of mouse skin were used as a positive control tissue in order to 
determine an appropriate concentration at which to use the integrin αV primary 
antibody (BD Biosciences).  Phalloidin-FITC (red), used at a 1:1000 dilution, labels 
muscle fibres within the skin (Figure 6-6 Aii) with the distinctive striated appearance of 
actin filaments evident in muscle fibres present within this tissue. Integrin αV (green) 
used at a dilution of 1:200, labelled only at the periphery of these muscle fibres (Figure 
6-6 Ai).  
The dilution established from positive control experiments was used to label cryostat 
sections of normal adult mouse utricles which had not been maintained in vitro. The 
results of these experiments proved to be far less well defined in terms of reliable, 
specific labelling with the integrin αV antibody. Figure 6-6 B represents the clearest 
example of immunohistochemistry in the normal utricle under these conditions; this 
result was not consistently replicable.  Integrin αV (green) exhibits widespread labelling 
in the mesenchymal tissue beneath the vestibular hair cells and supporting cells, with 
regions of greater signal intensity at the edge of the mesenchyme closest to the 
epithelium and also in a pattern which would correspond to blood vessels. Although 
there is a small amount of background staining of αV within the epithelium, calretinin 
(red) labelling of the vestibular hair cells indicates that there is no co-localisation of the 
two proteins within these cells. The calretinin antibody has also labelled the neurons of 
the utricle in this section (Figure 6-6 Bii). 
It was thought that the poor labelling for integrin αV might be improved in utricular 
tissue by using a tyramide signal amplification kit to enhance the signal from integrin 
αV above that of the abundant background level within the mesenchymal tissue. This 
signal amplification system utilises a horse radish peroxidase (HRP) conjugate to 
activate a fluorescently tagged tyramide derivative. This process (which requires 
hydrogen peroxide) creates tyramide radicals which will then localise in the vicinity of 
the site at which the HRP conjugate interacts with the primary antibody being used.  
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In normal uncultured adult mouse tissue immunolabelled for integrin αV (Figure 6-7) 
with the use of the TSA amplification kit, a region of intense labelling (green) is 
detected at the top of the mesenchyme i.e. the area directly beneath the basement 
membrane (Figure 6-7 Aii). This is similar to the pattern seen without the use of 
tyramide amplification, but this region appears brighter and more pronounced over and 
above the background labelling visible across the majority of the mesenchyme. Co-
labelling of cryosectioned normal utricular tissue with integrin αV and the basement 
membrane marker collagen type IV (Figure 6-9), shows that integrin αV appears to be 
expressed only in the underlying mesenchyme, in particular at the region of the 
connective tissue which lies directly beneath the basement membrane ( (Figure 6-9 
Biii). Integrin αV positive-staining does not extend above this membrane into the 
sensory epithelium, indicating that this integrin is not expressed normally in either 
vestibular hair cells or the surrounding supporting cells. Phalloidin-FITC (red) labels 
the stereociliary bundles at the apex of cells within the sensory epithelial layer (Figure 
6-7 Ai). Tissue which would correspond with the vascular network of the utricle within 
the mesenchyme also appears to be positively labelled for integrin αV (Figure 6-7 Bii). 
In wholemount tissue, integrin αV positive undulating lineate structures (Figure 6-8 Aii) 
are visible beneath the layer of the tissue which contains calretinin-positive (red) 
vestibular hair cells. The morphology of these structures would correlate with blood 
capillaries present in the utricle.  
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Figure 6-6 Integrin αV Labelling of Mouse Skin and the Normal Uncultured Mouse Utricle 
(A) Cryosection of mouse skin tissue (as a positive control) immunolabelled with Phalloidin-FITC (red) and integrin αV at a dilution of 1:200 (green). 
DAPI labels cell nuclei blue. (B) Cryosection of normal uncultured adult mouse utricle immunolabelled with integrin αV (green), calretinin (red) as a hair 
cell marker. DAPI labels cell nuclei blue. 
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Figure 6-7 Integrin αV Expression in the Normal Adult Mouse Utricle Amplified using a TSA Kit 
Cryosections of normal uncultured adult mouse utricle labelled for integrin αV using a TSA amplification kit to provide better definition of the true 
signal above background labelling.  (A) Phalloidin-FITC labels stereocilia (red).  Integrin αV (green) is detected predominantly in the 
mesenchyme. DAPI labels cell nuclei blue. (B) Arrows indicate blood capillaries within the mesenchymal tissue which are also positive for integrin 
αV. 
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Figure 6-8 Integrin αV Expression in Normal Wholemount Utricular Tissue 
Normal uncultured adult mouse utricular tissue immunolabelled as a wholemount with calretinin (red) as a hair cell marker, integrin αV (green) and 
DAPI (blue) indicating cell nuclei. (A) Integrin αV (signal amplified using TSA kit) positively labels the vascular network (arrows) of the utricle within 
the underlying mesenchyme.  
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 Figure 6-9 Integrin αV and Collagen Type IV Co-Expression in the Normal Utricle 
Cryostat sections of normal adult utricular tissue co-labelled for integrin αV (green) and collagen type IV (red).  DAPI labels cell nuclei blue. (A) 
Co-localisation of integrin αV and collagen type IV occurs predominately at the basement membrane. (B) There is no integrin αV expression 
above the basement membrane (Arrow indicates basement membrane at the epithelial-mesenchymal border); integrin αV is not expressed in the 
sensory epithelium. 
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6.2.2 Integrin αV Expression in Gentamicin Treated Utricles 
Cryosections of cultured utricular tissue were labelled for integrin αV (green, with the 
use of a TSA amplification kit) in conjunction with the hair cell marker calretinin (red). 
Control tissue was grown in vitro for the same total time period (i.e. 7 days in the case 
of control counterparts of 4 day post-gentamicin utricles) without receiving 
aminoglycoside treatment. 
In control sections across all three time points studied (Figure 6-10, 6-12 A & 6-13 A) 
integrin αV positive labelling appears similar to that observed in normal uncultured 
utricular tissue, with labelling most evident in the mesenchyme directly beneath the 
basement membrane (Figure 6-10 Aii & Bii). There is no co-localisation of calretinin 
and integrin αV visible (Figure 6-10 Aiii & Biii). As was observed in time series 
immunohistochemistry experiments with integrin β1, which also showed a tendency to 
label the vasculature of the utricle, staining of these structures is less evident in cultured 
tissue both in control and gentamicin treated utricles, since these features of the 
underlying mesenchyme tend to disappear after being maintained in vitro. The sensory 
epithelium remains populated with calretinin-positive vestibular hair cells in these 
cultures (Figure 6-13 Bi). 
At 4 days post-gentamicin, utricles have undergone considerable hair cell loss (Figure 
6-11 Ai) and exhibit the same pattern of integrin αV expression (Figure 6-11 Aii & Bii) 
as seen in their control counterparts. The remaining mesenchyme, as in control tissue at 
this time point, lacks the clearly defined labelling of blood capillaries with integrin αV 
that is seen in normal uncultured utricles. By 14 days post-gentamicin (Figure 6-12 C) 
there remains no significant difference in terms of integrin αV expression in comparison 
to either control tissue maintained in vitro for the same length of time, or utricular tissue 
at 4 days post-gentamicin treatment.    
Following a 21 day recovery period, the expression pattern of αV appears little different 
to that observed in control counterparts and in gentamicin treated utricles at earlier time 
points. Despite the sensory epithelium being largely depleted in terms of hair cell 
numbers (Figure 6-13 Ci), the band of mesenchymal tissue immediately beneath the 
epithelial layer remains the focal point of integrin αV positive labelling in these cultures 
(Figure 6-13 Cii).
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Figure 6-10 Integrin αV Expression in Control Utricular Tissue Cultured for 7 Days 
Cryostat sections of utricular tissue maintained in culture for a total of 7 days without gentamicin treatment, immunolabelled for calretinin (red)  and 
integrin αV (green). DAPI labels cell nuclei blue. (A) Control tissue is well populated with vestibular hair cells. (B) x63 objective view of the same 
utricle section. 
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 Figure 6-11 Integrin αV Expression in Utricular Tissue at 4 Days Post-Gentamicin Treatment 
Cryostat sections of cultured utricular tissue at 4 days post-gentamicin exposure were immunolabelled for calretinin (red) and integrin αV (green). DAPI 
labels cell nuclei blue. (A) Calretinin positive cellular ‘debris’ of hair cells which have undergone cell death (arrowhead). (B) A x63 objective view of 
the same section as in A.  
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Figure 6-12 Integrin αV Expression in Utricular Tissue at 14 Days Post-Gentamicin Treatment 
Cryostat sections of cultured control utricles grown for 17 days with any gentamicin exposure immunolabelled with calretinin (red) as a hair cell marker 
and integrin αV (green), using the TSA amplification kit. DAPI labels cell nuclei blue. (A & B) Control tissue cultured for 17 days in vitro. (C) Tissue 
treated with gentamicin after a 14 day recovery period. 
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Figure 6-13 Integrin αV Expression in Cultured Utricular Tissue at 21 Days Post-Gentamicin Treatment 
Cryostat sections of utricular tissue grown in culture for 21 days post gentamicin, immunolabelled for calretinin (red) and integrin αV (green). DAPI 
labels cell nuclei blue. (A & B) Control tissue demonstrates a well-populated sensory epithelium of calretinin-positive hair cells. (C) Gentamicin treated 
tissue at 21 days post aminoglycoside exposure.  
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6.3 The Expression of Integrin β5 in the Adult Mouse Utricle 
6.3.1 Integrin β5 Expression in the Normal Uncultured Adult Mouse Utricle 
Cryosections of adult mouse small intestine (Figure 6-14 A) were used as a positive 
control in order to establish an appropriate concentration at which to use the integrin β5 
primary antibody (Millipore). Phalloidin-FITC (red) positively labels the muscular outer 
wall of the intestinal tissue which is rich in filamentous actin (Figure 6-14 Aii). Integrin 
β5 (green) at a dilution of 1:100 positively labels cells located within the tissue at the 
centre of the numerous villi present at the luminal surface (Figure 6-14 Ai). Additional 
integrin β5 positive cell bodies are seen at the base of crypts and villi in close proximity 
to the outer wall.  
In cryosections of normal adult mouse utricular tissue which had not been maintained in 
vitro, labelled with integrin β5 (green) and myosin Viia (red) as a hair cell marker, there 
appeared to be relatively widespread β5 expression within both the mesenchyme and 
sensory epithelial layers of the tissue (Figure 6-14 Bi). This subunit does not appear to 
be associated with the basement membrane as was observed for integrin β1 and αV. 
Integrin β5 appears to be associated with vestibular hair cells (Figure 6-14 C), in 
particular, towards the base of type I hair cells where they associate with neural calyces. 
There is a clear ‘gap’ in the tissue between the underlying mesenchyme and the myosin 
Viia-positive hair cell layer which shows no integrin β5 expression, corresponding to 
the supporting cell layer of the epithelium.  
6.3.2 Integrin β5 Expression in Gentamicin Treated Utricles 
Control tissue shows greater numbers of myosin Viia positive hair cells than seen in 
sections of gentamicin treated utricles; this occurs at each of the time points examined 
in this study (Figure 6-15 A, 6-16 A & B). At 4 days post-gentamicin (Figure 6-15), 
both control counterparts and gentamicin treated utricles appear to have lost integrin β5 
positive labelling within hair cell bodies in the region of the nerve calyces, where it had 
been observed in normal tissue. Irregular plaques positive for integrin β5 appear at the 
apical region of the sensory epithelium.  
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At 14 days post-gentamicin (Figure 6-16), there appears to be a re-distribution of 
integrin β5 expression. Punctate β5-positive labelling is visible at the basement 
membrane, a region of the tissue where it had not been detected in normal, uncultured 
utricles. This change is observed both in gentamicin treated utricles and their control 
counterparts. The lack of integrin β5 expression within the hair cells in the region of 
afferent calyces seen at 4 days persists at 14 days post-gentamicin treatment (Figure 6-
16 C & D). The irregular integrin β5 positive plaques seen at 4 days are also still visible 
after a 14 day recovery period; both in control and drug exposed utricles.  
By 21 days post-gentamicin (Figure 6-17), it was possible to see evidence that integrin 
β5 expression had begun to return to its original distribution. Myosin Viia positive hair 
cells showing integrin β5 labelling within the hair cell body towards the basal region 
which associates with the neural calyces may be seen in the sensory epithelium. 
However, there remain hair cells which are positive for myosin Viia, which are not 
integrin β5 positive, suggesting that this redistribution may only be partial.  
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Figure 6-14 Expression of Integrin β5 in Small Intestine and the Normal Mouse Utricle 
Cryostat sections of (A) mouse small intestine and (B) normal, uncultured adult mouse 
utricle. (A) Small intestine was used a positive control to determine an appropriate primary 
antibody concentration. Phalloidin-FITC (red) labels the muscular outer wall of the 
intestine. Integrin β5 (green) diluted 1:100.  DAPI labels nuclei blue. (B) The normal mouse 
utricle labelled for integrin β5 (green) and the hair cell marker myosin Viia (red).  
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 Figure 6-15 Expression of Integrin β5 in Cultured Utricular Tissue at 4 Days Post-Gentamicin Treatment 
Cryostat sections of cultured utricle grown for 4 days after gentamicin treatment immunolabelled for integrin β5 (green) and myosin Viia (red). DAPI 
labels cell nuclei blue. (A) Control tissue cultured for a total of 7 days without receiving gentamicin treatment. (B & C) Gentamicin treated tissue 
after a 4 day recovery period.  
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Figure 6-16 Expression of Integrin β5 in Utricular Tissue Cultured for 14 Days Post-Gentamicin Treatment 
Cryostat sections of utricular tissue maintained in vitro for 14 days post gentamicin treatment immunolabelled for integrin β5 (green) and myosin Viia 
(red). DAPI labels cell nuclei blue. (A & B) Control tissue cultured for a total of 17 days without gentamicin exposure. (Bi) Arrows indicate β5-positive 
punctae at the basement membrane. (C & D) Gentamicin treated tissue following a 14 day recovery period. 
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Figure 6-17 Integrin β5 Expression in Utricular Tissue Cultured for 21 Days Post -
Gentamicin Treatment 
Cultured utricular tissue at 21 days post gentamicin treatment, immunolabelled for integrin 
β5 (green) and myosin Viia (red). DAPI labels cell nuclei blue. (Aii) Arrow indicates 
integrin β5 positive labelling similar to that observed in normal tissue.  
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6.4 The Expression of Integrin α6 in the Adult Mouse Utricle 
6.4.1 Integrin α6 in the Normal Uncultured Adult Mouse Utricle 
Cryosections of adult mouse lung tissue were used as a positive control in order to 
determine an appropriate concentration at which to use the integrin α6 (Serotec) primary 
antibody. Previous work on integrins in the inner ear using this α6 antibody used a 
1:200 dilution (Davies and Holley, 2002). Integrin α6 (green) shows widespread 
background labelling in mouse lung tissue (Figure 6-18 Aii), with lineate expression in 
regions that would correlate with the basement membranes of alveolar capillaries.  
Cryosections of normal adult mouse utricular tissue which had not been maintained in 
vitro were immunolabelled for integrin α6 (green) and myosin Viia (red) as a hair cell 
marker. Integrin α6 positive punctae are visible along the length of the epithelial-
basement membrane (Figure 6-18 Bi & Ci) similar to the pattern exhibited by integrin 
β1 in the same tissue. Integrin α6 also appears to label the vascular bed of the 
underlying mesenchyme and shows more widespread staining within the mesenchymal 
tissue at the lower regions of the utricle. There is no co-localisation of the hair cell 
marker and integrin α6 within the sensory epithelium.  
6.4.2 Integrin α6 Expression in Gentamicin Treated Utricles 
In control counterparts of utricles cultured for 4 days post-gentamicin, the sensory 
epithelium is populated with vestibular hair cells positive for myosin Viia (Figure 6-19 
Aii); the section shown does however exhibit a breakage point at the centre, likely to be 
the result of damage during the initial tissue dissection. Integrin α6 positive labelling is, 
as in normal uncultured utricular tissue, present at the border between the epithelial and 
mesenchymal layers of the utricle (Figure 19 Ai). As observed with other integrin 
subunits in this work which label the blood capillaries of the mesenchyme, the integrin 
α6 labelling of these structures is less defined and more irregular than in tissue which 
had not been maintained in vitro. This is attributed to the fact that the mesenchymal 
tissue undergoes considerable remodelling and outgrowth under culture conditions. 
Control tissue continues to show this pattern of integrin α6 expression in the non-treated 
counterparts of 14 and 21 days post-gentamicin utricles (Figure 6-20 A and Figure 6-21 
A).  
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At 4 days post-gentamicin (Figure 6-19), the integrin α6 expression pattern remains 
relatively unaltered from that seen in control tissue, in response to hair cell loss. Plaques 
of myosin Viia positive labelling believed to be cellular debris as the result of dying hair 
cells being extruded from the epithelial layer are visible in the tissue at this time point 
(Figure 6-19 Bii). Despite the loss of hair cells, integrin α6 expression persists at the 
epithelial-mesenchyme border in the region of the basement membrane (Figure 6-19 Bi 
& Ci). There are also large plaques positive for integrin α6 which are likely to 
correspond to the mesenchymal tissue and vascular network in which integrin α6 
expression was observed in uncultured tissue. The same tendency is seen in control 
counterparts, indicating that this occurrence is more likely to be as a result of 
remodelling of tissue in the mesenchyme caused by the culture process, than it is to be 
triggered through gentamicin treatment.  
Integrin α6 expression at the basement membrane is maintained in gentamicin treated 
tissue at both 14 (Figure 6-20 B) and 21 days (Figure 6-21 B) post drug exposure. The 
appearance of irregular integrin α6 positive plaques in the underlying mesenchyme also 
continues to be evident across each of the time points examined. Outgrowth and tissue 
remodelling continues in these organotypic cultures throughout the recovery period 
studied, and therefore these plaques would appear to be the result of the neural and 
vascular elements of the mesenchyme having been lost over time spent in vitro. 
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Figure 6-18 Integrin α6 Expression in Lung Positive Control Tissue and the Normal Adult Mouse Utricle 
(A) Cryosection of adult mouse lung tissue as a positive control to determine an appropriate concentration for the integrin α6 (green) primary 
antibody. DAPI labels cell nuclei blue. (B & C) Cryosections of normal, uncultured adult mouse utricle immunolabelled for integrin α6 (green) and 
myosin Viia (red). DAPI labels cell nuclei blue.  
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Figure 6-19 Integrin α6 Expression in Utricular Tissue Cultured for 4 Days Post-Gentamicin Treatment 
Cryosections of cultured utricular tissue at 4 days post gentamicin treatment immunolabelled for integrin α6 (green) and myosin Viia (red). DAPI 
labels cell nuclei blue. (A) Control tissue maintained in vitro for a total of 7 days without receiving gentamicin treatment. (B & C) Gentamicin treated 
utricular tissue after a 4 day recovery period. (B) This section remains sitting on top of the nitrocellulose filter upon which it was cultured; the filter 
tends to take up the TRITC secondary antibody thus appearing red.  
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Figure 6-20 Integrin α6 Expression in Utricular Tissue Cultured for 14 Days Post-Gentamicin Treatment 
Cryosections of cultured utricular tissue immunolabelled for integrin α6 (green) and myosin Viia (red). DAPI labels cell nuclei blue. (A) Control tissue 
maintained in vitro for 17 days without being treated with aminoglycoside antibiotic. (B) Gentamicin treated tissue following a 14 day recovery period. 
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 Figure 6-21 Integrin α6 Expression at 21 Days Post-Gentamicin Treatment 
Cryosections of cultured utricular tissue immunolabelled for integrin α6 (green) and myosin Viia (red). DAPI labels cell nuclei blue. (A) Control 
tissue grown in vitro for a total of 24 days without receiving 48 hours gentamicin exposure.(B) Gentamicin treated tissue after a 21 day recovery 
period in culture.  
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6.5 The Expression of Integrin β3 in the Adult Mouse Utricle 
6.5.1 Integrin β3 Expression in the Normal Adult Mouse Utricle 
Cryostat sections of mouse skin were used as a positive control tissue in order to 
determine an appropriate concentration for the use of the integrin β3 primary antibody 
(BD Biosciences). Phalloidin-FITC (red), used at a 1:1000 dilution, labels muscle fibres 
within the skin (Figure 6-22 Aii) with the distinctive striated appearance of actin 
filaments evident in muscle fibres present within this tissue. As was seen with integrin 
αV, the β3 antibody (green), at a dilution of 1:200, labelled only at the periphery of the 
muscle cells (Figure 6-22 Ai).  
When this primary antibody was used on cryosections of normal mouse utricle, it was 
generally very difficult to distinguish true β3 (green) positive labelling from widespread 
background staining (shown in Figure 6-22 B). There does appear (Figure 6-22 C 
represents the clearest labelling achieved with this antibody, although this result did not 
prove replicable) to be higher intensity β3 positive labelling in the region of neurons 
which are positive for calretinin (red). Further attempts to optimise the dilution at which 
the antibody was used did not prove successful in improving the quality of 
immunolabelling produced. An alternative β3 primary antibody (Novus Biochemicals) 
was tested on cryosectioned mouse small intestine to determine an appropriate dilution 
(Figure 6-23 A). When used to label cryosections of normal mouse utricle, there 
appeared to be widespread labelling within both the mesenchyme and the sensory 
epithelium (Figure 6-23 Bi). It was however, possible to observe regions of higher 
intensity β3 positive labelling within vestibular hair cells (believed to be type I hair cells 
base upon their shape) in the region of their neural calyces, similar to the labelling 
shown by integrin β5 (Figure 6-23 Ci).  
6.5.2 Integrin β3 Expression in Gentamicin Treated Utricles 
Control counterparts of utricles cultured for 4 days post-gentamicin show a similar 
pattern of integrin β3 labelling as that observed in normal, uncultured utricular tissue 
(Figure 6-24 Ai). The sensory epithelium is populated with myosin Viia-positive hair 
cells (Figure 6-24 Aii); integrin β3 is present in the hair cell layer in regions which 
correspond to the interface between type I hair cells and their neural calyces (Figure 6-
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24 Ai). There is also integrin β3 expression within the underlying mesenchyme. Control 
counterparts of 14 and 21 days post-gentamicin treatment utricles were not able to be 
carried out with the integrin β3 antibody due to a lack of tissue sections; 
immunohistochemistry experiments with this antibody were the last in the series of 
integrins investigated to be carried out.  
At 4 days post-gentamicin treatment (Figure 6-24 Bii), myosin Viia-positive hair cell 
numbers are substantially decreased – there are no hair cells visible in the section shown 
in this figure, only myosin Viia-positive debris. Integrin β3 labelling in this tissue, in the 
absence of hair cells, appears to have been redistributed, with integrin β3 expression 
associated with the supporting cells, suggesting that this integrin may be present at the 
interface between supporting cells and neurons. As seen with other integrins which 
localised to the mesenchyme, β3 labelling is present in the underlying connective tissue 
at 4 days post-gentamicin, but this expression appears more punctate and plaque-like 
due to the extensive remodelling which occurs in the mesenchyme in vitro. 
At 14 days post-gentamicin integrin β3 expression appears similar to that observed at 4 
days (Figure 8-25 i). The section shown in figure 8-25 lacks myosin-Viia positive hair 
cells. As seen at 4 days post-gentamicin, in the absence of vestibular hair cells, integrin 
β3 localises to regions which would correspond with the interface between a neuron and 
a supporting cell.  
By 21 days post-gentamicin, there is evidence which might suggest that integrin β3 is 
redistributed to the region of neural calyces at type I vestibular hair cells. It is not 
possible to determine from these immunohistochemistry experiments as to whether the 
myosin Viia-positive cells visible in figure 8-26 are hair cells which have been 
regenerated, or are instead hair cells which were able to survive the aminoglycoside 
treatment. The hair cells labelled with myosin Viia in this utricular section, however, 
demonstrate integrin β3 labelling which is similar to that observed in normal utricular 
tissue.  
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Figure 6-22 Integrin β3 Expression in Skin as a Positive Control Tissue and In the Normal Adult Mouse Utricle  
Cryostat sections of mouse tissue immunolabelled with an integrin β3 primary antibody (BD Biosciences). DAPI labels cell nuclei blue.(A) Adult 
mouse skin was used as a positive control to determine an appropriate concentration for the use of the integrin β3 (green) antibody. Phalloidin-FITC 
(red) labels actin filaments. (B & C) Normal uncultured adult mouse utricle cryosections labelled for integrin β3 (green) and calretinin (red). 
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Figure 6-23 Integrin β3 Expression in Positive Control Tissue and the Normal Adult 
Mouse Utricle  
Cryosections of adult mouse tissue were immunolabelled for integrin β3 with an alternative 
primary antibody (Novus Biochemicals). DAPI labels cell nuclei blue. (A) Mouse small 
intestine was used as a positive control tissue in order to determine an appropriate 
concentration at which to use the integrin β3 (green) primary antibody. (B & C) 
Cryosections of normal, uncultured adult mouse utricle immunolabelled for integrin β3 
(green) and myosin Viia (red).  
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 Figure 6-24 Integrin β3 Expression at 4 Days Post-Gentamicin Treatment 
Cryosections of cultured utricular tissue immunolabelled for integrin β3 (green) and myosin Viia (red). DAPI labels cell nuclei blue. (A) Control 
tissue cultured for a total of 7 days without exposure to gentamicin. (B) Gentamicin treated tissue following a 4 day recovery period.  
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Figure 6-25 Integrin β3 Expression at 14 Days Post-Gentamicin Treatment 
Cryosection of utricular tissue immunolabelled for integrin β3 (green) and myosin Viia 
(red) at 14 days post gentamicin. DAPI labels cell nuclei blue.  
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Figure 6-26 Integrin β3 Expression at 21 Days Post-Gentamicin Treatment 
Cryosection of utricular tissue at 21 days post gentamicin immunolabelled for integrin β3 (green) and myosin Viia (red). DAPI labels cell nuclei blue.  
  
207 
  
 
 
 
 
 
 
 
 
Chapter 7: Discussion 
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The experiments carried out during this project represent the first investigation into the 
expression of members of the integrin family of cell surface adhesion molecules within 
the adult mouse vestibular system. The data obtained also demonstrates a novel 
bioinformatics based assessment of the relationships between the alpha and beta integrin 
subunits in terms of their DNA sequence, which is specific to the mouse model species 
used.  
The mammalian utricle was chosen as the model tissue for this project since it has been 
established through previous work of this research group as being a sensory epithelium 
which is capable of some spontaneous regeneration. The structure of this tissue is such 
that the supporting cells of the sensory epithelium are in contact with the basement 
membrane which lies between the epithelium and the underlying mesenchymal tissue. 
Integrins are known to bind several extracellular matrix proteins which are major 
constituents of basement membranes, forming cellular adhesions between the membrane 
and cells such as epithelial cells which are in direct contact with it. Vestibular hair cells 
in the normal mature utricle do not have any contact with the basement membrane since 
they are surrounded by the supporting cells. However, during spontaneous regeneration 
following loss of hair cells, where supporting cells have been shown to undergo a 
phenotypic conversion  (Li and Forge, 1997), it is thought necessary for  these cells 
which are to become new hair cells to break their contacts with the basement 
membrane. This would allow regenerated cells to relocate to the apical layer of the 
sensory epithelium; previous work has shown cells believed to be undergoing 
transdifferentiation at several stages in this process of detachment, observing cells with 
apical bundles which appear immature, in addition to being in contact with the 
basement membrane by a ‘foot-like’ process (Li and Forge, 1997). The cellular 
processes which underlie these events during transdifferentiation would therefore be 
anticipated to involve integrin cell surface receptors. Additional events that could be 
suggested as requiring members of the integrin family are the cellular shape changes 
which occur as supporting cells fill the gaps in the epithelium created by the death of 
hair cells in order to seal the lesion and maintain the endocochlear potential. Supporting 
cells nearest utricular lesions have been shown to spread and become more squamous in 
their morphology (Meyers and Corwin, 2007). Integrins are known to be involved in 
cell spreading through their interaction with their surroundings via focal adhesion 
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complexes, in addition to playing a role in the re-organisation of the actin cytoskeleton 
(Cavalcanti-Adam et al., 2007). This work therefore presents the mouse utricle as a 
viable inner ear tissue for the study of integrin involvement in the repair and 
regeneration of the vestibular sensory epithelium.  
7.1 In Vitro Culture of Adult Mouse Utricular Tissue is a Viable Model System for 
the Induction of Hair Cell Loss 
7.1.1 In Vitro Vs In Vivo; Limitations of the Adult Mouse Utricular Culture Model 
The experimental data presented in chapter 4 illustrates the morphological changes 
which occur in organotypic adult mouse utricle cultures in response to exposure to the 
ototoxic aminoglycoside antibiotic gentamicin.  
Initial culture experiments were carried out on glass-bottomed Mattek™ dishes coated 
with laminin. Although utricles survived well on this culture surface, it was deemed 
unsatisfactory for continued use in the work carried out during this project. Utricles 
maintained in vitro on laminin coated glass showed a tendency to spread and ‘grow out’ 
from the original explant with the laminin acting as a substrate. Utricles maintained for 
longer time periods i.e. 14 days and longer, would prove to be very difficult to remove 
from the dish at the end of the experiment; in some instances the utricular tissue would 
appear virtually indistinguishable from the laminin coated glass. Laminin, an 
extracellular matrix protein is a known ligand for several integrin heterodimers 
including α3β1, α6β1 and αVβ5 (Belkin and Stepp, 2000). If utricular tissue maintained 
on a laminin substrate had been used for integrin immunofluorescent labelling, it would 
be possible that focal adhesion complexes containing one or more of the known 
laminin-binding integrin heterodimers might form at the base of the connective tissue 
i.e. the region of the explant in direct contact with the culture substrate. This could 
potentially have resulted in integrin positive immunofluorescent labelling being visible 
which is not usually present in the normal tissue.  Other previous studies which have 
carried out utricular culturing have allowed the dissected maculae to be maintained free 
floating in 24 well plate dishes containing culture medium (Cunningham, 2006). It 
could be suggested that this method of incubation might be less likely to induce 
artificial changes in the integrins of the utricular tissue, in particular the mesenchyme, if 
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the cultured utricles are not adhering to a culture substrate. However, tissue maintained 
in this manner has a tendency towards the utricle ‘curling inwards’ on itself at its 
peripheral regions. This would have implications for the manipulability of the tissue  for 
use in further experiments i.e. cryostat section for immunohistochemistry – tissue which 
is not flat would be extremely difficult to cut straight, even transverse sections through 
to provide optimal sections for immunolabelling . With the experimental requirements 
of the work to be carried out using the utricle culture model system in mind, it was 
deemed that the use of nitrocellulose filters as a surface on which to maintain explants 
was best suited to obtaining accurate results whilst preserving the ability to manipulate 
the tissue after the cessation of growth in vitro. It should be taken into consideration that 
the dissection methods utilised in order to prepare the tissue of interest for in vitro 
incubation are also altering the utricle in a manner that is not encountered in vivo. The 
utricular maculae cultured during this project had the overlying otolithic membrane and 
otoconia removed during the dissection process; these alterations to the utricle would 
not occur in an in vivo model, and represent an additional deviation of the culture 
system from the tissue in its natural state which might have the potential to influence the 
results observed in any studies of utricles maintained in vitro. 
The results of the immunolabelling experiments on cultured utricular tissue carried out 
during this study indicate that the tissue of interest, in particular the underlying 
mesenchyme, undergoes a considerable degree of remodelling and proliferation in 
response to the in vitro experimental conditions. The initial laminin culture substrate 
used was substituted for nitrocellulose filter paper due to the extent of cellular spreading 
observed and since laminin is a known ligand for multiple integrin heterodimers; in 
doing this it was hoped that a potential source of artificial changes to integrin 
localisation and expression had been removed from the model system. Despite this 
alteration to the culture technique, it is clear that the mesenchyme which underlies the 
vestibular epithelium continues to undergo cellular changes which are not representative 
of or comparable to the tissue in vivo. It is therefore possible that the remodelling which 
occurs in the mesenchymal tissue, particularly that which lies in closest proximity to the 
basement membrane (a key location within the tissue of interest where integrin 
expression would be expected), might artificially alter integrin expression levels or 
localisation patterns in a manner which does not occur naturally in vivo.  
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The immunohistochemistry experiments carried out in this project to investigate 
potential changes in the localisation pattern of several integrin alpha and beta subunits 
at several time points following gentamicin exposure were carried out only using the in 
vitro model. Control counterparts for each post-gentamicin time point were also 
immunolabelled for the integrin subunits investigated, in order to provide a comparison 
between untreated utricular tissue after a period of time grown in culture, and utricular 
tissue maintained in vitro for the same total length of time, but subjected to 48 hours 
gentamicin-treatment. However, based on the observation of these experiments, it is not 
possible rule out whether the results have been influenced by the culture conditions and 
show localisation patterns which would not be present in vivo. The 
immunohistochemistry experiments presented in this thesis could be repeated in vivo to 
verify the results obtained in vitro; this would involve treating adult mice with 
gentamicin (either systemically or directly into the inner ear. 
7.1.2 In Vitro Vs In Vivo Studies of the Effects of Aminoglycosides on Mammalian 
Utricular Sensory Hair Cells 
7.1.2.1 Gentamicin-Induced Hair Cell Loss  
The use of mammalian vestibular sensory epithelia to study changes which occur after 
hair cell loss induced by aminoglycoside antibiotics has been carried out in numerous 
previous studies. The work of members of this research group has developed and 
utilised organotypic utricular cultures as a method for investigating hair cell loss and 
spontaneous regeneration in the vestibular system, using tissue from several different 
species including the newt (Taylor and Forge, 2005), and guinea pigs (Forge and Li, 
2000).  The use of an in vitro system in this project in order to study the expression of 
integrins in a tissue undergoing hair cell loss and spontaneous regeneration therefore 
represents an original progression of the work established by other members of this 
research group.  
The selection of an in vitro model for gentamicin-induced hair cell loss in order to study 
the effects of this damage and any subsequent spontaneous regeneration on integrin 
expression was based upon consideration of the benefits and limitations of in vitro 
methods compared to an in vivo approach. A key benefit of using an in vitro system is 
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the ability to easily manipulate the environment in which the sensory epithelium is 
being maintained. During this project, the culture medium in which the tissue of interest 
was grown was utilised to treat the sensory epithelium with gentamicin at  a specific 
concentration for a given time period and additionally to expose the tissue to EdU in 
order to investigate cellular proliferation. Manipulation of the external environment to 
which the sensory epithelium is exposed is far easier with an in vitro system, with the 
culture medium being removed and replaced as required, and drug treatments added at 
the appropriate dilutions and removed from the culture dish after a specific incubation 
period has elapsed. This ease of manipulation would also be advantageous for potential 
future experiments i.e. for administering integrin chemical blockers or blocking 
antibodies in order to study the effects of integrin inactivation on gentamicin-induced 
hair cell loss and the regeneration. 
An in vivo model of gentamicin-induced hair cell loss requires that the aminoglycoside 
be administered to the animal directly. This may be carried out systemically via 
subcutaneous injection; requiring repeated injections over an extended time period in 
order to elicit a damage response – treatment carried out in this manner is not able to 
induce complete hair cell loss and it is not possible to carry out the drug treatment in a 
single dose, since this results in systemic toxicity to the animal, particularly in the 
mouse (Wu et al., 2001). Alternatively, aminoglycosides may be administered in vivo 
via several different surgical methods, including cochlear perfusion and direct 
application of a gentamicin-soaked pledget via the semi-circular canal or round window. 
The requirement of an in vivo model for repeated injection of an animal or surgery to 
manipulate experimental conditions is more complex and time consuming  than in vitro 
methods; surgery on an animal carries risks that the subject might die as a result of the 
procedure before the end point of the experiment; additionally, the injection of an 
animal with a drug treatment results in the ‘end point’ of drug treatment being less 
clearly distinguished, due to the potential for the antibiotic to remain present 
systemically even after cessation of treatment. Additionally, in an in vivo model, the 
damaged sensory epithelium will still be able to receive, and therefore respond to, 
stimuli and signalling molecules which originate outside of the epithelial and 
mesenchymal tissue. In vitro, the death and degeneration of the neurons which innervate 
the utricle is observed as the mesenchyme beneath the hair cell and supporting cell 
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layers undergoes considerable remodelling. Spontaneous regeneration in vitro is 
therefore reliant upon molecular signalling which originates from the remaining 
mesenchymal tissue and the supporting cells of the sensory epithelium. The cellular 
spreading and mesenchymal remodelling observed in vitro would not occur in vivo, and 
it could be that the changes taking place within this region as a result of being 
maintained in culture have an effect on the response of the sensory epithelium to 
aminoglycoside treatment.  
A key factor in the considered in the selection of an in vitro model over an in vivo 
system is that the underlying cellular mechanisms and pathways by which sensory hair 
cells die in response to aminoglycoside exposure appear to be the same. Despite 
variability of the number of hair cells lost from the vestibular epithelia of mammals 
depending upon the method of aminoglycoside administration and duration of exposure 
to the ototoxic drug, previous studies have shown that the mechanism of hair cell death 
is preserved both in vitro and in vivo. 
The entry of ototoxic aminoglycoside antibiotics, has been shown through previous 
work to involve the mechanotransduction (MET) channels located within hair cell 
stereocilia. The styryl dye FM1-43 had demonstrated the ability to selectively label 
sensory hair cells in several different species (Gale et al., 2000; Nishikawa and Sasaki, 
1996; Seiler and Nicolson, 1999). Having been shown to enter hair cells via MET 
channels, FM1-43 uptake by sensory hair cells resulted in these channels being 
permanently blocked. Pre-treatment of hair cells with FM1-43 prior to exposure to 
aminoglycosides resulted in a reduction of the damage and hair cell death observed. 
This finding suggests that aminoglycosides share the same route of entry into hair cells 
as FM1-43 (Gale et al., 2001; Marcotti et al., 2005). 
Exposure of the inner ear to aminoglycosides results in loss of the sensory hair cells in 
both the auditory and vestibular sensory epithelia. Previous studies have shown that this 
cell death is apoptotic in nature; occurring both in vitro and in vivo. Apoptosis, a type of 
programmed cell death, has distinctive morphological characteristics which include 
condensation of chromatin within the nucleus, cell shrinkage, ‘blebbing’ of the cell 
membrane and the formation of apoptotic bodies which may then be removed from the 
tissue by phagocytosis. Apoptotic hair cell death has been identified through visual 
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identification of these morphological changes in tissue obtained via an in vivo model (Li 
et al., 1995) , and also using terminal deoxynucleotidyl transferase dUTP nick end 
labelling (TUNEL) assay to detect apoptotic changes in the DNA of  dying hair cells 
(Lang and Liu, 1997) in the vestibular epithelia of guinea pigs.  
Further in vivo evidence of apoptotic hair cell death centres on the use of inhibitors of 
key apoptotic proteins and signalling pathways. Caspases are specialised proteases 
which when activated are able to cleave proteins linked to cell survival e.g. Bcl-2, as 
well as contributing to the disassembly of cellular structures and the cytoskeleton 
(Thornberry and Lazebnik, 1998). Observations made in vivo in  mammalian 
(Nakagawa et al., 2003) and avian (Matsui et al., 2003) species, indicate that the effects 
of aminoglycoside treatment are reduced by administration of the drug simultaneously 
with a caspase inhibitor; these animals exhibited increased hair cell survival and a 
reduction in the amount of apoptotic cells detected in both auditory and vestibular 
sensory epithelia.  Similar studies conducted in vitro using mouse (Cunningham et al., 
2002) and guinea pig (Forge and Li, 2000) vestibular epithelia also showed that 
aminoglycoside treatment resulted in the activation of multiple caspases, including the 
upstream caspase-9 and downstream caspase-3, and that incubation of cultures with a 
caspase inhibitor protected the vestibular epithelium from aminoglycoside-induced hair 
cell death. It would therefore appear that in vitro and in vivo models of mammalian hair 
cell loss induced by aminoglycosides share a common mechanism of cell death via 
apoptotic pathways. Some evidence suggests there may be other mechanisms involved 
in in vivo responses to ototoxicity; one in vivo mouse model of hair cell loss induced by 
kanamycin, demonstrated a lack of classic apoptosis markers and instead other 
molecules such as calpains, were detected – these proteases are involved in both 
apoptotic and necrotic cell death (Jiang et al., 2006). It is clear that whilst there are 
similarities in the response of inner ear sensory epithelia to ototoxic drugs and the way 
in which hair cells die in vitro in comparison to in vivo, there may also be differences 
that have consequences for results obtained using in vitro model systems.  
7.1.2.2 Similarities of the Adult Mouse Utricle In Vitro Model to Previous Studies 
The response of adult mouse utricles to gentamicin treatment over an in vitro recovery 
period of 21 days described in this work is similar temporally and spatially to previous 
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studies of regeneration of the mammalian vestibular epithelium in mouse (Lin et al., 
2011) and guinea pig (Forge et al., 1993; Warchol et al., 1993).  Relatively few previous 
studies have maintained murine utricular tissue in vitro long term;  utricular tissue was 
cultured for 21 to 28 days used utricles from early postnatal rats (Berggren et al., 2003; 
Werner et al., 2012). The culture experiments in this work present the adult mouse 
utricle as a tissue which is able to be maintained for up to 28 days in vitro whilst 
supporting the survival of sensory hair cells; mean hair cell counts of control utricles 
after 5 and 31 days in vitro showed no statistically significant difference.  Hair cell loss 
in these utricular cultures (Figure 4-4) occurs soon after gentamicin exposure. By 4 days 
post-treatment, hair cell numbers in the sensory epithelium are reduced in comparison to 
control counterparts cultured in parallel. Aminoglycoside treatment in vitro does not 
induce a complete loss of hair cells (Figure 4-6 and 4-7); the decrease in hair cell 
numbers compared to control utricles maintained in vitro for 5 days was not found to be 
statistically significant at 2 days post-gentamicin, but was significant both at 14 and 28 
days.  
FITC-phalloidin labelling of also reveals that some cells which remain positive for a 
hair cell marker (calretinin or myosin Viia) do not possess an apical stereociliary 
bundle. This occurs in tissue treated with ototoxic drugs and in control counterparts. 
Utricular cultures examined by transmission electron microscopy (Figure 4-2) also 
display evidence of hair cell bodies within the sensory epithelial layer which lack an 
apical hair bundle. Previous studies using the Organ of Corti (Sobkowicz et al., 1996) 
report the presence of auditory hair cells which remained following physical injury in 
vitro. In this instance, hair cells which did not die, yet which did not exhibit a 
stereociliary bundle, were often found to have been ‘covered over’ by the expansion of 
supporting cells to seal the breach in the epithelium following damage. This observation 
of supporting cell spreading is again, the kind of cellular shape change process in which 
it might be expected cell adhesion molecules like the integrin family to be involved. 
Scanning electron microscopy also shows evidence of stereocilia degeneration. At 5 
days post-gentamicin (Figure 4-13) examples of disorganised apical hair bundles can be 
seen on the epithelial surface. There are also stereociliary bundles present which have 
become fused; some of these bundles appear to have aggregated all of the filamentous 
actin from their stereocilia into one large projection. Disorganised stereocilia are also 
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observed in these utricular cultures at 14 days post-gentamicin treatment (Figure 4-16). 
Previous studies of the effect of aminoglycoside antibiotics on the mammalian 
vestibular epithelia (Forge and Li, 2000) have also observed these features of apical hair 
bundles under such experimental conditions.  
Scar formation as previously reported at the sites of hair cell loss (Meiteles and 
Raphael, 1994) in the mammalian utricle, is present in gentamicin treated utricular 
tissue at each of the time points investigated, from 4 to 28 days post-gentamicin 
exposure. Supporting cells have also been previously shown to engulf and phagocytose 
dying hair cells (Bird et al., 2010) in chick utricles when treated with aminoglycosides. 
Integrins have been documented as being mediators of phagocytosis  via both inside-out 
and outside-in signalling cascades which are able to trigger re-modelling of the actin 
cytoskeleton (Dupuy and Caron, 2008). Integrins αVβ5 and αVβ3 (all three constituent 
subunits of which have been detected during this project in normal mouse utricular 
tissue) have been described as being involved in the phagocytosis of apoptotic cells; 
αVβ5 has been shown to be involved in phagocytosis carried out by non-professional 
phagocytes such as retinal pigmented epithelial cells (Finnemann et al., 1997). It is 
therefore possible that integrins might play a role in facilitating the phagocytosis of 
apoptotic hair cells in the vestibular epithelium. 
 The reduction in hair cell numbers, stereociliary degeneration and scar formation 
observed in this study as a response to aminoglycoside treatment supports the idea that 
this in vitro model system responds in a manner which resembles hair cell loss in vivo in 
the vestibular epithelium. These findings support the use of an organotypic culture 
model in order to study the role of integrins in the mammalian vestibular system. If hair 
cells are dying and the supporting cells are undergoing morphological changes in order 
to maintain the integrity of the epithelial barrier, then there may be changes occurring in 
terms of the expression and localisation of members of the integrin family of proteins.  
7.1.3 Regenerative Capacity Following Gentamicin-Induced Hair Cell Loss 
Several non-mammalian vertebrate species have been shown to possess the ability to 
regenerate lost auditory and vestibular hair cells, including amphibians (Baird et al., 
1993; Taylor and Forge, 2005) and birds (Corwin and Cotanche, 1988; Cotanche, 1987) 
following both acoustic trauma and insult by ototoxic drug exposure. It has also been 
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established that in the avian vestibular epithelium, there is a continual turnover of 
vestibular hair cells, with on-going regeneration in response to the losses which occur 
naturally over time (Jorgensen and Mathiesen, 1988). The mammalian vestibular system 
possesses a limited ability to regenerate hair cells following aminoglycoside treatment 
or the physical creation of a lesion in the tissue. Previous work on the mouse utricle has 
documented the appearance of apparently regenerated vestibular hair cells with 
immature, embryonic-like apical bundles (Kawamoto et al., 2009; Lin et al., 2011). The 
appearance of these immature hair cell-like cells began to occur at between 14 to 21 
days after treatment with an aminoglycoside. The bundles then continued to elongate 
and acquire more mature morphological features e.g. tip-links between stereocilia. In 
this work, immature bundles did not become evident until 21 days post-gentamicin 
treatment; in order to determine an exact time point at which these structures start to 
emerge it would be necessary to examine organotypic cultures at time points between 
14 and 21 days post-gentamicin.  
Previous work on the utricular maculae of adult guinea pigs (Forge et al., 1993) 
observed the appearance of immature embryonic-like bundles by scanning electron 
microscopy which appear very similar in morphology to that observed on adult mouse 
utricles maintained in vitro for 14 days after ototoxic drug treatment (Figure 4-18). The 
immature bundles observed consist of short stereocilia which are all of an 
approximately similar length. The stereocilia are grouped very closely together and 
although they are not overtly dissimilar in length to the microvilli which cover the 
apices of the supporting cells surrounding them, they are easily distinguishable by their 
‘organised’ appearance. What appear to be new stereocilia are also visible in utricles at 
28 days post-gentamicin labelled with FITC-phalloidin (Figure 4-7). It may be possible 
to observe similar new bundles on utricles cultured for 14 days post-gentamicin (Figure 
4-6), however they are fewer in number and the bundle shorter and therefore less 
apparent than those seen at 28 days post-gentamicin.  
The use of mitotic trackers such as bromodeoxyuridine (BrdU) and tritiated thymidine 
in both in vitro and in vivo models of aminoglycoside-induced hair cell death in the 
mammalian vestibular system has been carried out in order to investigate whether 
cellular proliferation is responsible for the partial repopulation and regeneration of the 
utricle seen in this tissue. This project utilised EdU (a nucleoside analog which is an 
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alternative to BrdU) in order to investigate the proliferative events occurring in the in 
vitro culture model developed. Examination of cultured utricles incubated with EdU at 
21 days post-gentamicin did not detect the presence of any cells co-labelled for both 
myosin Viia and EdU, which is reminiscent of the findings of previous studies that 
regenerated hair cells were produced by phenotypic conversion of supporting cells and 
not mitotically; EdU-positive cells were visible predominantly at the level of the 
underlying utricular mesenchyme. 
The results presented in this thesis suggest that the in vitro adult mouse utricle model 
studied does possess some capacity to regenerate vestibular hair cells following 
gentamicin-induced hair cell loss.  
7.3 Integrin Expression in the Adult Mouse Utricle: A Potential Role for Integrins 
in the Mammalian Vestibular System 
The presence of the integrin family of cell surface glycoproteins within the inner ear has 
only been explored in a few previous studies (Davies, 2007; Davies and Holley, 2002; 
Littlewood Evans and Muller, 2000). This work presents evidence of the presence of 
multiple integrin α and β subunits in the adult murine utricle using a combination of RT 
and quantitative PCR. This cohort of integrins represents the subunits expressed by a 
number of different cell types, since the tissue from which cDNA was extracted 
contained mesenchyme, endothelium and other cell types in addition to the cells of the 
sensory epithelium. Relative quantification analysis of an initial qPCR-based screen of 
the tissue of interest suggests that some integrin subunits appear to be undergoing a 
change in their level of expression in response to damage and hair cell loss induced in 
by treatment with gentamicin in vitro. Immunofluorescent labelling of both normal and 
gentamicin treated utricular tissue has allowed the localisation of some of the integrins 
identified as being present in the tissue of interest to be investigated and for any changes 
in integrin distribution to be detected. 
Since this work has identified as many as 11 integrins as being present in the adult 
murine utricle in its normal state, in this discussion, integrins which have been 
previously identified in the inner ear as well as those which have been described in 
earlier studies as being involved in tissue repair in other model systems, are focussed 
on, in addition to those identified as showing significant expression level changes.  
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7.3.1 Integrin Immunohistochemistry 
During this project, primary antibodies raised against 5 different murine integrin 
subunits were used to label utricular sections, initially using tissue processed directly 
after dissection from normal adult mice, in order to visualise their expression pattern in 
the utricle in its normal state. These experiments observed the localisation of integrins 
at the basement membrane, to structures such as blood capillaries within the underlying 
mesenchyme, and in some cases the hair cells of the vestibular sensory epithelium. The 
localisation of each of the five integrin subunits examined is summarised in figure 7-1.  
Utricular sections of organotypic cultures maintained for 4, 14 and 21 days post-
gentamicin were also immunolabelled for α6, αV, β1, β3 and β5 in order to establish 
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Figure 7-1 Integrin Expression in the Normal Adult Mouse Utricle 
A summary of the integrin expression found in the normal, undamaged adult mouse utricle during this project through immunolabelling of 
utricular sections for five different α and β subunits. Integrins are present throughout the different structures of the tissue including the 
sensory epithelium, basement membrane and the underlying mesenchyme. Further work would be necessary to establish the α and β partners 
of each subunit detected and confirm which functional integrin heterodimers are present in this tissue.  
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Figure 7-2 Integrin Expression at 4 Days Post-Gentamicin in Adult Mouse Utricles Maintained In Vitro 
At 4 days post-gentamicin, the in vitro model of the response of adult mouse utricular tissue to the ototoxic aminoglycoside gentamicin shows a decrease 
in the number of vestibular hair cells labelled with myosin Viia. Integrin immunohistochemistry experiments suggest that expression of integrin β1 and 
α6 at the epithelial-basement membrane border remains unchanged from that observed in normal tissue, as does the localisation of integrin αV to the 
mesenchyme directly beneath the sensory epithelium. The structures of the mesenchyme i.e. blood vessels which expressed four integrin subunits in 
normal tissue, were labelled in a more ‘plaque-like’ manner, due to the remodelling of  this region exhibited by tissue maintained in culture. Of the two 
integrins believed to be localised to vestibular hair cells in normal, undamaged utricles, β3 appeared to associate with regions of supporting cells where 
there had been an interface with a neuron, whilst β5 accumulated at the apical surface of the epithelium in response to the loss of hair cells.  
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Figure 7-3 Integrin Expression at 14 and 21 Days Post-Gentamicin in Adult Mouse Utricles Maintained In Vitro 
Based upon immunohistochemistry experiments on cultured tissue, the expression of integrin β1 an α6 at the epithelial-basement membrane border 
appears to persist at both 14 and 21 days post-gentamicin, as does the localisation of αV in the mesenchyme which lies directly beneath the basement 
membrane; the mesenchyme has undergone considerable remodelling by these time points and is very thin, therefore integrin labelling in this region also 
appears to have been lost with the disappearance of structures such as blood capillaries. At 14 days post-gentamicin, β3 remains associated with 
supporting cells, whilst β5 appeared to be redistributed to the basement membrane; by 21 days post-gentamicin, both β3 and β5 were observed at the 
interface between vestibular hair cells and the region where neural calyx interfaces would be expected in normal tissue. 
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whether their localisation was altered in response to hair cell loss. The majority of these 
subunits did not show any changes in their localisation pattern i.e. β1 expression was 
detected at the basement membrane across all three of the time points studied. Where 
integrins were detected in the underlying mesenchyme and the structures associated 
with this region of the tissue, there was loss of integrin expression, however this was 
attributed to the fact that the mesenchyme undergoes considerable degradation and 
remodelling whilst in vitro. Utricular cultures were observed to become thin and 
flattened during the course of the culture time period, as the mesenchymal cells 
migrated away from the sensory epithelium. The localisation of each of the integrin 
subunits investigated during this project across the three time points post-gentamicin 
studied is summarised in figures 7-2 and 7-3.  
7.3.1.1 Limitations of Immunohistochemistry for the Detection of Utricular 
Integrins  
Whilst the degenerate and quantitative PCR molecular biology techniques utilised in 
this project have the ability to detect the expression of integrin subunit genes within a 
given cDNA sample, they do not provide information as to the presence or location of 
translated integrin proteins within the adult mouse utricle. The cDNA samples used for 
PCR experiments in this work were obtained from the entire utricular sensory 
epithelium and its underlying mesenchyme; any integrin gene expression detected could 
therefore be attributed to any of a number of different cell types found within this tissue. 
Immunohistochemistry allows a protein of interest to be detected within a tissue sample, 
providing qualitative information regarding its localisation to a particular region or cell 
type.  
This project investigated the expression pattern of five integrin subunits which had been 
positively detected by degenerate and quantitative PCR.  Of the integrin antibodies used 
in this study, the integrin β1 and α6 antibodies could be described as providing the best 
quality immunolabelling of utricular cryosections i.e. showed the lowest level of 
background staining in conjunction with strong positive labelling. The 
immunohistochemistry experiments presented in this thesis encountered problems with 
excessive levels of background staining with some of the antibodies used. Background 
labelling may have a number of causes; these include non-specific binding of the 
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primary or secondary antibodies during incubation, hydrophobic protein interactions, 
cross-reactivity of secondary antibodies and the level of efficiency and epitope affinity 
of the primary antibody used. High levels of background labelling can obscure the ‘true’ 
signal, making it difficult to interpret the results of these qualitative experiments as 
what is background and what is positive labelling of the intended antigen is subjective 
to the visual interpretation of each individual observer. Background labelling can be 
reduced through the use of serum, as part of blocking solution during the experimental 
protocol, utilising the ability of the large serum proteins to ‘block’ sites within the tissue 
which would be potential sources of non-specific antibody binding. The use, however of 
both serum and L-lysine (an amino acid) as the blocking strategy for the 
immunohistochemistry experiments carried out during this project did not sufficiently 
reduce the background labelling observed for some of the integrin antibodies tested.  
The labelling produced by the integrin αV antibody used in this study was improved by 
the use of a tyramide signal amplification (TSA) kit. This system allows for increased 
sensitivity (which may be of benefit where antigens are present at lower levels that 
might not be detected efficiently using a typical immunolabelling protocol, and which 
would also be masked by excess background staining).  The nature of the tyramide 
radicals produced using the TSA system means that the signal enhancement it provides 
is restricted to regions in very close proximity to the sites of initial primary antibody 
binding; this attribute allowed the tendency for integrin αV to be localised to the 
mesenchyme directly beneath the basement membrane and within blood capillaries to 
be distinguished above the background labelling experienced. The results obtained with 
this integrin antibody are still limited by the level of background staining and could be 
subject to further analysis in order to determine the cause of this background in order to 
reduce or eliminate this problem. The use of negative control experiments, where the 
primary antibody is not used during the first incubation stage, would establish whether 
background staining could be attributed to non-specific binding or cross reactivity of the 
secondary antibody used. The affinity of the primary antibody for the intended epitope 
alone is also a potential cause of background staining. If a primary antibody shows 
affinity for other similar epitopes within other proteins, then the resulting 
immunolabelling experiments will not be specific for the protein e.g. integrin αV, which 
is being investigated. One method of confirming antibody specificity is via a peptide 
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competition assay; the primary antibody is incubated with an excess of the peptide 
which it was intended to recognise, resulting in the antibody being ‘blocked.’ 
Immunohistochemistry experiments may then be carried out, comparing the staining 
observed when sections of the tissue of interest are incubated with the normal primary 
antibody to that observed with the blocked antibody solution. Successfully block 
primary antibodies within the blocked solution which are specific for the intended 
recognition epitope will be unable to bind and label this epitope within the tissue 
sample, therefore, any labelling observed with the normal primary which is not present   
Immunohistochemistry experiments used to investigate the expression pattern of 
integrin β3 utilised two different antibodies. The initial antibody used (CD61 
monoclonal, BD Biosciences) produced a significant amount of background staining 
which made it impossible to distinguish the true signal from antibody bound to the 
correct epitope, which was not reduced despite the testing of serial dilutions of the 
primary and secondary antibodies. There did appear to be higher intensity labelling in 
the region of the neuronal structures within the underlying mesenchyme of normal 
utricles with this antibody. A second β3 antibody (polyclonal, Novus Biologicals) was 
therefore utilised in order to determine whether the background staining was attributable 
to the affinity of the antibody tested initially. This β3 antibody also showed neural 
localisation in normal, undamaged utricular tissue similar to that observed with the 
monoclonal β3 antibody, but also exhibited labelling which appeared to correspond with 
regions of type I hair cells in closest proximity to their neural calyces. That the two β3 
antibodies tested show differences in their immunolabelling may be due to the different 
characteristics of monoclonal and polyclonal antibodies; polyclonal antibodies are more 
likely to produce non-specific binding, since they can recognise multiple epitopes on the 
target antigen. Correspondingly, the labelling shown by a monoclonal antibody can be 
affected as a result of these antibodies only recognising a single epitope – they can be 
‘too specific’ and their binding efficiency may be adversely affected by the epitope they 
recognise being inaccessible due the conformational state of the protein. The 
immunogen of the polyclonal (Novus Biologicals) β3 antibody was within the C-
terminal region of the integrin peptide; the supplier of the monoclonal β3 antibody (BD 
Biosciences) was not able to provide information on which region of the integrin 
peptide this antibody recognises, therefore differences in labelling exhibited by these 
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two antibodies may be as a result of a difference in accessibility of the epitopes they are 
able to recognise.  Additional factors which may affect how well a primary antibody 
binds include the abundance of the antigen in the tissue studied i.e. antibodies against 
proteins expressed at low levels would likely require higher antibody dilutions to be 
used (which would carry the risk of causing an increase in the level of background 
staining) and the potential for the fixation process, in this case paraformaldehyde, to 
damage protein epitopes within the tissue sample.  
The immunohistochemistry results presented here, in particular the labelling observed 
for integrin αV and β3, may be limited by some of the common difficulties encountered 
when carrying out these types of histological experiment. It must therefore be 
acknowledged that further work in order to reduce the level of background staining 
encountered would be beneficial and would improve the quality and reliability of the 
detection of these target antigens within the adult mouse utricle. Similar histology 
labelling techniques might also be carried out in order to obtain further information 
about expression patterns of integrins in the utricle i.e. in situ hybridisation of integrin 
subunits could be used to investigate whether mRNA distribution of these integrins 
corresponds to protein expression detected by immunohistochemistry. 
7.3.2 Integrin Subunits Detected in the Normal Undamaged Adult Mouse Utricle 
In this project, two PCR based approaches have been utilised, in addition to 
immunohistochemistry experiments, in order to identify which of the integrin α and β 
subunits are present in the tissue of interest in its normal, undamaged state. An initial 
screen of cDNA from the adult murine utricle was carried out by RT-PCR using a set of 
degenerate PCR primers, which detected the presence of a group of 5 subunits; α4, α9, 
β1, β5 and β8. The use of specific primers added a further 3 subunits to this group; α6, 
αV and β3.  
A set of qPCR experiments required a ‘calibrator’ sample in order to carry out a relative 
quantification (RQ) study, using customised integrin gene expression array plates to 
investigate whether the expression level of integrins is altered in response to 
gentamicin-induced hair cell loss. This was achieved by running one array plate with 
cDNA from normal, uncultured utricles and thus provided an additional ‘screen’ of the 
tissue of interest in its undamaged state. The use of this sample as a calibrator allowed 
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the RQ study to investigate changes in integrin gene expression in comparison to the 
level present in normal tissue.  The results of this qPCR study also indicate that β1, β5, 
β8, α6, αV and β3 (as identified by RT-PCR) are present in the normal mouse utricle. 
An additional 5 subunits; α3, α8, β4, β6 and β7 are also indicated as being expressed in 
this tissue.  Of these subunits, antibodies against integrins β1, β3, β5, αV and α6 were 
successfully used to investigate the localisation of a subset of the integrin subunits 
detected in normal utricular tissue by PCR. It would be of interest to carry out similar 
immunohistochemistry experiments with antibodies against the remaining subunits 
detected by PCR in order to learn more about which region of this tissue, which 
contains a number of different and often highly specialised cell types, they are 
expressed within.  
PCR-based methods using normal, uncultured utricular tissue cDNA have indicated the 
presence of 11 different integrin subunits in the utricle of the adult mouse. Since the 
tissue from which this cDNA sample was obtained consisted of the sensory epithelium 
(i.e. hair cells and supporting cells) and the underlying mesenchyme of the utricular 
macula, which would include the vasculature of this vestibular organ, in addition to 
some of the neurons which innervate this tissue, that as many as 11 integrins were 
detected is not surprising. It is highly likely that some of these integrins are restricted in 
their expression to one particular cell type i.e. endothelial cells, rather than being 
associated with the sensory epithelium directly. Immunolabelling of the tissue of 
interest with antibodies against some of the integrin subunits detected by molecular 
methods has provided additional information about the localisation of these proteins to 
particular regions of the utricle and these observations may be utilised in conjunction 
with degenerate and qPCR data in order to discuss potential functional roles for some of 
these integrins. As stated earlier in this chapter, the in vitro model of utricular response 
to gentamicin exposure is affected by the culture conditions in some aspects; the 
underlying mesenchymal tissue degrades and reduces in mass due to cellular migration 
away from the epithelium the longer the utricle is maintained in vitro. The utricular 
mesenchyme would not undergo the same reduction or remodelling in an in vivo mouse 
model. Integrins which may be present exclusively within the utricular mesenchyme 
might therefore still play a role in the cellular events triggered by damage to the sensory 
epithelium in vivo.  
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Two α subunits identified as being present by degenerate RT-PCR (and additionally 
confirmed by DNA sequencing), α4 and α9, were determined based on the analysis 
criteria described in chapter 5 as not being detected in the normal utricle by qPCR. The 
raw data from the ‘0 day’ (normal, uncultured utricular tissue cDNA) gene expression 
array plate shows that α4 was only detected by one of the four replicate assays in 
normal utricular cDNA and α9 detected by two of the four replicates.  
The discrepancy between these two PCR experiments over whether α4 and α9 are 
present in the tissue of interest may be due to the fact that the degenerate RT-PCR and 
the qPCR integrin assay were carried out using different cDNA samples. Yields of 
cDNA reverse transcribed from RNA extracted from pooled utricles (10 utricles 
dissected from 5 individual animals) were low in comparison to the amount of cDNA 
obtained from positive control tissues. Positive control tissue processed according to the 
RNeasy protocol, used 30mg of tissue; 10 utricles could not constitute anywhere near 
the same weight or number of cells. With the amount available it was not possible to use 
the same cDNA sample for the normal control qPCR array plate (which required a large 
volume of cDNA in order to distribute the sample across 96 wells) as had been used for 
the degenerate PCR experiments. It is therefore possible that integrin α4 and α9 were 
present in the cDNA sample used with the degenerate primers, but not in the second 
sample which was used for qPCR. If these experiments were repeated, it would be 
crucial to collect a greater number of cultured utricles at each time point in order to 
prevent the amount of cDNA being a limiting factor.  
Integrin α4 is generally considered to be a leucocyte specific integrin subunit and is 
found in two known heterodimers; α4β1 and α4β7. Integrin α4β1 is able to interact with 
vascular cell adhesion molecule 1 (VCAM-1) and the endothelium in order to mediate 
the extravasation and trafficking of leucocytes during the inflammatory response 
(Postigo et al., 1993). Integrin α4β7 is described as having a similar role in terms of 
interaction with the endothelium (Berlin et al., 1995) but it has also been implicated as 
having a role in the recruitment of leucocytes specifically to gastrointestinal lymphoid 
tissue i.e. Peyer’s patches (Ruegg et al., 1992).  
Integrin α9 associates with only one of the β integrin subunits, to form the α9β1 
heterodimer. This integrin has recently been implicated as having a key role in the 
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development of lymphatic valves (Bazigou et al., 2009). Earlier studies when this 
subunit was first discovered show that it is expressed in smooth and skeletal muscle in 
certain tissues, as well as within some epithelia e.g. airway epithelia and squamous 
epithelia, at cell-cell and cell-basement membrane contacts (Palmer et al., 1993). 
Although phylogenetic studies class α9 as being most closely related to the α4 subunit, 
α9 has only been described as being expressed on polymorphonuclear leucocytes 
(neutrophils) and not by any other types of leucocyte (Shang et al., 1999). 
Based upon previous studies of the expression and function of these two α subunits, α4 
would not be considered a subunit likely to be present in the mouse utricle, particularly 
not in terms of being associated with hair cells or supporting cells of the sensory 
epithelium. Integrin α9, having been described in some epithelia, at cell-cell contacts or 
in the region of the basement membrane, could be considered more likely to be found in 
the tissue of interest. In order to determine definitively whether α4 or α9 are present in 
the normal adult mouse utricle, further PCR replicates with several cDNA samples 
would be required (either using the degenerate primers or qPCR) in order to establish 
whether the detection of these subunits was due to a ‘quirk’ of the cDNA sample used 
for degenerate RT-PCR, or if this result is real. Immunofluorescent labelling of the 
utricle for these integrins would also potentially answer this question; however, there 
are only a limited number of primary antibodies raised against the murine integrin 
proteins which are commercially available.  
The results of the qPCR integrin arrays using cDNA from utricles at 4 and 14 days post-
gentamicin also indicate that integrin α4 and α9 are not present at these time points 
following gentamicin-induced hair cell loss. Although it would be required to repeat 
these qPCR experiments using several different samples of cDNA at each time point in 
order to confirm these results, for the purposes of this project, these two integrin 
subunits have not been considered for further discussion in terms of a potential role in 
the processes of hair cell loss and subsequent regeneration.  
This chapter has discussed the limitations of the results presented in terms of the model 
system and experimental approaches used. In order to present the findings of the 
immunohistochemistry of integrins in the adult mouse utricle and the qPCR RQ analysis 
of changes in integrin gene expression following gentamicin treatment as being truly 
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representative of the behaviour of the vestibular sensory epithelium in vitro, it will be 
necessary to carry out the further which has been described e.g. replication of qPCR 
experiments in triplicate. With the acceptance that additional work is required to 
confirm the results suggested by experimental observations presented here, the 
following section of this discussion addresses the potential implications of these initial 
studies, suggesting potential functions for several integrin subunits believed to be 
present within the tissue of interest.  
7.4 Changes in Integrin Subunit Expression Levels in Gentamicin Treated 
Utricular Tissue 
Relative quantification studies comparing the results of integrin gene expression arrays 
run using cDNA from tissue at 4 and 14 days post-gentamicin, time points where hair 
cell loss would be occurring, to those of the normal ‘0 day’ uncultured control array 
plate suggest that there are 10 integrin subunits which show different levels of 
expression across the 3 time points included in this study. A summary of the changes 
detected in these experiments is presented in table 7-1.  However, the relative 
quantification of these gene expression levels indicates that not all of the changes 
observed (i.e. those shown in Figure 5-4) are significant. For the purposes of the work 
carried out during this project, this discussion focuses primarily upon those integrin 
subunits observed to show significant changes in their expression levels by relative 
quantification of qPCR results, in addition to those integrins for which antibodies were 
available in order to carry out immunofluorescent labelling of the utricle to localise 
integrin proteins.  
All of the five integrin subunits for which immunohistochemistry experiments on 
cryosectioned utricular tissue were carried out were found to be expressed in samples 
from control adult mice which had not been maintained in vitro; each of these integrins 
was also detected by qPCR in cDNA samples from uncultured control utricles. Three of 
these integrins – namely β1, β3 and αV, were observed by RQ analysis of the qPCR 
data to show a significant increase in gene expression at 4 days post-gentamicin, 
compared to the control calibrator sample. In utricular sections immunolabelled for 
these integrins, however, there is no observable increase in the expression of these three 
integrin proteins. Immunohistochemistry evidence might actually suggest that there are 
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less of the integrin subunits which are found in the mesenchyme e.g. αV and β1, since 
this is the region of the tissue which has been shown to undergo extensive remodelling 
in vitro, resulting a loss of the structures to which these integrins were localised i.e. 
blood capillaries; by 14 and 21 days post-gentamicin, there is only a thin layer of 
mesenchyme remaining in these cultured utricles lying directly beneath the sensory 
epithelium. Integrins β3 and β5, which both appear to be localised to the region of 
vestibular hair cells which is in contact with neural calyces in the normal adult mouse 
utricle, can be observed to redistribute to other areas of the sensory epithelium 
following gentamicin treatment. Each of these subunits also demonstrated an increase in 
gene expression at 4 days post-gentamicin detectable by qPCR, although the increase 
shown by β5 was not calculated to be significant. Additionally, there are several 
discrepancies between the results of the immunolabelling and qPCR experiments; 
integrin α6 was not detected in the 4 days post-gentamicin cDNA sample used for qPCR 
analysis, but this subunit is clearly visible in immunolabelled utricular sections at this 
time point, remaining localised to the epithelial-basement membrane border. Integrin β3 
was not detected at 14 days post-gentamicin in the qPCR experiments, whilst 
immunohistochemistry suggest that this integrin is in fact present at this time point 
within the remodelling mesenchyme and potentially at the former sites of supporting 
cell-neuron interfaces. These differences between the immunolabelling and qPCR 
experiments may be explained due to the fact that the qPCR gene expression assays 
were only run using a single pooled sample of cDNA for each time point studied; this 
cDNA might therefore not be truly representative of the gene expression of the tissue at 
each time point and result in some integrins being undetectable by qPCR at a given 
stage post-gentamicin, despite being localised in the tissue at that same time point by 
immunohistochemistry.  
The immunohistochemistry time-series experiments presented here can only truly be 
said to provide qualitative information about the expression of a subset of integrin 
subunits in the normal adult mouse utricle and in gentamicin-treated tissue i.e. 
immunolabelling can detect the presence of a protein and its localisation within a tissue. 
However, it cannot be reliably used to ascertain whether the expression of the integrins 
in question is changing in terms of the amount present in response to gentamicin 
treatment. The qPCR data obtained in this study can provide quantitative information 
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about the expression of integrins in the tissue of interest at a mRNA level, relative to a 
chosen calibrator control sample. Changes in gene expression, such as those detected in 
these experiments, however, do not necessarily correspond to an equivalent increase or 
decrease in the amount of the protein encoded by that gene. Where integrin gene 
expression has been shown to increase e.g. integrin β1 at 4 days post-gentamicin, it may 
be the case that although more integrin β1 mRNA is present at this time point, there 
may not be a similar increase in the translation of this mRNA into the functional 
integrin β1 protein. Alternatively, the integrins which appear to be up-regulated in terms 
of gene expression based on qPCR data might be undergoing an increased rate of 
protein turnover as a response to the gentamicin treatment – thereby showing no visible 
difference by immunohistochemistry i.e. higher intensity staining, but manifesting as a 
detectable increase in gene expression in order to replenish these integrins as they 
turnover more rapidly. The qPCR data obtained in this work could be refined and 
focused on the sensory epithelium of the utricle to provide more specific insight into 
changes in integrin expression. Treatment of utricular tissue with thermolysin, to enable 
the removal of the sensory epithelium from the basement membrane and underlying 
mesenchyme would allow the qPCR gene assays to focus on integrin expression within 
supporting cells and hair cells only, and could yield different results to those presented 
in this thesis.  
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Integrin 
Subunit 
Normal Utricular Tissue 4 Days Post-
Gentamicin 
14 Days Post-
Gentamicin 
    
Itga1 Not Detected Not Detected Not Detected 
Itga2 Not Detected Detected Decreased ** 
Itga3 Detected Increased * Increased * 
Itga4 Not Detected Not Detected Not Detected 
Itga5 Not Detected Not Detected Not Detected 
Itga6 Detected Not Detected Increased 
Itga7 Not Detected Not Detected Not Detected 
Itga8 Detected Not Detected Not Detected 
Itga9 Not Detected Not Detected Not Detected 
Itga11 Not Detected Not Detected Not Detected 
Itgav Detected Increased * Increased 
Itgb1 Detected Increased * Increased * 
Itgb3 Detected Increased * Not Detected 
Itgb4 Detected Increased * Not Detected 
Itgb5 Detected Increased Increased 
Itgb6 Detected Not Detected Decreased 
Itgb7 Detected Not Detected Not Detected 
Itgb8 Detected Increased Increased 
Table 7-1 Summary of Changes in Integrin Expression Detected by qPCR 
This table summarises the results of the RQ analysis carried out on the qPCR data obtained 
during this project. Of the 18 integrin subunits screened for, six were not detected in either 
normal or gentamicin-treated utricular cDNA. Where an integrin subunit is referred to as 
‘increased’ or ‘decreased’ refers to the level of gene expression detected at a given time 
pointe post-gentamicin  in comparison to the calibrator control sample; the calibrator cDNA 
sample was obtained from normal utricles which had not been maintained in vitro. 
 * Denotes a change in expression which was calculated to be significant with 95% 
confidence based on the RQ max and min values across replicate assays.  
** Since α2 was not detected in the calibrator sample, the decrease referred to at 14 DPG is 
in comparison to the level observed at 4 DPG 
  
234 
  
 
7.4.1 Limitations of Quantitative PCR Experiments 
The data obtained through the qPCR screening experiments carried out in this project 
using customised TaqMan® Gene Expression assay plates is limited by the lack of 
replicate results. Although each gene assay included was replicated four times on each 
plate (with one plate being used per experimental condition investigated), only one pool 
of tissue was utilised and run as a qPCR experiment per time point. The data obtained 
for each culture incubation period post-gentamicin (plus the control calibrator sample) 
therefore represents an n number of 1. As a consequence of this, the changes in gene 
expression suggested by the results of RQ analysis of the qPCR data may not be truly 
representative of the typical behaviour exhibited by the tissue when maintained in vitro; 
cDNA from an individual utricle responding in a non-typical manner e.g. due to a lack 
of cellular nutrients required by the tissue during culture, could ‘contaminate’ a pooled 
cDNA sample. If the findings of these qPCR gene expression assays were to be 
published, and in order to ensure that any changes in integrin expression observed were 
representative of the normal response of the tissue to the experimental condition 
(gentamicin treatment) it would be necessary to repeat the experiments at least twice 
more in order to have assayed each gene of interest in triplicate at each experimental 
time point and in control tissue.  
The qPCR experiments presented here were intended to serve as a preliminary screen of 
the tissue, due to the large number of integrin alpha and beta subunits found in 
mammals, in order to identify a subset of the integrins as being of particular interest and 
to focus subsequent further analysis by immunohistochemistry. Additionally, the 
financial implications of running these qPCR experiments also had to be taken into 
consideration; a set of 6 customised qPCR gene expression assay plates represented a 
cost of £1800, before the purchase of the additional reaction cocktail reagents. 
Replication of these qPCR experiments in triplicate would incur costs of at least £3600 
for the TaqMan® assay plates alone, and due to the funding available for consumables 
used in this project, the financial costs of obtaining and running these plates was also a 
limiting factor in terms of repeating the qPCR experiments. The control sample plate 
which was used as the calibrator sample for the RQ analysis which was carried out on 
the data obtained from the qPCR gene expression assays consisted of cDNA obtained 
from utricles which had been dissected from adult mice and had been placed 
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immediately into RNAlater; these utricles had not been treated with gentamicin, nor had 
they been maintained in vitro. Immunostaining of mouse utricles maintained in culture 
revealed that this tissue undergoes cellular changes as a result of the in vitro 
experimental conditions; in particular the underlying mesenchyme shows evidence of 
considerable remodelling, cellular spreading and proliferation. The use of cDNA from 
control tissue which had not been subjected to culture conditions as the calibrator for 
the RQ study therefore means that it is not possible to ascertain whether the changes in 
expression levels of integrins and the other genes assayed for are a true representation of 
the effect of gentamicin treatment on gene expression, or whether some of these 
changes are a result of in vitro experimental conditions – this is particularly true of the 
comparison by RQ of utricular cDNA at 4 days post-gentamicin treatment to non-
gentamicin treated, non-cultured utricular cDNA. In order to account for changes in 
gene expression which are purely a consequence of the tissue having been maintained in 
culture, it would be necessary to obtain cDNA samples from control tissue incubated in 
vitro, but which had not been exposed to the ototoxic aminoglycoside. It would be 
preferable, in order to account for all cellular changes in the tissue which occur due to in 
vitro conditions, to obtain a control counterpart cDNA sample for each of the post-
gentamicin treatment time points (4, 14 and 21 days post-gentamicin) and to include 
these samples in the qPCR experiments carried out. However, as previously mentioned, 
the customised TaqMan® plates used in this project represent a considerable financial 
expense, and to both replicate the results of each cDNA sample in triplicate and include 
control counterpart cDNA samples for each time point would have raised the costs of 
this study yet further. 
The results of the qPCR experiments presented in this thesis, although limited in terms 
of the control sample used as a calibrator and the lack of true replicates, serve as a 
further screen of the tissue of interest in its normal state and as an indication of the 
changes in integrin gene expression which may be occurring in response to gentamicin-
induced hair cell loss. Whilst in order to be presented for publication as conclusive 
evidence that significant changes in integrin gene expression are taking place within the 
gentamicin-treated mouse utricle in vitro, the qPCR experiments discussed would 
require replication, they may be utilised to focus the attention of future work on 
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particular integrin subunits which this preliminary screen suggests are subject to up-
regulation of gene expression. 
7.4.2 Epithelial Integrins Appear to be Up-regulated in Utricular Tissue at 4 Days 
Post-Gentamicin  
Several integrin subunits, namely α2, α3 and β4, which exhibit significant increases in 
their expression level at 4 days post-gentamicin, have been shown in previous studies to 
have a role in the processes involved in wound healing of epithelia such as the skin, 
cornea and airways. Although the cellular mechanisms involved in wound repair in 
these tissues involve migration of cells to the site of the lesion (a process which is not 
believed to be involved in scar formation in inner ear sensory epithelia) they also 
require proliferation in order to re-epithelialize the injury site. Wound healing in the 
skin involves migration of fibroblasts and re-organization of the extracellular matrix at 
the site of the lesion, whereas scar formation in the inner ear has been shown to involve 
myosin-based contractility of the actin cytoskeleton (Hordichok and Steyger, 2007) as 
well as supporting cell shape changes.  In epithelia such as the skin, integrins such as 
α2β1, α3β1 and α6β4 are expressed in keratinocytes as cell adhesion molecules 
maintaining the integrity of the epithelium via cell-cell contacts.  
Integrin α2 was not detected by qPCR in normal utricular cDNA, but was found to be 
present at both 4 and 14 days post-gentamicin. This α integrin only associates as a 
heterodimer with the β1 subunit. It is one of the major collagen binding integrins, 
having been shown in previous work to be able to interact with multiple types of this 
extracellular matrix molecule (Tuckwell et al., 1995). Integrin α2β1 has been described 
functionally as having a role in the wound healing process in terms of fibroblast 
migration and re-organisation of collagen (Tuckwell et al., 1995) in addition to being 
involved in platelet adhesion to collagen (Kunicki et al., 1993). Integrin β1, discussed in 
depth later in this chapter, also showed a significant increase in gene expression at 4 
days post-gentamicin; it therefore might be suggested that expression of the integrin 
α2β1 heterodimer is being triggered in the utricle at this time point following 
gentamicin treatment. Although further confirmation that this observed change is truly 
representative of the behaviour of the tissue is required, through replication of the qPCR 
experiments, it would also be of interest to carry out immunolabelling of both normal 
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and gentamicin-exposed utricular tissue maintained in vitro. Labelling of the utricle 
with an antibody against α2, in conjunction with the antibody for β1 which has already 
been used successfully in this project, would have the ability to indicate the region of 
the tissue to which α2 localises, if it is indeed an integrin not present in normal tissue, 
and its expression is switched on as a result of aminoglycoside treatment.  
Integrin α3, another α subunit which only forms one heterodimer, α3β1, is a known 
receptor for laminin-5, the major laminin isoform found in basement membranes. The 
only basement membrane protein positively identified in the tissue of interest in this 
project was collagen type IV. There is little previous work on the composition of the 
basement membrane of the murine utricle; it would be of interest in future studies to 
investigate this, since integrin expression is highly dependent upon expression of 
integrin ligands. Integrin α3 was detected in normal adult mouse utricular cDNA by 
qPCR and was detected at significantly higher levels at both 4 and 14 days post-
gentamicin treatment.   
Integrin β4 also shows a significant increase in expression at 4 days post-gentamicin 
compared to levels detected in normal utricular tissue. This subunit however was not 
detectable at 14 days post-gentamicin. Integrin β4 is only able to associate with the α6 
subunit to form a functional heterodimer, however the RQ results for α6 differ from 
those of β4; α6 was found to be present in control utricular cDNA, but was then 
undetected at 4 days post-gentamicin. Unlike β4, α6 was detected at 14 days post-
gentamicin at a higher level than that of normal tissue, although this difference was not 
calculated as being significant.  In order to address whether these differences are real 
results, as discussed previously, further repeats of these qPCR gene expression assays 
are necessary, with different cDNA samples in order to rule out the possibility that these 
results are a product of one pooled sample containing tissue which is not truly 
representative of the utricle at each time point.   
Integrin α6β4 is the only known integrin which is able to interact with intermediate 
filaments (most integrins interact with the cytoskeleton via actin filaments) and has 
been shown to be a component of hemidesmosomes and to be involved in the 
interaction of basal keratinocytes with the basement membrane upon which they sit. 
Integrin β4 has been implicated as playing a role in repair of lung epithelial damage, 
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since β4 positive alveolar epithelial cells (of which there are relatively few present in 
undamaged tissue) were shown to increase in number significantly following injury by 
bleomycin treatment (Chapman et al., 2011). It was suggested that these alveolar 
epithelial cells could represent a population of progenitors maintained in the tissue 
which are stimulated to proliferate in response to damage. Corneal epithelial wound 
healing studies have also shown that integrin β4 expression increases following damage, 
and that its localisation was also altered in healing cornea compared to its normal 
pattern of expression (Stepp et al., 1996). 
Integrin α2, α3 and β4 have all been implicated in tissue repair in other epithelial organ 
systems, and have been suggested by the qPCR screen as showing changes in their 
expression level over time in utricular tissue damaged by gentamicin in culture. In order 
to further investigate these changes, it would be beneficial to carry out 
immunofluorescent labelling of utricular tissue with primary antibodies against these 
subunits to determine whether they show any visible alterations in their distribution i.e. 
re-localisation from cell-cell contacts or the epithelial-basement membrane border 
across the time points studied using the utricular organotypic culture model of hair cell 
loss and regeneration in the adult mouse.  
The results of the immunohistochemistry and PCR based strategies employed in this 
study to identify the integrins which are present in the adult mouse utricle maybe 
utilised in conjunction with one another to propose potential functions for these cellular 
adhesion proteins within the tissue of interest, and whether they might be involved in 
the processes of gentamicin-induced hair cell loss and spontaneous vestibular hair cell 
regeneration. The following discussion sections investigate several integrin subunits for 
which both immunolabelling and qPCR data was obtained during this project and 
present potential functional roles for these adhesion molecules within the utricle, in 
addition to the future experiments which could be carried out in order to test these 
hypotheses. 
7.4.3 Integrin β1 Expression in the Adult Mouse Utricle 
The integrin β1 subunit is the most ‘promiscuous’ of the eight known mammalian β 
subunits; it is able to form functional heterodimers with almost all of the known integrin 
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α subunits. It could therefore be suggested that this would be the most probable integrin 
subunit to be found in the tissue of interest.   
Immunohistochemistry experiments show evidence that in the normal adult mouse 
utricle, the integrin β1 subunit is present in several distinct regions of the tissue. 
Cryosections of utricular tissue labelled with an integrin β1 primary antibody in 
addition to the hair cell marker calretinin (Figure 6-1) reveal that this integrin subunit 
shows dense punctate expression at the border region between the sensory epithelium 
and the underlying connective tissue. Integrin β1 positive labelling is also present within 
the underlying mesenchyme which corresponds with the vascular network that exists in 
this region of the utricle.  
In order to further explore the localisation of integrin β1 at the epithelial-mesenchymal 
border region, cryosections were co-labelled for integrin β1 and collagen type IV 
(Figure 6-2). Collagen type IV is the major constituent extracellular matrix protein of 
basement membranes (Kefalides, 1973) and was therefore selected to serve as a 
basement membrane marker. The results of these experiments indicate that integrin β1 
is expressed in close proximity to the basement membrane which lies at the epithelial-
mesenchymal border indicated by collagen type IV expression. Collagen type IV is also 
found in perivascular basement membranes (Colorado et al., 2000) and is observed to 
localise at regions corresponding with these structures, co-localising with integrin β1.  
Integrin β1 expression does not appear to alter in response to gentamicin treatment in 
terms of its localisation within adult utricular tissue; integrin β1-positive labelling 
persists at the epithelial-mesenchymal border across all three post-gentamicin time 
points examined. Despite this lack of an obvious change in localisation pattern of 
integrin β1, the results of the initial qPCR screen are suggestive of a significant increase 
in the gene expression of this integrin subunit at 4 days post-gentamicin. Although β1 
remains evident at the epithelial-mesenchymal border in a manner which does not 
appear to differ from immunolabelled control counterparts, integrin β1 is also found in 
mesenchymal blood capillaries in the tissue underlying the sensory epithelium, a feature 
which is observed to degenerate over time spent in culture (occurring in both control 
and gentamicin treated utricles) as the mesenchyme undergoes extensive remodelling. 
Given these observations, it might be expected that integrin β1 gene expression would 
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be decreased in cDNA obtained from gentamicin-treated utricles maintained in vitro, 
however, the results of the qPCR RQ analysis indicate that integrin β1 gene expression 
is significantly higher (approximately 10-fold) at 4 days post-gentamicin treatment, in 
comparison to the control, non-treated calibrator sample. 
One of the few previous studies which investigated the presence of several integrin 
subunits within the murine utricle by in situ hybridisation, found that between the ages 
of E16 to P0, integrin β1 mRNA was distributed throughout the hair cell body in the 
sensory epithelial layer (Littlewood Evans and Muller, 2000). Although not mentioned 
specifically, observation of the in situ hybridization experiments carried out in this 
previous study using probes for α8 and β1 mRNA do appear to show that both are 
present at the epithelial-basement membrane border (the region at which the 
immunohistochemistry work carried out during this project has shown β1 expression to 
be localised), although mRNA localisation does not necessarily correlate with protein 
expression. This earlier study also identified a vestibular dysfunctional phenotype in 
mice deficient for integrin α8 which survived post-natally; many of these mice die a few 
days after birth due to severe kidney development defects (Muller et al., 1997). 
Immunohistochemistry localised this integrin α subunit to the apical surface of hair cells 
and to the developing stereocilia between the ages of E16 and P0. Since the integrin α8 
subunit is only able to bind integrin β1 to form a functional heterodimer, then it would 
be suggested that integrin β1 protein is expressed in these regions of the immature 
mouse utricle also. Additional work was carried out in this previous study to localise 
several extracellular matrix proteins, including collagen type IV. In control tissue, 
collagen type IV was seen to be expressed at the apical surface of the vestibular hair 
cells; this is not seen in the immunohistochemistry co-labelling experiments of this 
project where utricular cryosections were labelled for collagen type IV to determine the 
location of basement membranes within the tissue, and showed this collagen isoform to 
be present at the border between the sensory epithelium and the underlying 
mesenchyme. This difference would suggest that there may be re-distribution of both 
the integrin β1 subunit and collagen type IV between P0 and adulthood in the mouse 
utricle.  
Immunohistochemistry in this work on adult vestibular tissue does not suggest that 
integrin β1 is expressed in vestibular hair cells, nor in the stereocilia bundles of mature 
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utricular maculae. Since previous work has postulated a theory that the expression of 
integrin α8β1 is linked to development of the stereocilia (Littlewood Evans and Muller, 
2000) then it may be the case that the expression of this particular integrin heterodimer 
is transient and once stereocilia development is complete, this protein is no longer 
required in this region. Since the previous study did not examine integrin α8 expression 
in animals older than P0, it might be anticipated that at some time point between birth 
and the animal being fully mature, an immunolabelling study, if conducted, would 
reveal at which point the stereocilia and hair cell apices cease to be integrin α8 positive.  
Integrin β1 expression at the sub-epithelial basement membrane of the utricle would be 
expected based upon previous studies of the interaction of this integrin subunit with 
basement membranes and their major constituent, collagen type IV.  This study has 
confirmed the presence of integrin β1 within the mouse utricle by both RT-PCR and 
qPCR, and has additionally localised this integrin to the epithelial-mesenchymal border 
of this tissue. Of the integrin heterodimers which are able to bind collagen extracellular 
matrix proteins, α1β1 and α2β1 are the two main integrins for which binding sites have 
been located within a triple helical region of the collagen type IV molecule (Eble et al., 
1993) (Kern et al., 1993). It would therefore be considered likely that the integrin α 
subunit partner for integrin β1 at this basement membrane is either α1 or α2, however, 
integrin α1 was not detected in utricular cDNA from normal or gentamicin treated 
cultures by qPCR, and integrin α2 was only detected in cDNA from 4 and 14 days post-
gentamicin utricles. On the basis of these results from this study, it is possible that one 
of the other α integrins which associates with β1 forms the integrin β1-containing 
heterodimer present at the basement membrane in the utricle.  
The endothelial cells which form capillaries are known to interact with their 
extracellular matrix through several integrins which contain the β1 subunit; namely 
α1β1, α2β1, α3β1, α5β1 and α6β1 (Dejana et al, 1993). Work carried out in this project 
also identified integrin β1 as being expressed within the vasculature of the mature 
utricle within the underlying connective tissue and in some regions this co-localised 
with collagen type IV. Although this work does not confirm which β1-containing 
heterodimers are present in this tissue, it would be expected that the positive labelling 
for integrin β1 in the capillary network would be due to one or more of the known 
endothelial integrins, which play a key role in the adhesion of endothelial cells to the 
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perivascular basement membrane and extracellular matrix via binding of the ligands 
collagen type IV and laminin, which are the two major components of the basement 
membrane (Stupack and Cheresh, 2002).  
Integrin β1 possesses the ability to form twelve functional integrin heterodimers in 
mammalian species. The work carried out during this project has identified integrin α6 
as showing a similar localisation pattern by immunolabelling as that exhibited by 
integrin β1, suggesting that α6 might be a potential partner for β1 in this location. 
However, previous studies have identified the integrin α6β1 heterodimer as being the 
key laminin-binding integrin that is present on platelets and involved in the processes of 
platelet spreading and adhesion (Inoue et al., 2006); this would indicate that the integrin 
α6 and β1 subunits localised by immunohistochemistry are found in similar regions of 
the tissue, but are not present in the same heterodimer. The degenerate and qPCR 
experiments carried out in this work have each detected the presence of a number of the 
other potential alpha subunits which could associate with integrin β1: α3, α4, α8, α9 and 
αV. Immunolabelling of utricular sections for integrin αV indicates that this alpha 
subunit is restricted to the mesenchymal regions which lie directly beneath the sensory 
epithelium; it does not appear to be localised within either vestibular hair cells or the 
supporting cells. Based on these findings, it would seem less likely that αV is 
associating to form a heterodimer with β1 in this region of the utricle. In order to 
definitively identify which integrin alpha subunit or subunits make up the integrin β1-
containing heterodimers present at the epithelial-mesenchymal border within the mouse 
utricle, it would be necessary to carry out co-immunoprecipitation experiments as part 
of future work. Co-immunoprecipitation using integrin β1 antibodies immobilised on 
agarose bead supports would be able to isolate β1-containing protein complexes from 
utricular tissue lysate, and allow subsequent analysis by SDS-PAGE and western blot in 
order to identify the co-precipitated proteins. In addition to identifying the 
heterodimeric partners for integrin β1, co-immunoprecipitation studies could also reveal 
the extracellular matrix ligands with which these integrins are binding, providing further 
insight into the function of these integrins in the tissue of interest.   
Based on the location of integrin β1 and the potential alpha partners which this study 
has identified, integrin β1 could be anticipated as providing a typical adhesive role as is 
common to many integrin heterodimers. In order to provide structural integrity to the 
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utricle, the supporting cells must be sufficiently well anchored to the basement 
membrane upon which they are situated. It might therefore be speculated that integrin 
β1-containing heterodimers are responsible for the adhesive structures that would be 
expected to be present within any epithelial tissue, interacting with extracellular matrix 
proteins which are constituents of the basement membrane i.e. collagen type IV, as has 
been positively identified as being present in the basement membrane which underlies 
the sensory epithelium of the utricle.  
In order to investigate this hypothesis, it would be of interest to examine what effect a 
lack of integrin β1 has upon the structure of the utricle. Integrin β1 deficient mice die 
very early on in development, so an experimental approach to investigate the effect of 
β1 deficiency in the utricle would require an inducible knockout system to overcome 
this problem. Producing a mutant mouse strain using the Cre/lox system, it would be 
possible to create an animal in which an integrin β1 deficiency could be induced 
through drug treatment e.g. by administering tamoxifen. Experiments with the intention 
of investigating the role of β1 in the utricle could potentially be carried out both in vivo 
and in vitro if necessary.Previous work on the development of Cre/lox mice strains for 
inducible β1 knockouts has encountered issue with lethality after induction, which 
might prove problematic if conducting long-term in vivo experiments e.g. looking at the 
effect of β1 knockout at 21 days-post gentamicin treatment. In non-gentamicin treated 
animals or control in vitro utricular tissue from Cre/lox β1 knockout mice, induction of 
the mutation would be used to investigate whether β1 is critical for the adhesion of 
supporting cells to the basement membrane. Previous work in other epithelial cells in 
vitro has shown that integrin β1 has a half-life of approximately 24 hours 
(Delcommenne and Streuli, 1995), although since no previous work has looked into 
integrin expression in depth within the inner ear, the level of integrin turnover in the 
utricle may differ from that observed in other tissue types. Testing a range of incubation 
time points following induction of the integrin knockout would therefore be required in 
order to examine whether a lack of new β1 protein affects the structure of the utricle; if 
the hypothesis that β1 is key for the adhesion of supporting cells to the basement 
membrane, it would be expected that the structural integrity of the tissue would be 
disrupted if deficient of this integrin subunit. This might result in the observation, by 
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immunolabelling of utricular sections with appropriate markers, of supporting cells 
which have become detached from the basement membrane.  
Since the qPCR experiments carried out in this study suggest that β1 gene expression is 
significantly increased at 4 days post-gentamicin, there is the potential for a further role 
for this subunit in utricular tissue which has been exposed to ototoxic aminoglycosides. 
In gentamicin-damaged tissue, β1-containing heterodimers could be involved in cellular 
signalling stimulated by hair cell death or the reorganisation of the cytoskeleton and 
cellular spreading undergone by supporting cells as they change shape in order to close 
up holes left in the sensory epithelium where vestibular hair cells have been lost. The 
observed increase in integrin β1 at 4 days post-gentamicin could therefore be as a result 
of increased focal adhesion formation as the supporting cells undergo various 
morphological changes. These hypotheses could be investigated using the proposed 
inducible β1 knockout mouse – by treating with the aminoglycoside and then 
administering the tamoxifen required to induce the β1 deficiency. On examination of the 
utricular tissue at 4 days post-gentamicin by phalloidin labelling, it would anticipated 
that the supporting cell shape changes observed through the appearance of scars on the 
apical surface of the epithelium would be impaired if the tissue was unable to up-
regulate β1; rather than the typical surface appearance at this stage post-gentamicin, it 
would be expected that the supporting cells would not be able to spread effectively, 
leaving gaps in the epithelial layer created by hair cell loss.   
Integrin β1 has been previously shown to be involved in cutaneous wound healing; mice 
with a fibroblast-specific deletion of integrin β1 were observed to show delayed wound 
healing in comparison to wild-type control mice (Liu et al., 2010). Mice lacking β1 also 
displayed defects in the production of new extracellular matrix and reduced activation 
of latent TGF-β, a key signalling molecule known to be involved numerous cellular 
processes which occur during wound healing (Werner and Grose, 2003). Integrin β1 has 
also been shown to be critical for keratinocyte migration during re-epithelialisation of 
cutaneous wounds, since mice with a keratinocyte-specific deletion of β1 exhibited 
migration impairment and their wounds failed to close as did those of their control 
littermates (Grose et al., 2002).  
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Based upon both the results of experiments carried out in this project and the findings of 
previous studies regarding the numerous cellular processes in which this integrin has 
been shown to play a role, the integrin β1 subunit should be considered for further 
research into its function in the adult mouse utricle. 
7.4.4 Integrin β3 and β5 Expression in the Adult Mouse Utricle is Associated with 
Vestibular Hair Cells 
7.4.4.1 Integrin β3  
Integrin β3 is one of two integrin subunits which have been identified as being 
associated with vestibular hair cells based upon the results of the immunohistochemistry 
experiments carried out during this study. The localisation pattern of integrin β3 in the 
utricle was also observed to change in response to gentamicin-induced hair cell loss; 
this subunit appears to be expressed within type I hair cells at the region in closest 
proximity to the neural calyx, but is redistributed at 4 days post-gentamicin to regions at 
which there would be an interface between supporting cells and neurons.  
Immunohistochemistry results suggest that this redistribution persists at 14 day-post 
gentamicin, however, at 21 days post-gentamicin β3 could be seen to localise within 
vestibular hair cells in a manner similar to that observed in normal utricular tissue.  
Integrin β3 is able to associate with two α subunits to form the heterodimers αIIbβ3 and 
αVβ3. Whilst the αIIbβ3 integrin is specifically expressed on blood platelets, playing a 
critical role in the control of blood clot formation (Hodivala-Dilke et al., 1999), the 
αVβ3 heterodimer shows more widespread expression and is involved in many cellular 
processes, including angiogenesis (Brooks et al., 1994) and wound healing (Clark et al., 
1996). A previous study demonstrated that integrin β3 null mice showed enhancement 
of the cutaneous wound healing process compared to their wild-type littermates 
(Reynolds et al., 2005). This enhanced wound closure (β3-deficient mice showed 
complete wound closure by day 5 after wounding, whereas wild-type controls had not 
completed the re-epithelialisation process until day 10) was found to be the result of 
increased levels of TGF-β1  in the platelets of mice which lack integrin β3. These 
previous findings highlight the ability of integrins to alter signalling pathways which 
regulate key cellular processes in addition to their cell-adhesion molecule properties. 
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With regards to the inner ear, integrin β3 has been implicated in previous work as 
having a role in the differentiation of hair cells through studies carried out on OC-2 cells 
(an immortalised cell line derived from the mouse inner ear). OC-2 cells can be 
maintained in a proliferative, undifferentiated state by incubation at 33°C, but can be 
induced to differentiate and express known hair cell markers such as myosin VI and 
myosin Viia by increasing the incubation temperature to 39°C (Rivolta et al., 1998). In 
this previous study, OC-2 cells were shown to increase surface levels of integrin β3 
when switched to their differentiating state (Brunetta et al., 2012). This increase in β3 
expression correlated with an increase in myosin VI and myosin Viia. This earlier study 
also showed that over-expression of β3 in undifferentiated OC-2 cells incubated at 33°C 
was able to produce an increase in myosin VI and myosin Viia that was comparable to 
levels seen in differentiated OC-2 cells.  
That the work carried out in this project has detected β3 expression in vestibular hair 
cells supports the theory that integrins may play a role in the events of hair cell 
development, perhaps through facilitating the release of differentiated hair cells from 
the basement membrane. Myosin Viia expression was also investigated in cultured 
utricles at several time points by qPCR. Relative quantification of this data indicated 
that after being initially detected in normal, undamaged tissue, myosin Viia was 
undetectable at 4 days post-gentamicin treatment. Myosin Viia was detectable again by 
14 days post-gentamicin, at a level that was significantly lower than that observed in 
normal tissue. That myosin Viia expression begins to re-emerge following a significant 
increase in β3 expression would support a potential role for this integrin in the 
differentiation of hair cells through transdifferentiation events triggered by gentamicin-
induced hair cell loss in the mammalian utricle.  
If integrin β3 is able to influence the expression of proteins such as myosin Viia (a key 
marker of hair cell differentiation) in the same manner observed in the OC-2 hair cell 
line in vestibular hair cells, i.e. via an integrin-mediated cell signalling pathway, this 
may indicate a role for integrin β3 in the spontaneous hair cell regeneration observed in 
the mammalian utricle. Based upon RQ analysis of the qPCR experiments carried out 
during this project, integrin β3 appears to show a significant increase in gene expression 
at 4 days post-gentamicin, which could also support a role for this integrin in 
phenotypic conversion of supporting cells to hair cells. In order to test the hypothesis 
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that integrin β3 has a functional role in spontaneous regeneration in the adult mouse 
utricle, it would be of interest to examine the effects of both a lack of integrin β3 and 
the over-expression of this integrin subunit. Integrin β3 knockout mice are viable, 
however, litter numbers are reduced due to placental defects and these animals remain 
susceptible post-natally to internal haemorrhaging, particularly of the gastrointestinal 
tract (Hodivala-Dilke et al., 1999).This is due to the fact that this integrin forms part of 
the αIIbβ3 heterodimer which is expressed on blood platelets and is critical for platelet 
aggregation following vascular injury. In order to study the effect of a lack of β3 on hair 
cell regeneration, it would therefore be preferable to either conduct the study in vivo 
using such β3 knockout animals, or alternatively, to develop an inducible β3 knockout 
strain via the Cre/lox recombinase system as described earlier in this chapter for integrin 
β1. Due to the long term nature of the experiments required to observe regeneration, 
there would be a risk of the knockout animals dying during the experimental time 
period - surgical administration of the aminoglycoside would also be extremely risky to 
such mice, due to their impaired blood clotting capabilities.  
Using an in vivo model, with an inducible β3 knockout mouse strain, it would be 
possible to expose the vestibular epithelium to the aminoglycoside gentamicin, before 
administering tamoxifen to induce the gene disruption and knockout integrin β3. Whilst 
also running control experiments in parallel, the utricular tissue of mice unable to 
produce new integrin β3 protein would be examined at multiple time points post-
gentamicin treatment by carrying out hair cell counts. If integrin β3 is required for the 
cellular processes which contribute to the phenotypic conversion of supporting cells to 
hair cells, then it would be expected that mice lacking this subunit would exhibit a 
reduction in the number of new hair cells produced following gentamicin treatment in 
comparison to control counterparts with the functional integrin β3 gene. A concomitant 
reduced level of gene expression of hair cell markers such as myosin Viia and myosin 
VI would also be expected if the tissue from these experiments was examined by qPCR.  
Conversely, if β3 was overexpressed within the utricle e.g. by transfection of this tissue 
with an appropriate integrin β3 adenoviral construct, following gentamicin treatment it 
would be expected that hair cell numbers in aminoglycoside treated tissue would be 
higher, in addition to an increase in hair cell markers detectable by qPCR, than in 
control utricular tissue. Over-expression of integrin β3 in normal, non-gentamicin 
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treated animals would be expected to produce an increase in the number of vestibular 
hair cells above the numbers which are normally found in the adult epithelium.  
7.4.3.2 Integrin β5 
The integrin β5 subunit was detected in this study by both immunohistochemistry and 
qPCR; this integrin appears to localise to the base of type I hair cells in the utricular 
epithelium in the region at which they associate with neural calyces, based upon 
immunolabelling of adult mouse utricular sections. However, the only known alpha 
integrin partner for β5 is the αV subunit, and the immunohistochemistry experiments 
carried out with an anti-integrin αV antibody indicated that this integrin subunit was not 
present at all in the sensory epithelium, only in the underlying mesenchymal tissue. 
These observations suggest that further experiments are required in order to confirm the 
presence of β5 in the sensory epithelium e.g. through additional immunohistological 
investigation (having made further attempts to reduce background labelling or through 
use of another αV primary antibody with greater efficacy and antigen specificity), in 
situ hybridisation or western blot. If the results of further work were to support the 
expression of the integrin αVβ5 heterodimer in vestibular type I hair cells, the 
localisation pattern of β5 observed might be indicative of a potential role for this 
integrin in the utricle. Numerous previous studies have shown that members of the 
integrin family are able to increase the regenerative capacity of adult neurons e.g.  
integrin α1 and α5 (Condic, 2001), enhancing the extension of neurites, required for the 
re-innervation of tissue. Changes in the expression of integrin α6 in the mouse inner ear 
during development have also been shown in previous work to be involved in neuronal 
outgrowth. Expression of α6 at E10.5 is restricted to the otic epithelium and the 
neuroblasts migrating out of this region by E12.5 were shown to be those cells which 
had lost expression of this integrin subunit. Instead, glial cells which interact with the 
developing neurons in the CVG were found to be α6-positive, indicating that integrins 
may be involved in the survival and organisation of auditory neurons during 
development (Davies, 2007).   
One potential hypothesis for the presence of integrin β5 in proximity to the neural 
calyces of type I hair cells in the utricle is that this integrin functions as a target for 
neurons which innervate the vestibular hair cells. Within the in vitro model used in this 
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project, neurons of the utricular tissue degenerate as the mesenchymal tissue undergoes 
extensive remodelling – this process occurs in both control and gentamicin-treated 
tissue and is therefore a side effect of the culture conditions. A potential interaction 
between integrin β5 and vestibular neurons would therefore have to be tested in vivo 
where the neural processes have been observed to regrow from remnants of the neuronal 
architecture e.g. spiral ganglion cells, following hair cell loss, rather than being 
regenerated in their entirety (Strominger et al., 1995) . Integrin β5-null mice reproduce 
and develop normally (Huang et al., 2000b) , unlike other integrin knockout mice. It 
would therefore be of interest to examine the inner ears of these animals to investigate 
whether the formation of the utricle, in particular the innervation of the tissue i.e. 
through immunolabelling with markers such as myosin Viia and anti-neurofilament 
antibodies or calretinin to label the utricular neurons, is affected by a lack of β5 – at the 
time of writing this thesis, no reference to a vestibular phenotype was found in studies 
using β5-null mice to examine the role of this integrin in other organ systems. Several 
cellular processes thought to involve integrin β5 have been observed to be unaffected by 
a lack of this subunit in β5-null mice e.g. cutaneous wound healing; it may therefore be 
the case that if utricular tissue from these β5-deficient mice does not differ from that 
observed in normal animals, that other proteins, including other members of the integrin 
family, are able to compensate for a lack of integrin β5.  
7.4.5 Integrin αV Expression in the Adult Mouse Utricle 
The integrin αV subunit is the α integrin which is able to form the most functional 
heterodimers, being present in 5 of the 24 known mammalian integrins; αVβ3, αVβ5, 
αVβ6, αVβ8 and αVβ1.  Αlpha V integrins are commonly able to bind the ECM 
proteins vitronectin and fibronectin, with αVβ3 considered the ‘classical vitronectin 
receptor.’ Studies in the mouse have shown that αV integrins are predominantly 
expressed in the developing nervous system and skeletal muscle (Hirsch et al., 1994). 
αV integrins have also been implicated in vasculogenesis, angiogenesis (Brooks et al., 
1994) and the activation of TGFβ1 (Li et al., 2010).  
In this work, integrin αV appears to localise to the utricular mesenchyme which is in 
closest proximity to the basement membrane (Figure 6-7) as well as to the capillary 
network which is found within this tissue beneath the sensory epithelium. The only 
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previous study which shows any evidence of αV expression in the utricle indicates 
through in situ hybridisation that αV mRNA is distributed throughout vestibular hair 
cells in mice at P0 (Littlewood Evans and Muller, 2000), although this was not 
investigated further to establish whether the αV protein showed the same localisation 
pattern. Immunohistochemistry experiments carried out in this project did not detect any 
expression of integrin αV within the sensory epithelium in either normal utricular tissue, 
or in sections of utricular cultures damaged by gentamicin in vitro; αV expression was 
maintained in the mesenchyme at the region most proximal to the basement membrane 
at all three of the time points studied post-gentamicin exposure. The findings of this 
work suggest that like integrin β1, there may be redistribution of the integrin αV subunit 
during the maturation of the murine inner ear between P0 and the animal becoming an 
adult, possibly implicating that this integrin has a role in development of this sensory 
epithelium. 
The integrin αV subunit showed a significant increase in gene expression at 4 days post-
gentamicin in comparison to the level detected in normal utricular cDNA (Figure 5-4 
A).  Although the work completed during this project does not definitely identify which 
of the αV-containing integrins are present in the tissue of interest, of the 5 possible β 
subunits that αV can associate with, only integrin β1 and β3 demonstrate a similar 
significant increase in expression at 4 days post-gentamicin (Figure 5-5).  Identification 
of the β subunit partner or partners for αV in the mouse utricle by co-
immunoprecipitation would therefore be of benefit for future studies. 
αV integrins, in particular αVβ5, have been previously identified as playing a vital role 
in the success of adenovirus infection (Summerford et al., 1999). αVβ5 has been shown 
to promote the internalisation of adenovirus particles and host-cell membrane 
permeablisation (Wickham et al., 1994).  Due to this capability, αVβ5 expression on the 
cell surface has also been shown to correlate with greater efficacy of gene delivery 
using adenoviral vectors (Goldman and Wilson, 1995). That the αVβ5 integrin 
heterodimer is potentially expressed in the adult mouse utricle could be beneficial for 
treatment of vestibular disorders/damage by gene therapy. Previous studies using an 
adenoviral vector to transfect vestibular hair cells of cultured mouse utricles with Atoh1 
in order to enhance the regenerative capability of the tissue (Staecker et al., 2011), by 
directly inducing cells to become hair cells, show that the mouse utricle is able to 
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successfully internalise adenoviruses, and therefore it could be the presence of integrin 
αVβ5 that facilitates this process.   
Integrin αVβ5 has also been shown to be involved in phagocytosis of apoptotic cells by 
amateur phagocytes in other organ systems such as the retina (Finnemann et al., 1997). 
That integrin αV has been shown to be significantly increased in the utricle at 4 days 
post-gentamicin, in comparison to normal tissue, might potentially be linked to 
supporting cells removing dying vestibular hair cells from the sensory epithelium by 
phagocytosis.  
7.5 Future Work 
The work presented in this thesis represents the first study to investigate the expression 
of the integrin family of cell-adhesion molecules in the adult mouse utricle. Having 
screened this tissue for the known α and β subunits, a subset of integrins has been 
identified as being expressed in utricular macula of adult mice within both the sensory 
epithelium and the underlying mesenchyme. 
As addressed earlier in this discussion, there is some immediate future work which 
would be necessary in order to further corroborate the results obtained during this 
project. Although samples of utricular tissue used to produce cDNA for qPCR gene 
expression array experiments contained 8 to 10 individual utricles from several different 
animals, each ‘pool’ of tissue can only be technically classified as a single sample of 
cDNA for a particular time point. The qPCR array plates run with control utricular 
cDNA and cDNA from organotypic cultures maintained for three different time points 
post-gentamicin treatment represent an initial screen of the tissue for the majority of the 
known α and β integrins. Those integrins which have been highlighted as being present 
in this screen, and in particular, those which have shown significant expression level 
changes in response to hair cell damage and loss, would be candidates for replicate 
qPCR assays to be carried out with several different ‘pooled’ samples of cDNA for each 
time point. It was not possible to utilise the qPCR array plate data collected from the 
experiment run with cDNA from utricles at 21 days post-gentamicin treatment. This 
was due to the cDNA yield, despite using the same number of utricles as other time 
points, being significantly lower – possibly a consequence of the remodelling and 
migration of mesenchymal cells observed in long term cultures. This low cDNA yield 
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resulted in the integrin subunits detected only beginning to be amplified by the PCR 
reaction very late into the 50 cycle run of the experiment; the consistency of detection 
across replicate assays was also considerably reduced i.e. of the 4 replicate assays for 
each gene present on the plate, a given gene was often only detected by one or two of 
the replicates. Replication of these qPCR experiments in triplicate would increase the 
reliability of the results and the likelihood that they represent the true response of the 
tissue following gentamicin treatment.Since immunolabelling of utricles cultured for 21 
days post-gentamicin treatment showed evidence of immature stereocilia bundles on the 
apical surface of the sensory epithelium, it would be of interest to be able to compare 
the expression levels of the integrins in tissue undergoing this kind of regenerative 
process, with their expression in normal, undamaged tissue. This would be particularly 
relevant where integrins such as α8β1 have been implicated by previous studies as 
having a role in the formation of stereocilia in vestibular hair cells (Littlewood Evans 
and Muller, 2000), as it might be anticipated based upon this work  that expression of 
these two subunits would be up-regulated in the utricle if there are new apical hair 
bundles being produced in a manner similar to that which occurs during development.  
A total of five integrin subunits were investigated further with immunohistochemistry in 
order to examine their localisation within the tissue, in addition to exploring the 
possibility of temporal-spatial changes in their expression pattern at several time points 
following gentamicin treatment. It would be of interest to obtain primary antibodies to 
allow the localisation of the remaining subunits detected by PCR in order to complete a 
full study of the expression pattern of these integrins, establishing which region of the 
tissue they are associated with i.e. are they linked to the mesenchyme or the sensory 
epithelium. Since functionally, the integrin subunits must exist as a heterodimer, it 
would be of interest to establish the pairings of α and β subunits which exist in the 
murine utricle. Although some of the subunits detected are only able to form a single 
heterodimer, and thus if they are present it must be inferred that this is the heterodimer 
present, in the case of the more ‘promiscuous’ α V and β 1 subunits, it might be possible 
that they are present in the utricle as part of several yet unknown pairings. Co-
immunoprecipitation experiments could therefore be utilised in order to pull down 
particular integrins from utricular tissue cell lysate whilst still associated with their 
heterodimer partner. These experiments could also result in integrin-associated proteins 
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i.e. proteins through which integrins interact with the cytoskeleton being pulled down 
simultaneously, lending further insight into how the integrins which are present in the 
tissue are interacting with their intra and extracellular surroundings. Since the integrins 
expressed on any given cell type are directly influenced by the extracellular matrix 
ligands present in a particular tissue, identification and localisation of the integrin 
ligands present in the utricle would also be important for future investigation of the 
function of integrin heterodimers in the vestibular sensory epithelium.  
The long-term culture model established during this project represents a successful 
method of inducing hair cell loss in the adult mouse utricle, in order to study the 
potential role of integrins in the repair and limited spontaneous regeneration which 
occurs in this tissue. However, it cannot be ruled out, as discussed earlier in this chapter, 
that the behaviour of the tissue in vitro in response to gentamicin treatment might differ 
from that which would occur in vivo. It would therefore be beneficial for future work to 
explore whether these differences i.e. the remodelling of the mesenchyme, have an 
influence on the expression and localisation of integrins by repeating both the 
immunohistochemistry experiments and the qPCR gene expression assays using an in 
vivo mouse model. The integrin subunits identified in this work as showing significant 
changes in expression level e.g. β3, β1 and αV would be candidates for further 
investigation using this culture model.  
Inhibition of integrins has been the subject of numerous previous studies, with particular 
emphasis in the field of cancer research and their effect on tumour growth and 
angiogenesis. Integrin inhibitors, such as CNTO 95 (Trikha et al., 2004) an αV inhibitor 
antibody and LM609 (Brooks et al., 1995) an αVβ3 blocking monoclonal antibody, as 
well as small molecule (Kerr et al., 1999) and cyclic RGD-containing peptides i.e. 
cilengitide (Desgrosellier and Cheresh, 2010) have all been previously used to inhibit 
integrins and reduce tumour proliferation and angiogenesis. Utricular cultures incubated 
in vitro with a specific integrin inhibitor could be used in order to investigate whether 
some of the integrins highlighted by this project play a role in the cellular processes 
involved in hair cell loss and regeneration of the sensory epithelium. Immunolabelling 
of these cultured tissues for actin and myosin Viia could then be used to investigate 
whether blocking a particular integrin subunit has an effect upon the behaviour of the 
tissue of interest during a subsequent recovery period following gentamicin exposure 
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i.e. whether hair cell regeneration might be reduced or enhanced by inducing a loss of 
function of a particular integrin known to be present in normal tissue and up-regulated 
significantly following damage. Further in vivo based experiments were discussed at 
length in 7.4, describing the potential for the use of integrin knockout mice to explore 
the effect of deficiency in particular integrin subunits within both normal utricular tissue 
and in animals treated with an aminoglycoside to induce hair cell loss. This additional 
approach would provide a means of comparing the response of the utricle when lacking 
a given integrin subunit, when incubated in culture and when maintained in vivo.  
The work carried out in this thesis has already begun to be applied to human vestibular 
epithelium within this research group. It will be of interest to observe how similar the 
integrin expression of the human tissue is in comparison to the mouse model used in 
this project and whether cultured utricles show similar changes in integrin expression 
level following gentamicin treatment. Mammalian vestibular epithelia are known to 
show limited regeneration of hair cells following damage, although not to the extent of 
the capabilities shown by birds and amphibians. The human organ of Corti is incapable 
of regenerating following the loss or damage of auditory hair cells. It would be of 
interest to explore the integrin expression of the mammalian organ of Corti and to 
compare this with that observed in the utricle. Although both epithelia contain hair cells 
which have a mechanosensory function, their arrangement and the supporting cells 
which surround them differ significantly. Recent studies on regeneration of auditory 
hair cells have demonstrated that treatment of noise-damaged mice in vivo with a γ-
secretase inhibitor (producing an increase in Atoh1), was sufficient to induce 
phenotypic conversion of supporting cells into hair cells (Mizutari et al., 2013). 
However, despite being myosin Viia positive, these supporting cell-derived regenerated 
hair cells were still found to be attached to the basement membrane. It might be possible 
that integrins present in the utricle which could play a role in the processes of repair and 
regeneration are not found in the organ of Corti, and that the inability to replace 
auditory hair cells may be partially attributed to a lack of integrins which may 
potentially be involved in the utricle in the release of supporting cells which have 
converted to hair cells from their surface adhesions to the basement membrane.  
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7.6 Conclusion 
The aim of this project was to investigate the integrin family of cell-surface adhesion 
molecules in an adult inner ear sensory epithelium that was known to undergo a degree 
of spontaneous regeneration following hair cell loss. Few previous studies had been 
conducted with regards to the presence of integrins in the inner ear, and those which 
existed had primarily been conducted on embryonic or very early postnatal animals.  
The work presented in this thesis represents the first study of the integrin family in the 
adult mammalian utricle. A subset of the known mammalian integrin α and β subunits 
have been identified through a series of degenerate and quantitative PCR experiments as 
being present in the adult mouse utricle in its normal, undamaged state. 
Immunohistochemistry reveals the localisation of some of these subunits and 
demonstrates that they are present throughout the epithelial and mesenchymal structures 
of the utricle.  
Through the use of an in vitro organotypic culture system as a model for the induction 
of damage responses and spontaneous regeneration in adult utricular tissue, qPCR and 
immunohistochemistry based experiments have been applied in order to investigate 
whether integrin expression is affected by the loss of vestibular hair cells. Several 
integrin subunits which have been previously described as being involved in tissue 
repair in other organ systems e.g. integrins β1, β3 and αV, have been shown in this 
project to demonstrate significant changes in gene expression level in tissue, in 
particular at 4 days post-gentamicin, when the utricle shows a large decrease in hair cell 
numbers, although further replicate qPCR experiments would be required to confirm 
that these results are a true representation of the typical behaviour of the utricle in terms 
of integrin expression. Immunofluorescent labelling of integrins in sectioned utricular 
tissue at three individual time points post-gentamicin treatment indicates that at least 
two of the integrin subunits studied in this project exhibited evidence of re-distribution 
following gentamicin treatment, suggesting that integrins might play a role in the 
cellular events of vestibular epithelial repair and regeneration. 
The work described in this thesis represents a foundational study of the integrins of the 
adult mouse utricle and presents the integrin family as a group of cell-adhesion 
molecules which warrant further examination and research in order to learn more about 
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what their exact role might be in the vestibular sensory epithelium, and whether this 
might allow integrins to be manipulated in order to enhance the regenerative capabilities 
of the mammalian vestibular epithelium.  
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Gel Images for Restriction Digests of Degenerate PCR Products 
The results of the restriction digests carried out on cloned degenerate RT-PCR products 
are illustrated by the images of agarose gels on which restriction digest products were 
run. As described in 2.8.4,these digests were used to identify which of the potentially 
detected amplicons were present in the PCR products for each degenerate primer pair. 
Table A-1 summarises the integrin subunits each restriction digest was intended to 
distinguish between, and the expected banding patterns for each restriction digest.  
Figure  Integrins to be 
Identified  
Restriction 
Digest 
Expected Bands 
    
A αX, αM, αE & αD BglI αX/αD = 1766, 1763, 1318 & 206 bp bands 
   αM/αE = 1447, 1318, 289, 286 & 206 bp bands 
B α1, α2, α10 & α11 BamHI α1 = linearised plasmid, does not cut other 
amplicons/the vector 
C α1, α2, α10 & α11 XhoI α2 = linearised plasmid, does not cut other 
amplicons/the vector 
D α1, α2, α10 & α11 RsaI Cuts all amplicons once (linearises), except α10 
E α5, αV, αIIb & α8 HaeII αV/αIIb = 1990, 906, 370 & 8 bp bands 
   α5/ α8 = 1990, 476, 433, 370 & 8 bp bands 
F αV & αIIb ApaI Linearises if αV. αIIb = 3071 & 212 bp bands 
F α5, αV, αIIb & α8 PstI Linearises if α8. α5 = 3142 & 138 bp bands 
G α3, α6 & α7 EcoRV α7 = linearised plasmid, does not cut other 
amplicons/the vector 
H α6 & α3 TaqI  α3 = 1444, 576, 434, 82 & 80 bp bands  
   α6 = 1444, 576, 434 & 165 bp bands 
I β1, β4 & β7 HindIII β7 = linearised, does not cut other amplicons/the 
vector 
J  β1, β4 & β7 TaqI β1 = 1444, 576, 526, 434 & 377 bp bands 
   β4 = 1444, 576, 526, 434 & 368 bp bands 
   β7 = 1444, 576, 526, 434, 273 & 107 bp bands 
K β3, β5 & β6 TaqI β3 = 1444, 576, 526, 434, 309 & 75 bp bands 
   β5 = 1444, 576, 526, 434, 266 & 121 bp bands 
   β7 = 1444, 576, 526, 434 & 381 bp bands 
L β2 & β8 NcoI β2 = linearised, plasmid, β8 = 3108 & 255 bp 
bands 
Table A-1 Restriction Digest Figures Reference Table 
Summary of the restriction digests used to identify integrin amplicons from degenerate PCR 
products. References are provided for gel photo images which show representative results of 
each of the digests carried out. 
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Figure A-1 Restriction Digests of Cloned Degenerate PCR Products 
Images of restriction digest products run on an appropriate weight agarose gel. A 1kb DNA ladder (NEB) was used to determine the size of the digest 
products.   
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Figure A-2 Restriction Digests of Cloned Degenerate PCR Products 
Images of restriction digest products run on an appropriate weight agarose gel. A 1kb DNA ladder (NEB) was used to determine the size of the digest 
products. 
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Figure A-3 Restriction Digests of Cloned Degenerate PCR Products 
Images of restriction digest products run on an appropriate weight agarose gel. A 1kb DNA ladder (NEB) was used to determine the size of the digest 
products. (K) P1, P2 & P3 indicate the three different banding patterns detected in restriction digests produced – a sample of each was sent for DNA 
sequencing to confirm the identity of the integrin subunit amplified.  
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One-way ANOVA with Tukey’s Test  
The following data represents the full output generated by the GraphPad software used 
to analyse hair cell count data by one-way ANOVA with the post hoc Tukey’s Test. The 
summary data from this statistical analysis is shown in table 4-1. 
              One-way Analysis of Variance (ANOVA)                
 
The P value is 0.0012, considered very significant. 
Variation among column means is significantly greater than expected 
by chance. 
 
 
Tukey-Kramer Multiple Comparisons Test 
If the value of q is greater than 4.508 then the P value is less 
than 0.05. 
 
 
                                      Mean    
            Comparison             Difference    q      P value   
================================== ========== ======= =========== 
  Control (2 D) vs Gent (2 DPG)         2.530   3.239  ns  P>0.05 
  Control (2 D) vs Gent (14 DPG)        4.761   6.095  **  P<0.01 
  Control (2 D) vs Control (28 D)       1.080   1.312  ns  P>0.05 
  Control (2 D) vs Gent (28 DPG)        5.116   6.550  **  P<0.01 
   Gent (2 DPG) vs Gent (14 DPG)        2.231   3.498  ns  P>0.05 
   Gent (2 DPG) vs Control (28 D)      -1.449   2.104  ns  P>0.05 
   Gent (2 DPG) vs Gent (28 DPG)        2.586   4.055  ns  P>0.05 
  Gent (14 DPG) vs Control (28 D)      -3.681   5.343  *   P<0.05 
  Gent (14 DPG) vs Gent (28 DPG)       0.3551  0.5568  ns  P>0.05 
 Control (28 D) vs Gent (28 DPG)        4.036   5.858  **  P<0.01 
 
                                Mean       95% Confidence Interval 
            Difference        Difference            From     To    
================================== ========== ======= ======= 
  Control (2 D) - Gent (2 DPG)          2.530     -0.9915   6.051 
  Control (2 D) - Gent (14 DPG)         4.761   1.240   8.282 
  Control (2 D) - Control (28 D)        1.080  -2.631   4.792 
  Control (2 D) - Gent (28 DPG)         5.116   1.595   8.638 
   Gent (2 DPG) - Gent (14 DPG)         2.231 -0.6440   5.106 
   Gent (2 DPG) - Control (28 D)       -1.449  -4.555   1.656 
   Gent (2 DPG) - Gent (28 DPG)         2.586 -0.2889   5.462 
  Gent (14 DPG) - Control (28 D)       -3.681  -6.786 -0.5751 
  Gent (14 DPG) - Gent (28 DPG)        0.3551  -2.520   3.230 
 Control (28 D) - Gent (28 DPG)         4.036  0.9302   7.141 
 
Assumption test: Are the standard deviations of the groups equal? 
 
ANOVA assumes that the data are sampled from populations with 
identical 
SDs. This assumption is tested using the method of Bartlett. 
 
Bartlett's test can only be performed when every column has 
at least five values. 
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Assumption test: Are the data sampled from Gaussian distributions? 
 
ANOVA assumes that the data are sampled from populations that 
follow  
Gaussian distributions. This assumption is tested using the method  
Kolmogorov and Smirnov: 
 
     Group        KS     P Value  Passed normality test? 
=============== ======   ======== ======================= 
  Control (2 D)   Too few values to test. 
   Gent (2 DPG)   Too few values to test. 
  Gent (14 DPG)   Too few values to test. 
 Control (28 D)   Too few values to test. 
  Gent (28 DPG)   Too few values to test. 
 
Intermediate calculations. ANOVA table 
 
        Source of             Degrees of   Sum of     Mean   
        variation              freedom    squares    square  
============================  ==========  ========  ======== 
Treatments (between columns)           4    60.050    15.013 
Residuals (within columns)            12    19.526     1.627 
----------------------------  ----------  -------- 
Total                                 16    79.576 
 
F = 9.226  =(MStreatment/MSresidual)  
 
 
                         Summary of Data                          
 
                Number                       Standard 
                  of              Standard   Error of 
     Group      Points     Mean   Deviation    Mean     Median  
=============== ======   ======== =========  ========  ======== 
  Control (2 D)     2       5.988   0.6571     0.4646     5.988 
   Gent (2 DPG)     4       3.458    1.185     0.5927     2.946 
  Gent (14 DPG)     4       1.227   0.4745     0.2373     1.170 
 Control (28 D)     3       4.907    2.578      1.489     5.755 
  Gent (28 DPG)     4      0.8714   0.5501     0.2750    0.7836 
 
                                  95% Confidence Interval 
     Group      Minimum  Maximum     From        To     
=============== ======== ======== ========== ========== 
  Control (2 D)    5.523    6.452    0.08409     11.891 
   Gent (2 DPG)    2.714    5.224      1.572      5.344 
  Gent (14 DPG)   0.7252    1.842     0.4715      1.982 
 Control (28 D)    2.012    6.955     -1.498     11.313 
  Gent (28 DPG)   0.3275    1.591  -0.003768      1.747 
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